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Capsaicin is the active ingredient derived from hot chilli peppers from the genus 
Capsicum. It is known to activate vanilloid receptor (VRl) on the primary sensory 
afferents, and has been shown to release vasoactive neuropeptides, such as substance 
P (SP) and calcitonin gene related peptide (CGRP). Anandamide (AEA) is the 
endogenous eicosanoid that activates caimabinoid (CB) receptors. Recently, AEA 
was found to activate VRl and releases neuropeptides from sensory nerves. The aim 
of the present study is to investigate the actions of capsaicin and AEA on blood flow 
and vascular permeability in the rat knee joint using Laser Doppler Perfusion 
Imaging (LDI) and measurements of Evans blue extravasation, respectively. 
Both capsaicin and AEA elicited vasodilatation in the rat knee joint, but the 
characteristics of their vasodilator actions were different. The vasodilator action of 
capsaicin was sustained, and it was not blocked by the classical VRl antagonist, 
capsazepine, but was inhibited by a newly developed VRl antagonist, iodo-
resiniferatoxin (I-RTX). On the other hand, AEA produced a transient vasodilator 
action that was susceptible to inhibition by both VRl antagonists. The AEA 
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transporter inhibitor also abrogated the vasodilator response to AEA. This effect is 
specific to AEA as the inhibitor did not affect the vasodilator response to capsaicin. 
Cannabinoid receptor antagonists had little influence on the AEA-induced 
vasodilator response. Taken together, these findings do not support a role for 
cannabinoid receptors in mediating the vasodilator action of AEA, and they implicate 
different populations of VRl mediate the vasodilator actions of capsaicin and AEA. 
The vasodilator action of capsaicin was found to be sensitive to inhibition by a 
CGRP antagonist, CGRPg-s?, but resistant to NKi receptor blockade by SR140333 
and RP67580. However, all these antagonists suppressed the AEA-induced 
vasodilator response. These results indicate the vasodilator action of capsaicin is 
mediated solely by CGRP, whereas the vasodilator action of AEA is mediated by 
both substance P and CGRP. In general, surgical and chemical denervation of the rat 
knees produced minor inhibition on the vasodilator responses to capsaicin and AEA, 
implicating that there could be non-neuronal release of neuropeptides. 
At non-toxic doses, capsaicin and AEA did not increase vascular permeability. 
Nevertheless, a toxic high dose of capsaicin did increased plasma extravasation. 
These findings suggest that at non-toxic doses, the two vanilloid agonists could 
release sufficient amount of neuropeptides to produce vasodilatation, but insufficient 
amount to increase vascular permeability. Furthermore, acute pretreatment of the 
knee joint with non-toxic doses of capsaicin had no effect on carrageenan-induced 
inflammation, but pretreatment with AEA did produced a small inhibition. It is 
suspected that the quantities of neuropeptides released by these two agonists were 
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Chapter 1 - Introduction 
Chapter 1 Introduction 
1.1, Arthritis and Inflammation 
The term arthritis literally means a localized inflammatory lesion within the knee 
joint that is mostly chronic. The exact trigger of inflammation in arthritic knees 
remains uncertain, but inflammatory arthritis such as rheumatoid arthritis (RA) is 
considered as an autoimmune disease (Etzioni，2003). Under normal circumstances, 
inflammation is a protective mechanism that attempts to maintain the integrity of our 
body by eradicating foreign material, altered 'self , or damaged body cells. A 
properly functioning immune system can differentiate self and non-self molecules. 
In an autoimmune condition, such specificity is lost and the immune system goes 
awry and attacks the body itself, resulting in inflammation and tissue damages 
(Gelman & Turka, 2003). 
Although inflammation is a complicated mechanism consists of numerous cascades, 
it can be divided into two main reactions: the innate response (or non-adaptive 
response) and the adaptive response. The adaptive response is a specific 
immunological reaction against the invading pathogens, which can be antibodies-
mediated and cell-mediated. Innate response is a rapid process that immediately 
provides host defense, and may also send a wake-up signal to the adaptive response. 
Many enzymatic cascades are involved in the process, including the complement 
cascade, coagulation, fibrinolysis and kinin forming systems. The details of these 
pathways will not be discussed here. 
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1.1.1. Tissue Reaction in Inflammation 
Haemodynamic change of the microcirculation is the initial response of tissue 
towards inflammation. The first reaction is usually vasodilatation, which is a result 
of relaxation of the vascular smooth muscle. This consequently leads to an increase 
in blood flow through the microcirculation, giving rise to cardinal signs of 
inflammation such as redness (rubor) and warmth (calor) of the tissue. 
Vasodilatation is often accompanied or followed by plasma extravasation (swelling). 
This occurs as the blood vessels become leaky, which therefore let through the 
plasma proteins (which are usually too large to penetrate through the vascular wall) 
into the extravasacular space (McGill et al., 1998). The role of these vascular 
changes is to facilitate the infiltration of inflammatory cells into the damaged tissue. 
1.1.1.1. Mechanism of Vasodilatation 
1.1.1.LI. Endothelial-derivedMediators 
The vascular endothelium is not a static barrier as it was originally thought. It is now 
considered to have a vital role in the regulation of vascular tone as it is a source of 
numerous vasoactive mediators. Some mediators such as acetylcholine (ACh), 
bradykinin (BK), histamine and thrombin activate their respective receptors on the 
endothelial cells to promote a rise in intracellular calcium (Ca*) concentration. This 
triggers a production of vasodilators which act on the nearby smooth muscle cells to 
elicit relaxation (Buckley & Brain, 1994). These vasodilators include prostaglandins 
(PG) such as PGE2 and PGI2, nitric oxide (NO), and an unidentified agent called 
endothelium-derived hypeipolarizing factor (EDHF) (Busse et al., 2002). The 
contractility of the vascular smooth muscle is controlled by the intracellular levels of 
2 
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C a * ions as the presence of this divalent ion is required in the formation of cross-
bridge formation (Mathews et al., 1999; Rang et al., 2003). Agents cause 
contractions by releasing intracellular C a * via inositol trisphosphate (IP3) formation, 
I I I I 
by depolarizing the membrane to allow the entry of Ca through voltage-gated Ca 
channels or by letting in the Ca"^ through receptor-operated C a ^ channels (Rang et 
On the other hand, vasodilators may achieve vascular smooth muscle relaxation via 
several ways to decrease the intracellular concentration of C a ^ and by a decrease in 
the sensitivity of the contractile system to Ca杆(Carvajal et al, 2000). Cyclic 
adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) 
are the major intracellular second messengers involved in mediating vasodilatation 
(Carvajal et al., 2000). Some vasodilators may do so by blocking Ca"^ entry directly 
by inhibiting the voltage-gated Ca"^ channels or indirectly by causing 
hyperpolarisation of the membrane e.g. via activation of potassium (K+) channels. 
1.1.1.1.2. cAMP and cGMP Mediated 
cAMP is involved in vasorelaxation elicited by vasodilators such as PGE2 and PGI2 
(Breyer et al., 2001). Elevated intracellular levels of cAMP reduce the sensitivity of 
calmodulin/contractile proteins to calcium (Ca*) and opens K+ channels leading to 
hyperpolarization. Hyperpolarization causes the closure of C a * channels, and 
relaxation takes place as a result of decreased C a * level within the smooth muscle 
cells (Wise & Jones, 2000). 
3 
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cGMP is involved in NO-induced vasodilatation. NO produced in endothelial cells 
diffuses into smooth muscle cells and binds to guanylyl cyclase (GC), leading to an 
increased production of cGMP (Carvajal et aL, 2000). A number of ways are 
thought to be involved in cGMP-mediated decrease in intracellular Ca杆 levels: 1) 
activating C a * activated K+ channels (Kca), 2) reducing the opening probability of 
voltage dependent C a * channels, 3) increases efflux of sodium (Na+)-dependent 
Ca"^ efflux via Ca力ATPase pump, 4) inhibition of IP3 production and its receptor. 
1.1.1.1.3. Endothelial Hyperpolarisation 
It was found that there is a part of endothelium-dependent relaxations that is resistant 
to the inhibitors of cyclooxygenases (COX) and NO synthase and do not involve 
intracellular cAMP and cGMP (Busse et aL, 2002). The phenomenon is attributed to 
a yet unidentified factor called EDHF. The EDHF-elicited vasorelaxation has a 
I j. 
characteristic of being blocked by an unusual combination of Ca dependent 
potassium channel blockers: apamin and charybdotoxin, but not by these toxins 
individually or by related inhibitors (Rang et aL, 2003). EDHF-evoked relaxation 
involves an increase in intracellular Ca++，and activation of endothelial potassium 
channels, resulting in hyperpolarization of the endothelial cells. Hyperpolarisation 
then propagates from the endothelial cells to the surrounding smooth cells, thereby 
causing vasodilatation. There are several mediators that are proposed to be 
responsible for EDHF relaxation: epoxyeicosanoids, gap junctions, K+ ions (Busse et 
aL, 2002). Anandamide was once suggested to be EDHF, but there is substantial 
evidence against such proposition. 
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1.1.1.2. Plasma Extravasation 
Endothelial cells form the interface between blood and tissue, and control the 
exchange of solutes, macromolecules and white blood cells. Under normal condition, 
the endothelium forms a closed barrier for marcromolecules in most tissues, 
preventing the loss of blood constituents and volume in order to maintain continuous 
flow of blood. During inflammation the injured tissue requires a delivery of plasma 
constituents such as plasma proteins, complement factors and immunoglobulins for 
tissue repair (van Hinsbergh & van Nieuw Amerongen, 2002). The vascular 
endothelium therefore responds to inflammatory mediators by becoming 
hyperpermeable and leaky. Oedema formation is a hallmark of inflammatory 
reaction and would usually subside after a while to allow tissue repair to take place. 
However, extensive and uncontrolled extravasation also contributes to pathological 
conditions such as migraine, rheumatoid arthritis and asthma (Brain, 1994). 
Morphologically, the hyperpermeability of the vascular endothelium is characterized 
by the formation of intercellular gaps (Lum & Malik, 1994; Silverstein, 1999; van 
Hinsbergh & van Nieuw Amerongen, 2002). It is thought that the integrity of the 
endothelium is maintained by the equilibrium of the contractile force generated at the 
endothelial cytoskeleton and intercellular adhesive force (tethering forces) 
(Bogatcheva et aL, 2002; Yuan, 2002). An increase in the contractile force at the cell 
margins and a decrease in the tethering force at the endothelial cell-cell junctions 
therefore results in intercellular gaps formation (van Hinsbergh & van Nieuw 
Amerongen, 2002; Wojciak-Stothard & Ridley, 2002). An array of inflammatory 
mediators such as histamine, bradykinin, cytokines and substance P (SP) are released 
during inflammation that elicit microvascular hyperpermeability. These mediators 
5 
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produce their effects by interacting with their respective receptors that are coupled to 
several intracellular components, which influence the balance between the contractile 
and tethering forces (Yuan, 2002). 
1.1.1.2.1. Actin-myosin Interaction 
Actin and myosin are the major contractile components in the cytoskeleton of 
endothelial cells. The interaction (i.e. cross-bridge movements) between actin and 
myosin contributes to the contractility of the endothelial cells and leads to increase 
plasma leakage (Lum & Malik，1994; van Hinsbergh & van Nieuw Amerongen, 
2002; Yuan, 2002). The process manifests itself by the formation of stress fibres, 
which are bundles of actin filaments associated with non-muscle myosin (Wojciak-
Stothard & Ridley, 2002). Such reaction is stimulated by phosphorylation of the 
regulatory part of myosin molecule, the myosin light chain (MLC), at the position 
Thr-18 and/or Ser-19 by MLC kinase (MLKC), thereby promoting actin-myosin 
interaction. The level of phosphorylation of MLC is determined by three factors: 
calcium/calmodulin signaling and increasing the Ca* sensitivity by inhibiting MLC 
phosphatase activity (Bogatcheva et al., 2002; Lum & Malik，1994; van Hinsbergh & 
van Nieuw Amerongen, 2002; Yuan, 2002). 
Some G-protein coupled receptors mediate endothelial permeability by increasing the 
intracellular Ca杆 concentration within the cell (Tiruppathi et al., 2002; van 
Hinsbergh & van Nieuw Amerongen, 2002). The increase in Ca* level is achieved 
via capacitative Ca杆 entry. This involves the generation of IP3, activating IP3 
receptors leading to depletion of intracellular store of Ca++, which will in turn 
6 
Chapter 1 - Introduction 
activate the store operated cation channels (SOC) to cause an influx of Ca^ into the 
endothelial cells. Free calcium ions inside the cell then promote the 
calcium/calmodulin dependent activation of MLCK, causing phosphorylation of 
MLC and eventually contraction of the endothelial cells. Histamine has been shown 
to mediated short-lasting (<10 minutes) plasma extravasation that involves an 
increase of C a * in the cell, as a calcium chelator 1，2-bis(2-aminophenoxy)-ethane-
N, N, N',N'-tetraacetic acid (BAPTA) can completely block its effect. Substance P 
also has been shown to produce an increase in intracellular levels of Ca"^ and IP3 
levels to produce plasma extravasation (Harrison & Geppetti，2001). Increase of 
Ca"^ is also partly (approx. 50%) responsible for thrombin-evoked plasma 
extravasation (van Hinsbergh & van Nieuw Amerongen, 2002). 
1.1.1.2.2. Retraction of Endothelial Cells 
Intercellular junctional complexes between endothelial cells mainly consist of tight 
junctions and adherens junctions (Lum & Malik, 1994; Yuan, 2002) with their 
components contributing to the tethering forces that hold the endothelium together. 
Vascular-endothelial (VE)-cadherin is the major component of adheren junctions. It 
has an extracellular domain that connects to adjacent endothelial cells and an 
intracellular domain that interacts with the actin cytoskeleton via P-catenin. It was 
suggested that the cytoskeletal connection of cadherin is more important in 
maintaining the junctional strength and paracellular permeability (Lum & Malik， 
1994; Yuan, 2002). The organization is regulated by the phosphorylation state of P-
catenin that determines the cell adhesive strength. Many inflammatory mediators 
affect the junction by stimulating P-catenin phosphorylation (Yuan, 2002). Increase 
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in Ca"^ concentration also can lead to disassembly of VE-cadherin junctions 
(Tiruppathi et al., 2002). 
1.2. Neurogenic Inflammation 
Neurogenic inflammation describes the ability of primary sensory afferents in 
mediating a local inflammatory reaction at their peripheral endings (Holzer，1998; 
Richardson & Vasko, 2002). The role of afferent nerves in inflammation has long 
been focused on its role in transmitting sensory signals since its discovery, but the 
realization of nerve having a role in mediating inflammation was noticed a century 
ago by Bayliss in 1901. He was the first to report an antidromic stimulation of a 
centrally cut sensory neurone at the dorsal root results in vasodilatation in the skin 
(Baluk, 1997; Brain, 1997; Schmelz & Petersen, 2001). The pivotal role of nerve in 
inflammation was further expanded by the work of Bruce (1913) which demonstrated 
the requirement of intact nerve supply for mustard oil-induced inflammation. The 
term ‘neurogenic inflammation' was introduced by Jansco to describe the 
inflammation elicited by electrical stimuli and chemical irritants that is mediated by 
nerves (Baluk, 1997). He pioneers the field by introducing the use of Evans Blue 
Method to quantify plasma leakage and the use of capsaicin, the pungent ingredient 
of red chilli peppers, as a tool to stimulate sensory neurones (Baluk, 1997). The use 
of capsaicin is the main interest of the current project and will be discussed in details 
in later sections. 
It is now clear that sensory nerves have dual actions: an afferent role which transmits 
action potential orthodromically to the central nervous system (CNS)，and an efferent 
8 
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role that releases transmitter at their nerve endings via antidromic impulses to elicit 
inflammatory responses (see figure 1.1.) (Baluk, 1997). The cardinal signs of 
neurogenic inflammation have been described as 'triple response' from the 
observation on the skin, which comprises local redness, swelling and flare (Baluk, 
1997; Brain, 1997). All of these symptoms are the result of haemodynamic change 
of blood vessels, i.e. vasodilatation and plasma extravasation as mentioned earlier. 
In fact, these two phenomena are generally regarded as the major components of 
neurogenic inflammation. The physiological role of these events have been 
highlighted by Lewis as the endogenous defense in the early phase of tissue damage, 
which he referred as 'Nocifensive System' (Westerman et al, 1987). 
< \ Orthrodromic Dorsal Root 
义 impulses Ganglion (DRG) 
、： y ' ^ ^ # ^ ^ ,,,,臂 
Antidromic I I _ . . • 1 y % Dorsal liorn impulses • 
I 
i . , Neuropeptide 
) release 
Figure 1.1. Stimulation of nerve induces a transmission of orthrodromic impulses that propagates 
towards the central nervous system, and antidromic impulses that cause a release of neuropeptides 
from the peripheral endings of the sensory nerves. 
1.2.1. Axon Reflex and Local Efferent Action of Primary Afferents 
With the use of local anaesthetics, Bruce (1913) found that neurogenic inflammation 
requires axonal conduction. The term ‘axon reflex flare' was then introduced by 
Lewis (1927) to explain the vasodilatation that spreads around the original site of 
9 
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stimulation (Baluk, 1997; Szolcsanyi, 1996). Making use of the selective action of 
capsaicin on sensory nerves, the flare reaction was found to be mediated by afferent 
C-fibres (Bharali & Lisney，1992). C-fibres are not a homogenous class of fibres, 
and can be subdivided into two major groups, the mechano-responsive fibres and 
mechano-insensitive fibres. Both groups contain heat sensitive and heat insensitive 
units (Schmidt et aL, 1995). Recently it was found that in pig and human skin the 
mechano-insensitive fibres held responsible for persistent flare. These fibres are also 
excited by capsaicin and other pungent ingredients (Schmelz et al., 2000). It is 
thought that flare is a signaling device that plays a physiological role to warn the 
surrounding tissue of trauma (Brain, 1997). 
1.2.2. Mediators of Neurogenic Inflammation 
Neurogenic inflammation involves a release of mediators from the nerve terminals, 
and the identity of these mediators has been debated over the years. A number of 
mediators have been identified in primary afferent neurones, including SP, calcitonin 
gene-related peptide (CGRP), neurokinin A (NKA), neurokinin B (NKB), 
somatostatin, galanin, endomorphins, PGE2 and glutamate etc (Richardson & Vasko， 
2002; Schmelz & Petersen, 2001). 
Several lines of evidence indicate that SP and CGRP are the main initiators of 
neurogenic inflammation (Brain, 1997; Richardson & Vasko，2002). Both 
neuropeptides are also found to be co-localized in large amount in the trigeminal 
sensory nerves and in dorsal root ganglia of the spinal cord (Buckley & Brain, 1994; 
Harrison & Geppetti, 2001; Hokfelt et al., 1975; Wallengren, 1997). These peptides 
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are also found in sensory nerve fibres in the periphery associated with vascular 
smooth muscle (Brain et aL, 1986b; Brain & Williams, 1988; Buckley & Brain, 1994; 
Hokfelt et aL, 1975). In addition, releases of CGRP and SP in response to 
antidromic stimulation of primary afferents have been demonstrated in various 
tissues, including skin (Kress et aL, 1999; Sauerstein et aL, 2000), trachea (Helyes et 
aL, 1997) and knee joints (Oku et aL, 1987; Takeba et aL, 1999; Yaksh, 1988) of 
several species. These mediators are also released locally from the sensory afferents 
in response to chemical stimuli such as capsaicin and mustard oil. Last but not least, 
exogenous administration of these neuropeptides has been shown to produce similar 
effects as neurogenic inflammation induced by electrical or chemical stimuli (Baluk, 
1997). Thus, researchers have been putting an intensive effort in elucidating the role 
of SP and CGRP in neurogenic inflammation, especially in terms of their vascular 
effects. 
1.2.3. Microvascular Effect of Substance P 
Together with NKA and NKB, SP constitute the family of tachykinins peptides. SP 
has been long suspected to be a mediator from nerves since its discovery in the 1930s， 
and this was eventually confirmed four decades later as its structure was finally 
identified and when antibodies to it became available (Baluk, 1997; Wallengren, 
1997). SP is an 11 amino acids peptide that elicits its effects via tachykinin (NK) 
receptors. There are three types of NK receptors identified (NKi, NK2 and NK3), and 
SP is the preferred agonist for NKi receptors. SP produces vasoactive responses 
such as vasodilatation, plasma extravasation and leukocyte adhesion (Harrison & 
Geppetti, 2001). It has also been shown to produce vasodilatation in both arteriole 
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and veins via stimulation of NKi receptors. The effect is endothelium-dependent and 
involves a combination of cyclooxygenase and NO activities (Katz et al., 2003; 
Mechiche et al., 2003). Such vasodilatatory effect, however, does not contribute to 
the maintenance of peripheral blood flow (Newby et al., 1999). 
Despite its vasodilatatory actions, in the microvasculature, SP is mainly active in 
inducing plasma extravasation (Brain, 1997; Sauerstein et al., 2000). SP is an 
activator of mast cells as it possesses a basic N-terminus on its amino acid structure 
which interacts with the mast cell membrane (Brain & Williams，1988; Holzer, 1998). 
SP has been reported to induce a dose-dependent release of histamine and flare 
response on human skin (Devillier et al., 1986), while neurogenic vasodilatation and 
plasma extravasation have been shown to be reduced by antihistamines (Schmelz & 
Petersen, 2001). Immunohistochemical methods have also shown that mast cells and 
SP-containing nerves positioned in close proximity in different tissues (Schmelz & 
Petersen, 2001). However, SP caused mast cell degranulation only in skin, and this 
occurs only when SP concentration reaches micromolar level (Holzer, 1998, Schmelz 
et al., 2001). Mast cell degranulation therefore only contributes to neurogenic 
inflammation only when SP level is high. 
SP-induced plasma extravasation is indeed a direct action via NKi receptor on the 
venular endothelium. NKi receptors have been localized and quantified in venular 
endothelial cells at sites of inflammation. The use of NKi receptor antagonist such 
as SR140333, L-733,060 and CP96,345 has proved this receptor has a direct role in 
mediating plasma leakage (Grady et al., 2000; Herbert & Bemat, 1996; Seabrook et 
al., 1996). 
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1.2.4. Microvascular Effect of Calcitonin Gene-Related Peptide 
CGRP is a 37 amino acid peptide that was first discovered by Rosenfeld et al in 1982 
(Brain & Williams，1988). It is a product of alternative processing of mRNA from 
the calcitonin gene found to be concentrated in the sensory nerves that distribute in 
the cardiovascular system. Its potent vasodilatatory effect was first identified on 
rabbit skin (Brain et al., 1986a) and has been extensively studied in various tissues 
including the skin (Brain et al., 1986b; Brain & Williams，1988; Holzer, 1998)， 
bronchial blood vessels (Barnes, 2001, 1996; Springer et al., 2003) and knee joint 
(Ferrell et al； 1997b). 
Its vasodilatatory action is found to be tardy but long lasting. On the skin, erythema 
induced by CGRP has been shown to persist for several hours. The long-lasting 
feature of CGRP-induced vasodilatation is probably due to its stability in the 
interstitial tissue fluid (Weidner et al., 2000). The exact pathway of CGRP 
metabolism has not been elucidated. One of the possible mechanism is via the 
cleavage by mast cell derived tryptase and chymase (Brain & Cambridge, 1996). 
Another possible enzyme responsible for the break down of CGRP is neutral 
endopeptidase (NEP), inhibition of which has been shown to increase the vascular 
effect of CGRP in the airways (Springer et al., 2003). 
To date, the exact identity of the receptor responsible for the CGRP effects is not 
certain. There are two proposed types of CGRP receptors (CGRPi and CGRP2 
receptors), classified solely by the inhibitory potency of its antagonist CGRPs-s? 
which is the C terminal fragment of CGRP (Hall & Brain, 1996). It is generally 
considered that the vascular effects of CGRP are mediated via CGRPi receptors. 
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These receptors are found to be present on both endothelium and vascular smooth 
muscle cells (de Hoon et al, 2003). 
Although its vasodilatatory effect has been well documented, the exact mechanism 
that gives rise to CGRP-evoke vasodilatation has been a matter of debate. It is 
thought that the mode of action of CGRP can be endothelium-dependent or 
endothelium-independent depending on size, species and location of the blood 
vessels (Wisskirchen et al., 1999). It was proposed that the vasodilatatory effect of 
CGRP is a direct action on vascular smooth muscle, especially in the 
micro vasculature, as removal of endothelium did not seem to affect its action (Barnes, 
1996; Hall & Brain，1996; Springer et al., 2003). There is evidence that cAMP is 
responsible for the endothelium-independent vasodilatation of CGRP. CGRP 
relaxation has been shown to be accompanied by an elevation of intracellular cAMP 
in thoracic aorta. There is also a strong correlation between CGRP relaxation and 
increases in intracellular cAMP (Wimalawansa, 1996). 
In the thoracic aorta, the vasorelaxant responses to CGRP and cAMP elevation were 
found to be endothelium-dependent and was blocked by haemoglobin and methylene 
blue, suggesting that the effect involves NO and accumulation of intracellular cGMP 
(Wang et al, 1991; Gray & Marshall, 1992; Wimalawansa, 1996). In blood vessels, 
NO is mainly derived from (e)NOS of the endothelial cells. Recently it has been 
shown that the dependency of CGRP effect on endothelium was lost on aorta rings 
derived from eNOS-knockout mice (Chan & Fiscus, 2003). It has also been 
suggested that NO acts by enhancing the direct cAMP and vasodilatatory effect of 
CGRP via elevation ofcGMP levels (Lu & Fiscus，1999). 
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CGRP has also been shown to cause a direct hypeipolarizing effect in vascular 
smooth muscle (Wimalawansa, 1996). A role of muscarinic receptor-gated K+ 
channels on the effect of CGRP in the atrial cells has also been reported (Hall & 
Brain, 1996). In rabbit and rat mesenteric arteries, the CGRP relaxation involves 
ATP-gated potassium channels as the effect was inhibited by glibenclamide 
(Wimalawansa, 1996). However, whether CGRP receptors are coupled to the ATP-
sensitive K+ channels remains to be established. It was suggested that the 
contribution of ATP-sensitive K+ channels may depend on the nature of underlying 
vasoconstriction (Reslerova & Loutzenhiser, 1998). 
CGRP itself does not induce plasma extravasation. (Barnes, 1996; Holzer, 1998; 
Weidner et al., 2000). By virtue of its vasodilator effect, CGRP, however, has been 
shown to enhance plasma leakage induced by a wide variety of mediators, electrical 
stimulation and capsaicin (Brain, 1996; Hall & Brain, 1996). Co-administration of 
exogenous CGRP and SP has also proved the potentiation effect of CGRP on SP-
evoked plasma extravasation in the rat skin (Brain & Williams，1988). The 
potentiation effect is thought to be a result of increased hydrostatic pressure caused 
by vasodilatation, thereby increasing the driving force that facilitates plasma 
extravasation (Brain & Williams, 1988; Weidner et al., 2000). Nonetheless, its 
action is not essential in initiating oedema. 
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1.3. Neurogenic Inflammation in the Joint 
1.3.1 Neuropeptides in Arthritic Knee 
The role of neuropeptides in neurogenic inflammation suggested their possible 
contribution in the etiology of arthritis. There were attempts to demonstrate the 
presence of neuropeptides in the inflammatory joint fluid. Indeed neuropeptides 
have been detected in the aspiration derived from RA patients, but an absence of SP 
has also been reported. It is important to note that neuropeptides may be degraded 
by enzymes that are present in the specimens and that some of the neuropeptides 
such as SP could bind to serum albumin. This is further complicated by the detection 
limit of assay that is used in the measurements, the lack of agreement in the values 
and control samples from normal subject (Mapp, 1995; Scott et al., 1994). Non-
steroidal anti-inflammatory drugs, a class of drugs that are commonly used in 
treating RA, has been shown to decrease both the plasma and synovial level of SP, 
indicating that SP plays a role in the disease activity of RA (Sacerdote et al, 1995). 
In addition, CGRP is present at a low concentration of 4-100 x lO'^ ^M in healthy 
individuals. The level is elevated in the synovial fluids of RA patients (Takeba et al., 
1999). 
1.3.2. Effects of Neuropeptides on Normal Knee 
Several lines of experimental evidence have indicated the role of SP in inflammation 
in the knee joint. Electrically evoked plasma extravasation in the knee joint has been 
shown to be mediated by SP as it can be abolished by SP antagonist (Ferrell & 
Russell, 1986). Direct intra-articular injection of SP has been shown to evoke a 
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marked inflammatory response (Lam & Ferrell, 1989). SP also takes part in the 
model of acute inflammation elicited by carrageenan, as it could be abolished by 
prior administration of SP antagonist (Lam & Ferrell, 1989). SP-mediated plasma 
extravasation is transient, and usually lasts no more than 30 minutes (Scott et aL, 
1994). In addition, SP has a direct action on the articular blood vessels to produce 
potent vasodilatation, which is also transient (Lam & Wong，1996). The 
extravasation effect of SP in the knee joint has been shown to be mediated by NKi 
receptors (Lam & Ferrell，1991). The vasodilatatory effect of SP, unlike its plasma 
extravasation effect, is thought to be mediated by multiple receptors, i.e. NKi and 
NK2 receptors (Scott et aL，1994). 
In rat knee joint, CGRP has been demonstrated to be potent in producing a long 
lasting vasodilatation. The effect lasts longer than that elicited by SP (Lam & Ferrell， 
1993). One interesting feature of CGRP is that the duration of its action is reduced 
when co-administered with SP, which is suggested to be due to the substance P-
induced release of proteases from mast cells (Lam & Ferrell, 1993; Lam & Wong， 
1996). However, on the other hand, the vasodilatatory effect of CGRP can prolong 
the plasma extravasation produced by SP (Brain & Williams, 1988). 
1.3.3. Effects of Neuropeptides on Inflamed Knee 
Inflammation can considerably alter the effects of neuropeptides in the knee joints. 
An increase in neuropeptide synthesis in the dorsal root ganglion cell bodies in 
response to inflammation has been reported. Freund's adjuvant-induced hind paw 
inflammation has been shown to increase SP concentration in the dorsal root ganglia 
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by 30-40% (Mapp, 1995). In polyarthritic rats, there was also a spontaneous release 
of immunoreactive SP from the spinal dorsal horn (Oku et al., 1987). In the dorsal 
root ganglia, increased mRNA levels of preprotachykinin A, the precursor of SP, 
following monoarthritis also indicates an increase in biosynthesis of SP (Mapp, 
1995). In the periphery, experimental monoarthritis increases SP- and NKA-
imuimoreactivity in knee joint to levels that were significantly higher than those in 
control knees (Bileviciute et al, 1993). Content of SP in the sciatic nerve 
innervating the inflamed paw was also increased by 60-75% (Mapp, 1995). 
Inflammation has also been shown to increase the synthesis of CGRP in joint 
afferents. However, in the same study, the synthesis of SP was unaffected 
(Heppelmaim et al, 1997). 
In inflamed joint, the effect of SP is exacerbated. In acute joint inflammation 
induced by intra-articular 2% carrageenan, plasma extravasation and vasodilatation 
to SP were enhanced compared to normal joint, and become more long lasting 
(persist up to 2 hours) (Scott et al., 1994). The mechanism of how inflammation 
alters the duration of the effect of SP is not known. Two possible ways have been 
postulated: up-regulation of SP receptors or altered second messenger pathways 
(Ferrell & Lam, 1996). Although not being demonstrated in the knee joint, there is 
evidence of up-regulation of SP-binding sites in primary afferent neurones (von 
Banchet et al., 2000). 
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1.3.4. Activation of Efferent Function of the Nerves 
There are several substances and conditions that are known to activate the sensory 
neurones to release neuropeptides (see table 5.4). Some of the agents are known to 
act directly on the sensory neurones via a receptor-mediated mechanism. It is 
thought these agents should have their receptors expressed on sensory neurones. 
Their actions should involve an increase of intracellular Ca* level and 
depolarization. Increase in intracellular Ca"^ level is usually dependent on the influx 
of extracellular calcium. Intracellular calcium store may contribute, but its relative 
importance is not well understood (Richardson & Vasko，2002). Bradykinin triggers 
a release of neuropeptides via activation of bradykinin-2 (B2) receptors of the 
sensory nerves, which activates the phospholipase C (PLC) pathway, causing a 
release of calcium from intracellular store. B2 activation also results in stimulation 
of protein kinase C (PKC), which can increase neuropeptide release and excites the 
sensory neurones. 
Another receptor that evokes the efferent function of sensory nerves is protease-
activated receptor-2 (PAR2) (Brain, 2000). PAR2 is a G-protein couple receptor that 
is activated by trypsin, thrombin and other related proteases. These proteases cleave 
PAR2 to unmask a tethered N-terminal terminus which is a ligand that binds and 
activates the cleaved receptor (Brain, 2000; Richardson & Vasko，2002). PAR2 has 
been shown to release SP and CGRP from the dorsal spinal cord and peripheral 
tissues. 
Capsaicin is known to activate vanilloid receptor-1 (VRl), its action on efferent 
function of the nerves will be discussed in the next section. 
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Types [Substances 
Principles derived Capsaicin, Resiniferatoxin, Mustard oil, 
from plant Gurcumin，£ugenol etc.  
Mediators Anandamide, Arachidonic Acid Metabolites, 
Thrombin,已radykinin，Interleukin 1， 
Histamine, 5-Hydroxytryptamine, etc.  
Chemicals Xylene, Formalin etc. 
Others Protons, Heat, Mechanical Stimuli etc 
Table 1.4. Types of substances that evoke the release of sensory neuropeptides. 
1.4. Vanilloid Receptor 
1.4.1. The Use of Capsaicin as an Experimental Tool 
Capsaicin is the principle pungent component of the genus Capsicum. One may 
wonder how a spicy flavour giving ingredient eaten on a daily basis can become one 
of the most valuable tools in laboratories all over the world. In fact, other uses of 
capsaicin apart from being used in the kitchen as a food flavouring are not a novel 
one. For centuries, capsaicin has been reported to be used as an analgesic among 
Native Americans and European folks for relieving toothache (Szallasi & Blumberg, 
1999). Capsaicin was first isolated by Thresh in the m i d - c e n t u r y . The first 
biological activity of capsaicin was obtained by Hogyes. He demonstrated the 
hypothermal, algesic effect of alcoholic extract of paprika (Capsicum annuum) when 
administered systemically (Szallasi, 1994), which he proposed to be a selective 
action on sensory neurones (Szallasi & Blumberg, 1999). The use of capsaicin did 
not gain much attendance until Nicholas Jancso described that repetitive 
administration of capsaicin produced initially an excitatory effect, followed by a 
refractory period of the nerve to respond to painful stimuli (Caterina & Julius, 2001). 
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The resistance to subsequent stimuli that the nerve develops is referred to as 
desensitization. It is the ability of capsaicin to act specifically on sensory neurones 
and to cause desensitization that made it one of the most widely used experimental 
tools in research. 
1.4.2. Identification of Vanilloid Receptor 
The selectivity of capsaicin on a subset of primary afferent neurones has led to the 
term 'capsaicin-sensitive neurones', but this was not able to explain why certain 
vagal neurones can also be capsaicin-sensitive (Szallasi，1994). It was thought that 
the action of capsaicin should be defined at a receptor level. However, radiolabeled 
dihydrocapsaicin or capsaicin-like probes did not allow the identification of a 
specific recognition site for capsaicin, nor did synthesized capsaicin analogues yield 
any success (Szallasi 1994). The isolation of an irritant diterpene, resiniferatoxin 
(RTX), from Euphorbia Resinifera and the realization that RTX is structurally 
similar to capsaicin has subsequently provided the first proof of the actual existence 
of the long-sought capsaicin receptor (Szallasi，1994; Caterina & Julius, 2001; 
Szallasi, 2002). [H^JRTX binding assay has displayed specific, saturable binding to 
sensory neurones, and this binding can be fully displaced by capsaicin and RTX. As 
the vanilloid moiety is the common feature of capsaicin and resiniferatoxin, the 
receptor is designated as vanilloid receptor (Holzer, 1991). Development of the first 
specific capsaicin antagonist, capsazepine, has further confirmed the existence of 
vanilloid receptor (Szallasi, 1994). Finally, the direct evidence of the existence of 
vanilloid receptors came from the cloning of the receptor by Caterina et al in 1997. 
They transfected HEK293 cells with pools of a rat cDNA library to identify the cells 
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that respond to capsaicin using calcium imaging, with the assumption that activation 
of vanilloid receptors would lead to an increase in intracellular Ca种 levels. The 
receptor was named VR-1. The identified pool was divided into smaller pool until a 
single cDNA encoding the capsaicin-gated channel was found (Caterina & Julius, 
2001; Szallasi & Blumberg, 1999). Another major advance in the field of vanilloids 
is the development of VR-1 deficient mice that have impaired pain sensation 
(Caterina et al., 2000). 
1.4.3. Molecular Biology of Vanilloid Receptor 
The nucleotide sequence of VRl predicts a protein of 838 amino acids with a 
molecular weight of 95kDa (McCleskey & Gold, 1999). The topology of VRl is 
known to consist of six complete transmembrane spanning segments (SI to S6) and 
an extracellular p-loop between S5 and S6 that is thought to line the pore of the 
channel (See Fig 1.2.). There are three ankyrin repeats domains located at the N-
terminus, while the C terminus has no recognizable motifs (Szallasi, 2002; Szallasi & 
Blumberg, 1999). 
The amino acid sequence shown that VRl is a distant relative of a superfamily of 
store-operated calcium channels, called transient receptor potential channels (TRP 
channels). Another significant feature shared by some members of TRP channels 
and VRl is that they both contain multiple ankyrin repeats within their N-terminal. 
Base on the amino acid sequence, VRl, vanilloid receptor-like receptor (VRL-1), 
VRL-2, and Ca++ transport gatekeepers now define their own subfamily of TRP 
channels that is referred as TRPV channels. (Harteneck et al., 2000). 
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Fig 1.2. Topology of VRl. 
1.4.4. Electrophysiolgocial Properties of Vanilloid Receptors 
Vanilloid receptor is a non-selective cation channel with a preference for divalent 
cations, especially Ca++ (Szallasi & Blumberg, 1999). The permeability sequence of 
the channel is C a + + � M g + + � K + � N a + (Holzer, 1991; Szallasi & Blumberg，1999). 
Under normal physiological condition, the channel opens to let through Ca++ and Na+ 
ions upon activation, while K+ ions leave the cell. The influx of Ca++ may lead to an 
accumulation of intracellular Ca++ that has been estimated to increase the 
concentration up to 12|liM . Intracellular level of Ca++ usually would not exceed 0.6-
0.9|iM, thus extra Ca++ is sequested by intracellular organelles, such as mitochondria 
(Holzer, 1991). Accumulation of Ca++ seems to play a role in mediating 
desensitization, which will be discussed in Section 1.5.3.2.. 
1.5. Activation of Vanilloid Receptors - A Detector of Physical Stimuli 
Vanilloid receptor is originally regarded as the molecular target for vanilloid 
compounds, i.e. capsaicin and RTX. In fact, skin nerves that respond to capsaicin 
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also respond to heat, and there is an unequivocal overlap between the populations of 
sensory neurones that exhibit heat-evoked current and capsaicin-evoked current 
(McCleskey & Gold, 1999). It is now clear that the receptor is gated by heat that 
exceeds 43°C，which is also the temperature threshold that evokes pain in humans 
and mammals. Capsaicin and other activators of VRl act by lowering the 
temperature threshold (Caterina & Julius, 2001; Szallasi，2002). Direct evidence of 
activation of vanilloid receptors by heat is provided by the currents detected on VRl-
transfected HEK293 cells in respond to heat as well as capsaicin, and the currents 
have been shown to be blocked by ruthenium red and capsazepine (Caterina & Julius, 
2001). Thus VRl is thought to be a molecular transducer of noxious thermal stimuli. 
Protons are also capable of modulating the activity of VRl and were once proposed 
to be the endogenous ligand of the receptor. Moderately acidic condition augments 
capsaicin-induced response on VRl-epxressing mammalian cells and xenopus 
oocytes as well as heat-activated currents. Reducing the extracellular pH has been 
shown to evoke a current at temperature as low as 35°C, condition under which the 
channel is normally closed. Protons are thought to potentiate the effects of VRi by 
increasing the channel opening probability. Protons do not seem to interact with the 
vanilloid binding site. Instead mutagenesis studies have indicated an extracellular 
binding site of proton that probably lies between the S5 and p-loop segment, thereby 
conferring an allosteric modulation of the channel activity (Caterina & Julius, 2001). 
Together with its sensitivity to thermal sensation, VRl is thought as a polymodal 
detector of noxious physical as well as chemical stimuli. 
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1.5.1. Exogenous Activators of Vanilloid Receptors 
As mentioned in previous sections, capsaicin and RTX are the two most well-known 
plant derivatives that activate VRl. The original idea of capsaicin and RTX 
recognize the same receptors was based on their structural and functional similarities 
(Szallasi, 1994). The structure of capsaicin can be divided into three regions, the 
vanillyl moiety, the amide bond and the hydrophobic side-chain (see figure 1.3.) 
(Holzer, 1991; Szallasi, 1994，1996). Structure-activity comparison reveals that 
RTX shares homovanillic acid constituent, which is thought to be essential for its 
inflammatory activity (Szallasi, 1994). However, the hydrophobic side chain also 
contributes to the activity of the vanilloids as the diteipene moiety in RTX plays a 
significant role in its activation (Szallasi, 1996). The binding site of vanilloids is 
proposed to be located in the intracellular domain of the receptor, probably lies on 
either the N-terminus or S6 (Jung et al., 1999; Szallasi, 2002). It is recently 
suggested that there might be more than one vanilloid binding site on a single 
receptor (Szallasi, 2002). 
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Figure 1.3. Chemical structure of capsaicin, anandamide and resiniferatoxin. 
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1.5.2. Endogenous Activators of Vanilloid Receptors 
The presence of VRl on sensory neurones strongly suggests the existence of 
endogenous activator. The identity of the endogenous VRl activator has not been 
confirmed, but a potential candidate is discussed below. The fact that VRl is 
broadly expressed also made the isolation of endogenous ligand more difficult. 
There is a postulation that VRl expressed in different tissue may have distinct 
endogenous activators. 
1.5.2.1. Anandamide as an Endovanilloid 
One of the most attractive candidates for endogenous VR agonist is arachidonyl-
ethanolamide, which is commonly known as anandamide (AEA) (Caterina & Julius， 
2001; Szallasi & Blumberg, 1999; Szallasi & Di Marzo, 2000). AEA was first 
identified in porcine brain extract and was shown to have cannabinoid activity. This 
endogenous cannabinoid has been detected in skin, testis, spleen, plasma as well as 
brains of various mammals including rat and man. It is also found in cell types 
including neurones, macrophages and endothelial cells. AEA is synthesized ‘on 
demand' from hydrolysis of N-arachidonoyl-phosphatidylethanolamine catalyzed by 
phospholipase D (PLD)-like enzyme (Di Marzo et al,, 2001; Mechoulam et al., 1998; 
Piomelli et al., 2000). AEA synthesis has been shown to be induced in neurones, 
macrophages and basophils by agents that cause Ca杆 influx (Di Marzo et al, 2001). 
As with other classical neurotransmitters, AEA was found to be inactivated through a 
sequential re-uptake mechanism in a Na+-independent manner. The existence of a 
selective and saturable carrier has been confirmed, and is shown to be stimulated by 
nitric oxide (Di Marzo et al., 2001). The release of AEA does not involve vesicle 
formation, but a facilitated diffusion through the cell membrane after its formation, 
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which is thought to involve the same transporter that works in both directions (Di 
Marzo et al., 2001). AEA re-uptake is blocked by a transporter inhibitor, AM404 
(Beltramo et al, 1997). 
The concept of AEA being the endovanilloid has gained support from several 
evidence. AEA produces similar kinetic and electrophysiological properties in 
human HEK293 cells stably expressing human VRl to capsaicin (Ralevic et al., 
2002). AEA also behaves as a full agonist on native and recombinant rat VRl 
receptors (Di Marzo et al., 2002; Szallasi & Di Marzo, 2000). These responses have 
been shown to be inhibited by capsazepine but not by cannabinoid antagonists 
(Caterina et al, 1997; Szallasi & Di Marzo, 2000). Binding studies also have shown 
the ability of AEA to displace RTX from VRl expressing cells, indicating that AEA 
interacting with the same intracellular binding site as capsaicin (Ralevic et al,, 2002). 
There is increasing evidence showing VRl mediates actions of AEA both in vitro 
and ex vivo. It has been shown to activate VRl, which in turn leads to a release of 
CGRP. A release of SP from dorsal root ganglion (DRG) neurones in response to 
AEA-induced depolarization and calcium influx has also been reported (Ralevic et 
al., 2002). Vascular relaxation to AEA can be blocked by capsazepine and CGRP 
antagonists, and also after depleting sensory nerves of CGRP (Zygmunt et al., 1999). 
However, it appears that the vasodilatatory action of AEA is more complex than 
expected. This will be discussed further in Section 8.1. 
Due to its low affinity, there is argument against AEA as the endogenous ligand for 
vanilloid receptors. The potency of AEA at recombinant human VRl was reported 
to be \\iM, which is 5-10 folds lower than its potency for CBi (Ralevic et al., 2002). 
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In in vitro situation, relaxation of mesenteric and hepatic arteries of the rat, and 
basilar arteries of guinea pig requires concentrations of AEA up to submicromolar 
concentration (Zygmunt et al., 1999). It was suggested that several factors have to 
be taken into account while interpreting these data. Degradation of AEA may 
underestimate its activity at VRl. Indeed, inhibiting fatty acid amide hydrolase that 
hydrolyse AEA has been shown to enhance the potency of AEA by at least five folds 
(Di Marzo et al., 2001). Furthermore, AEA may be required to work with other 
factors in a synergistic manner to produce an effect. PKC-mediated phosphorylation 
of VRl has been shown to enhance the effect of anandamide (Di Marzo et al, 2001). 
Cell studies also show that noxious heat increased AEA response by 2.5 folds 
(Ralevic et al., 2002). Stimulation of cAMP-dependent kinase also enhances the 
activation of AEA on VRl (Di Marzo et al., 2001). 
1.5.2.2. Other Possible Endovanilloid 
Protons were once proposed to be the endogenous ligand, however, this remains 
uncertain as protons did not activate VRl on cultured dorsal root neurone, nor do 
they compete for binding with RTX (Szallasi, 1996). Lipoxygenase (LO) products 
are the other candidates for the endogenous activator of VRl. LO is produced during 
inflaimnation and is implicated in mediating inflammatory nociception. 
Electrophysiological studies have evident its ability to activate VRl, as it evokes 
currents with properties nearly identical to that of capsaicin on sensory nerve 
membrane patches (Hwang et al., 2000). The current is mediated via VRl as it can 
be blocked by capsazepine. Furthermore, one of the LO products, 12- or 15-(S)-
hydroperoxyeciosa-5Z, 8Z, IIZ and 13E-tetraenoic acid (12-(S)-HPETE) has a three 
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dimensional structure that exactly superimpose to that of capsaicin (Hwang et al.， 
2000). 
1.5.3. Biological Effects of Capsaicin 
1.5.3.1 Efferent Function: Neuropeptide Release 
Capsaicin is known to evoke an efferent function of sensory neurones via a release of 
neuropeptides from the nerve terminals. A variety of neuropeptides are released by 
capsaicin, including SP, NKA, CGRP and somtatostatin (Bevan & Docherty，1996; 
Lao et al, 2003; Nemeth et al., 2003a). Direct evidence of capsaicin releasing 
immunoreactive CGRP has been observed in rat buccal mucosa, which can be 
inhibited by capsazepine (Flores et al,, 2001). The process of capsaicin-evoked 
neuropeptide release is rather complicated in that it sometimes involves generation of 
action potential (i.e. axon reflex), but not always. Capsaicin may release 
neuropeptides locally, an effect that is independent of action potential generation and 
propagation. Local release of neuropeptides to capsaicin has been shown to be 
resistant to voltage-dependent Na+ channels, tetradotoxin (TTX), and voltage-
dependent N-type Ca"^ channels blocker (Bevan & Docherty, 1996). Likewise, it 
has been shown recently that release of neuropeptides caused by a near threshold 
concentration of capsaicin was not blocked by TTX, lidocaine, N-type Ca* channel 
inhibitor co-conotoxin GVIA, and co-agatoxin in isolated rat trachea (Nemeth et al., 
2003a). Capsaicin-induced influx of Ca^ via VRl has been shown to be sufficient 
to evoke a release of neuropeptides, without the voltage-dependent Ca* channels 
being involved (Holzer, 1991). The TTX- and co-conotoxin GVIA-resistant release 
of neuropeptides is also dependent on the presence of extracellular Ca"^, as shown by 
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the inhibition caused by Cd付(Nemeth et aL, 2003a). A rise in intracellular level of 
C a * in turn leads to a fusion of vesicles with the plasma membrane, resulting in 
exocytosis (Szallasi & Blumberg，1999). 
Capsaicin can also evoke release of neuropeptides via a TTX- and CTX-sensitive 
mechanism (Szallasi & Blumberg, 1999)，indicating its dependence on nerve activity 
and voltage-sensitive Ca++ channels (Bevan & Docherty, 1996). This is in accord 
with the classic axon reflex theory. Action potential propagation may travel in an 
antidromic direction to cause a retrograde activation, and may activate a collateral 
terminal of the same nerve (Caterina & Julius, 2001). It was suggested that whether 
capsaicin-evoked release involves action potential propagation is largely dose 
dependent (Bevan & Docherty, 1996; Nemeth et al., 2003a). 
The involvement of neuropeptides on biological action of capsaicin has been 
illustrated by the blocking effect of CGRPg-s? on capsaicin-induced vasodilatation on 
rat abdominal skin (Escott & Brain, 1993). Capsaicin elicits vasodilatation and 
plasma extravasation in mouse ear has also been shown to involve both NKi and 
CGRP receptors as both effects were blocked by SR140333 and CGRPg-s? (Grant et 
al., 2002). 
1.5.3.2. Desensitization 
One of the hallmark of capsaicin action is the refractory state that follow the 
excitation of the sensory neurones during which subsequent vanilloid challenges do 
not produce a response in the neurones (Caterina & Julius，2001; Holzer, 1991; 
Szallasi, 1994, 1996; Szallasi & Blumberg, 1999). In some cases, desensitization 
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also renders in-responsiveness of the sensory neurones to other stimuli, ranging from 
noxious heat to mechanical pressure, to endogenous (e.g. histamine, bradykinin) and 
exogenous (e.g. xylene, mustard oil) agents. This form of desensitization is referred 
as functional desensitization. The exact mechanism of desensitization remains 
largely elusive, but was found to be dependent on several factors: dosage, duration 
and frequency of treatment, temperature, and concentration of Ca"^. In dissociated 
sensory neurones, prolonged exposure of capsaicin produced an electrophysiological 
response that subsides despite the continuous presence of the agonist (Caterina & 
Julius, 2001). Administrating capsaicin repeatedly also produced a series of 
responses that decrease in magnitude, especially the first and second application 
(Caterina & Julius，2001). The range of concentrations of capsaicin producing 
desensitization is found to be extended by lowering the experimental temperature 
(Holzer, 1991). Furthermore, the dependence of C a * has been demonstrated with 
the use of BAPTA an antagonist of calcium-dependent phosphatase calcineurin 
which inhibits the capsaicin-induced desensitization (Caterina, 2001). Calcineurin 
has been implicated in mediating the process. Removing extracellular Ca杆 also 
causes a complete reduction of desensitization (Szallasi, 1996). 
Neuronal impairment can also contribute to desensitization, especially long-term 
desensitization. Chronic treatment of capsaicin has been shown to deplete 
neuropeptides in the DRG neurones, as shown by a reduction of SP- and CGRP-like 
immunoreactivity after vanilloid treatment. There is also a dose-dependent loss of 
vanilloid binding site in the central and peripheral endings of sensory neurones 
(Szallasi, 1994). The effect of capsaicin on axonal transport of macromolecules such 
as nerve growth factor (NGF) within the sensory neurones is thought to be 
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responsible for these changes. The absence o fNGF in DRG has also been shown to 
reduce vanilloid binding sites. NGF is required for the expression of SP and NKA. 
Thus deprivation in the somata of the sensory nerves of NGF contributes to the loss 
of response to capsaicin. 
The term desensitization was first introduced by Jancso in 1949. Desensitization is 
not a single, well-defined biochemical process. It is a cascade of events that produce 
an acute or chronic effect that can be reversible or irreversible, indicating the 
necessity for a more accurate terminology (Szallasi & Blumberg，1999). For this 
reason, there was attempt to differentiate the forms of desensitization mediated at the 
receptor from that involves mechanisms beyond the receptor level, i.e. impairment of 
neuronal functions. Desensitization has also been further clarified to describe the 
rapid loss of function of VRl (i.e. closure of the channel) caused by the agonist via 
conformation change in the receptor protein�While the term 'tachyphylaxis' refers 
to the gradual diminishing response to repeated capsaicin administration (Szallasi & 
Blumberg, 1999). 
1.5.3.3. Neurotoxicity 
Another unique characteristic of capsaicin is its ability to sacrifice a majority of 
small to medium sized DRG neurones when given to new bom rats (Szallasi & 
Blumberg, 1999). This property has made capsaicin a useful tool to identify the 
contribution of capsaicin-sensitive fibres in various physiological and pathological 
conditions. The process is thought to involve depletion of NGF, as lack of NGF can 
eventually kill the neurones. In accord with this, exogenous NGF has been shown to 
enhance the survival of DRG neurones (Szallasi, 1994; Szallasi & Blumberg, 1999). 
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Ca"^ may also take part in causing neurotoxicity as removing extracellular Ca"^ 
reduced capsaicin-induced cell death in in vitro studies. However, there is doubt 
whether capsaicin-induced increase of intracellular Ca* is sufficiently high enough 
to render irreversible neuronal damage (Szallasi & Blumberg，1999). 
Capsaicin-induced neuronal death is often preceded by ultrastructural change such as 
fibre enlargement and swelling of mitochondria (Holzer, 1991). It is thought that 
these changes can be attributed to the accumulation of NaCl intracellularly. This is 
achieved by a Na+ influx through the VRl channel, which is accompanied by a 
passive influx of CI" through resting leakage route. The two events altogether 
contribute to a net uptake of NaCl of the neurones. This is followed by an influx of 
water and lysis as a consequence, that may account for the neuronal death. 
1.5.4. Biological Effects of Anandamide 
1.5.4.1. Vascular Effect of Anandamide 
AEA has been shown to produce vasodilatation in many vasculatures including 
mesenteric, hepatic and cerebral vessels, and also in skeletal muscle. Studies on the 
effects of AEA-mediated vasodilatation in the last decade revealed that the process is 
surprisingly complex and controversial. The exact mechanism of how anandamide 
mediates vasodilatation remains elusive. Both endothelium-dependent and non-
endothelial-dependent vasodilatations have been reported, and several possible 
cellular targets (i.e. receptors or channels) have been proposed. 
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1.9.4.1.1. Prostanoids 
One of the earlier studies on AEA-induced vasodilatation has shown a role of 
prostanoids in cerebral vessels as the effect is sensitive to inhibition by indomethacin 
(Ellis et al,, 1995; Hillard, 2000; Ralevic et al, 2002; Randall, 2003). However, 
there are discrepancies on involvement of prostanoids in AEA-induced vasodilatation 
in other vessels as relaxations to AEA were unaffected by indomethacin in rabbit 
superior mesenteric artery and in justamedullary afferent arterioles of the kidney, 
(Chaytor et al,, 1999) while other laboratories have shown indomethacin-sensitive 
AEA-induced vasodilatation in the sheep and bovine coronary vessels (Grainger & 
Boachie-Ansah, 2001; Pratt et al., 1998). Base on the inhibitory actions of AEA 
transporter inhibitor, AM404, and amidohydrolase inhibitors on AEA-induced 
vasodilatation, it has also been postulated that AEA vasodilatatory action involves a 
conversion of AEA into metabolites of arachidonic acid (Grainger & Boachie-Ansah, 
2001; Pratt et al., 1998; Randall, 2003). Some authors suggested breakdown of AEA 
into vasoactive substances is not likely, but a direct action of AEA is more likely as 
blockade of cyclooxygenase or cytochrome P-450 epoxygenase pathways do not 
inhibit AEA-induced relaxations (Ishioka & Bukoski，1999; White et al., 2001). 
Vasodilatation induced by a stable analogue of AEA methanandamide also suggested 
that a breakdown of AEA is not essential for the action (Chaytor et al., 1999). 
1.5.4.1.2. Cannabinoid Receptors 
The original concept of CBi mediating the AEA-induced vasodilatation is largely 
base on the inhibitory action of the once thought selective CBi antagonist, 
SR141716A. In cat cerebral arteries, AEA-evoked vasodilatation was blocked by 
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SR141716A, and was mimicked by Win55212-2 (Hillard, 2000). Antagonism by 
SR141716A has also been shown in mesenteric arterial bed, hepatic artery, 
juxtamedullary afferent arterioles and coronary vessels (Deutsch et al., 2001; Fulton 
& Quilley，1998; Randall et al., 1996; Zygmunt et al,, 1997). In support with the 
involvement of CBi receptors in AEA actions is the presence of CBi receptor mRNA 
in the endothelial cells of human aorta (Liu et al., 2000). However, in other studies, 
high affinity CBi agonists such as CP55940 and Win 55212-2 produced small or no 
vasodilatation (Hillard, 2000; Hogestatt & Zygmimt，2002). In addition, CBi 
antagonists such as LY320135 and AM251 have been shown to be ineffective in 
affecting the AEA-induced response (Chaytor et al., 1999; White et al., 2001). CB2 
antagonist such as AM630 and SR144528 also do not interfere with AEA-induced 
vasodilatation (Ho & Hiley, 2003; White et al., 2001). Others have also reported the 
inability of CBi and CB2 agonist (i.e. HU210, WIN 55212-2 and CP 55,940) to 
mimic the action of AEA (Zygmimt et al., 1999). Moreover, the development of CB 
knockout mice has disproved the role of CBi in AEA-induced vasodilatation, as the 
AEA vasodilator effect remains intact in these mice (Hogestatt & Zygmunt, 2002; 
Ralevic et al., 2002). 
AEA-induced vasodilatation in the CBi knockout mice also suggested the existence 
of a new receptor type. In fact, the previously unsuspected selectivity of SR141716A 
on CBi has been questioned, suggested a non-CBi mediated mechanism (Chaytor et 
al., 1999). In CBi knockout mice, the vasodilator response to AEA was still 
abolished by SR141716A (Jarai et al., 1999). This has led to the postulation of an 
unidentified 'anandamide receptor', and such novel receptor is thought to be 
responsible for the endothelium-dependent AEA-induced vasodilatation that is 
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sensitive to SR141716A (Mukhopadhyay et al, 2002; Wagner et al., 1999). 
Recently, a cannabinoid analog, 0-1918, is found to be a selective, silent antagonist 
of such 'endothelial anandamide receptor，(Bukoski et al., 2002; Offertaler et al., 
2003). 
1.5.4.1.3. Vanilloid Receptors 
Early studies of endothelial-independent anandamide-induced vasorelaxation have 
led to the discovery of the involvement of VRl in the effect (Hogestatt & Zygmimt, 
2002). The role of VRl was first shown by Zygmunt and co-workers that 
capsazepine and capsaicin-induced desensitization significantly inhibited the AEA-
induced vasodilatation. The action involves a release of CGRP, as it was inhibited 
by CGRPg-s? (Zygmunt et al., 1999). This has gained support from later studies that 
the vasorelaxation of its metabolically stable analogue was inhibited by capsaicin, 
ruthenium red, CGRPg-s? as well as capsazepine in mesenteric arteries (Ho & Hiley, 
2003; Ralevic et aL, 2000). However, the antagonist effect of capsaicin pretreatment 
and ruthenium red has been shown to disappear in the presence of L-NAME (Harris 
et aL, 2002). Furthermore, AEA actions were found to be absent in VRl knockout 
mice (Hogestatt & Zygmimt, 2002), and in coronary artery, AEA-induced 
vasodilatation was unaffected by capsazepine and capsaicin (White et al., 2001). 
Therefore, it was postulated that AEA-induced vasodilatation consists of two 
components: an endothelium-dependent component that is SR141716A sensitive, 
whereas the endothelium-independent component can be attributed to VRl 
(Mukhopadhyay et al., 2002). 
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1.5.4.1.4. Potassium Channels 
Inhibitors of K+ channels have been shown to attenuate the vasodilatatory effect of 
anandamide. But different laboratories have yielded conflicting results. Blocking 
effect of clotrimazole, a cytochrome P450 inhibitor that possesses inhibitory action 
on K+ channels, and calcium-dependent potassium channel (Kca) blocker, 
tetrabutylammonium (TEA), iberiotoxin, and charbdotoxin (ChTX) on AEA-induced 
vasodilatation have also been observed in coronary artery of the sheep, coronary 
artery, heart, hepatic artery and mesenteric arterial bed of the rat (Grainger & 
Boachie-Ansah, 2001; Ishioka & Bukoski, 1999; Plane et al” 1997; Randall & 
Kendall, 1998, 1997; Randall et al., 1997; White et al., 2001). In some studies, TEA 
and ChTX failed to interfere with the action of AEA (Fulton & Quilley，1998; 
Ishioka & Bukoski，1999). Relaxant effect of AEA was also inhibited by a 
combination of ChTX and apamin, which led to the speculation of AEA being the 
endogenous vasodilator endothelium-derived hyperpolarising factor, EDHF. This 
has, however, been disproved by subsequent studies (Fulton & Quilley, 1998; Plane 
et al, 1997; Zygmunt et al., 1997). The vasodilatatory activity of AEA was blocked 
by antagonists of the ATP-sensitive K+ channels (Ralevic et al., 2002). 
AEA-induced vasodilatation does involve hyperpolarisation. The concept emerged 
from the inhibitory effect of high extracellular potassium (Ralevic et al., 2002). 
Electrophysiological experiment reveals that hyperpolarisation induced by AEA on 
vascular smooth muscle cell is independent of CBi receptor, but requires the 
presence of endothelium (Plane et al, 1997; Zygmunt et al., 1997). It was suggested 
that AEA effect might involve a release of EDHF from the endothelium (Ralevic et 
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a/.， 2002). Hyperpolarisation to AEA has been shown to be abolished by 
capsazepine. 
1.5.4.2. Interaction of the Vanilloid and Cannabinoid systems 
It is now widely accepted that AEA acts both as an endocannabionoid and 
endovanilloid. In fact, there are increasing amount of evidence pointing at the 
interaction between the two systems, giving rise to the dual effects of AEA. 
Activation of VRl receptors by capsaicin is known to produce inflammatory reaction 
and hyperalgesia, while AEA has been shown to inhibit plasma extravasation to 
capsaicin and produce antinociception (Richardson et al., 1998b; Szolcsanyi, 2000). 
The effect was found to be blocked by SR141716A, and involves a release of CGRP 
(Richardson et al., 1998a; Szolcsanyi, 2000). Systemic release of CGRP by 
resiniferatoxin was also inhibited by AEA. Interestingly, high concentration of AEA 
produces opposite effect, a release of sensory peptides (Helyes et aL, 2003; 
Szolcsanyi, 2000). Dual effects of AEA have also been demonstrated in cell studies: 
AEA produced an increase in intracellular Ca++ and an inhibition on capsaicin-
evoked increase in Ca杆(Nemeth et al., 2003b). Lower concentration of AEA has 
been shown to inhibit substance P-LI and CGRP-LI in the rat spinal cord via CBi 
receptors, while the opposite VRl-responsible effect has also been observed (Nemeth 
et aL, 2003b). It was suggested that the interaction of AEA with the cannabinoid and 
vanilloid receptor is concentration-dependent; low concentration of AEA activates 
CBi, whereas high concentration of AEA activates VRl. Taken together, these 
results suggest a regulatory role of AEA on excitability and transmitter release of 
capsaicin-sensitive neurones (Ahluwalia et al., 2003). 
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There is evidence that VRl and CBi are co-expressed in DRG neurones. AEA 
binding sites have been shown to be intracellular on VRl, while that on CBi was 
extracellular. This has led to the proposition that anandamide transporter would 
determine the net effect of anandamide on neurones: i.e. excitatory (VRl) or 
inhibitory (CBi), by redistributing AEA between the extracellular and intracellular 
compartments (Di Marzo et al, 2002). Co-expression of receptors mediating 
opposite effects is not a new idea (e.g. inhibitory adenosine (Ai) receptor and 
excitatory P2X receptors), but it is rather unusual to have the same ligand (i.e. AEA) 
activating two receptor systems that have opposite effects (Ralevic et al., 2002). 
1.6, Aim of Study 
The aims of the present study were to assess the in vivo action of capsaicin and AEA 
on blood flow and plasma extravasation in rat knee joints using laser Doppler 
perfusion imager (LDI) and Evans blue extravasation technique, respectively. 
Specific VRl antagonists were tested on their vasodilator actions to confirm 
mediation via VRl. In addition, involvement of neuropeptides in their actions was 
investigated using NKi and CGRP receptor antagonists. AEA is suggested to interact 
with the same intracellular binding site on VRl as capsaicin, and this binding would 
be facilitated by the AEA transporter system (Jordt et al., 2002). Therefore, an AEA 
transport inhibitor was tested to confirm the necessity of this intracellular binding for 
AEA-induced responses. The role of CB receptors in mediating the AEA-induced 
response was tested using specific CB receptor antagonists. Finally, it is suspected 
that VRl-mediated release of neuropeptides could influence the course of 
development of arthritis. This hypothesis was tested by examining the effects of 
acute pre-treatment with capsaicin and anandamide on carrageenan-induced joint 
inflammation. 
39 
Chapter 2 - Methods 
Chapter 2 Method 
2.1. Materials 
Drugs were provided in powder form (except anandamide). Stocks were prepared at 
a higher concentration which was diluted to the desirable concentration using 
physiological saline shortly prior to experiments. 
Absolute ethanol (Merck) was stored at room temperature. 
Acetone (Ajax chemicals) was stored at room temperature. 
AM281[l-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholmyl-lH-
pyrazole-3-carboxainide] (Tocris) was dissolved in DMSO, and further diluted in 
physiological saline (0.9%, AnalaR, BDH Laboratories Supplies), and stored at 10' 
AM404 [N-(4-Hydroxyphenyl)-5Z, 8Z, IIZ, 14Z-eicosatetraenamide] (Tocris) 
was dissolved in absolute ethanol and diluted in physiological saline to lO'^M, stored 
a t - 2 0 � C . 
AM630 [6-iodo-2-methyl-l[2-(4-morpholinyl)ethyl]-lH-mdol-3-yl](4-ethoxy-
phenyl)methanone] (Tocris) was dissolved in DMSO, and further diluted in 
physiological saline and stored at lO'^M at -20®C. 
Anandamide (AEA, Tocris) was purchased in a form of water dispersible emulsion 
(soya oil/water (1:4) with a droplet diameter of 250 nanometers) at concentrations of 
lO.lmg/ml and 6.5mg/ml. It was dissolved and diluted in physiological saline to 
lO'^M and stored at 
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Calcitonin Gene Related Peptide fragment 8-37，human (hCGRPg-s?, synthetic, 
Sigma) was dissolved in distilled water and diluted in physiological saline. It was 
stored at -20°C. 
Capsaicin [8-methyl-N-vanillyl-6-nonenamide] (sigma) was dissolved in absolute 
ethanol (5%) and cremophor (5%). It was then further diluted in saline (90%) to 
10' M and stored at -20 °C. For denervation purpose, drug solution was prepared as 
1% just before the treatment, first dissolved in ethanol (5%) and cremophor (5%), 
and further diluted using saline. 
Capsazepine (RBI) was dissolved in absolute ethanol and was diluted in saline to 
10_1m. It was stored at -20°C. 
Carrageenan Lambda 2% (Sigma) was dissolved in saline. The drug was prepared 
just before the experiment. 
Evans Blue 50mg/ml (BDH Laboratory Supplies) was dissolved in saline. 
Heparinized Saline lOOunit/ml (Sigma). Heparin sodium salt was dissolved in 
saline and stored at room temperature. 
RP67580 [2-[l-immo-2-(2-methoxyphenylethye]-7,7diphenyl-4-perky-droiso-
indolone] (Rhone-poulenc Rorer) kindly donated as a gift. The drug was dissolved 
in absolute ethanol, and diluted in saline to lO'^M, stored at -20°C. 
5，-iodoresiniferatoxin [6,7-Deepoxy-6,7-didehydro-5-deoxy-21-dephenyl-21-
(phenylmethyl)-daphnetoxin,20-(4-hydroxy-5-iodo-3-methoxybenzeneacetate)] 
(Tocris) was dissolved in absolute ethanol and diluted in saline to lO'^M. Stored at 
-20°C. 
Sodium Sulphate 1% (Merck) anhydrous was dissolved in saline and stored at 
room temperature. 
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SR140333 (Sanofi) donated as a gift. The drug was dissolved in ethanol and diluted 
in saline to lO'^M. Stored at -20°C. 
Thiopentone Sodium 50mg/ml (Abbott) was dissolved in saline. Prepared just 
before the experiment to prevent precipitation. 
Tocrisolve TM 100 (Tocris). A water soluble emulsion composed of 1:4 ratio of 
soyaoil/water, emulsified with co-polymer Pluronic F68. The solution was dissolved 
in physiological saline and stored at 4°C. 
Urethane 25% [Ethyl Cabamate](Sigma) was dissolved in saline and stored at 
room temperature. 
2.2. Protocols 
2.2.1. General Procedures 
All experiments were performed on male Sprague-Dawley (SD) rats (250-300g). SD 
rats were bred and kept by the Laboratory Animal Services Centre of Chinese 
University of Hong Kong. The rats were supplied with sufficient food and water 
throughout the course of husbandry. 
Rats were injected intra-peritoneally with 25% urethane (1.7g/kg) to produce a deep 
and long-lasting anaesthesia that can sustain throughout the duration of experiments. 
For recovery experiments in which short duration of anaesthesia was favoured (i.e. 
the rats were allowed to regain consciousness after surgical procedures or injections) 
anaesthesia was achieved by intra-peritoneal injection of thiopentone (40mg/kg). 
The depth of anaesthesia was judged by the abolition of withdrawal reflex when the 
hind paw was gently squeezed, and by the loss of corneal blinking reflex that occurs 
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when the cornea is touched. The breathing rate of the anaesthetized rat should be 
slow and regular. Deep anaesthesia was also indicated by a stable blood pressure 
when the arterial-blood pressure of the rat was monitored. 
To ensure euthanasia, the rats were exsanguinated when they were still under deep 
anaesthesia. 
2.2.2. Preparatory Procedure 
2.2.2.7. Intra-articular Injection 
Intra-articular injection was performed to allow local dosing of various drugs into the 
joint space. Animals were ensured to be immobile and properly anaesthetized. The 
knee joint was palpated to estimate the position of joint space. A 25G x 5/8" needle 
was then inserted through the anterior aspect of the joint. The penetration through 
the joint space was felt as a sudden movement of the needle after it passed the skin 
and capsule of the knee joint. The needle was advanced through the cruciate 
ligaments until it penetrated into the posterior compartment. After injection of 
0.05ml, the needle was withdrawn into the anterior compartment and the remaining 
0.05ml was injected. 
2.2.2.2. Cannulation of Trachea 
Caimulation of trachea was performed to prevent the animal from being suffocated 
during the experiments. The animal was placed in dorsal recumbency on a dissecting 
tray, and a longitudinal incision on the neck was made, exposing the longitudinal 
muscle covering the trachea. The longitudinal muscle was cut along the midline 
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cautiously by blunt dissection, without damaging the trachea that lies within. The 
trachea was freed from the muscles and connective tissues, and a small cut was made 
between two cartilage rings, into which the cannula was carefully inserted. Finally, 
the cannula was secured by tiding two threads to the trachea. 
2.2.2.3. Cannulation of Carotid Artery 
Carotid artery locates deep in the neck running parallel to the trachea. Following the 
cannulation of trachea, the artery was carefully separated from the surrounding 
tissues. A forcep was placed underneath the region of artery to be cannulated, 
drawing the artery slightly away from the connective tissues. To restrict blood 
flowing through the region of the artery to be cannulated, a bulldog clip was clipped 
onto the end closer to the heart, while another end was ligated tightly with a thread. 
A slanting cut was made in the artery, an arterial cannula filled with heparinised 
saline was then inserted into the artery. The cannula was secured by tiding two more 
threads around the artery. The forcep and bulldog clip was then removed carefully to 
let blood flow into the cannula. 
2.2.2.4. Blood Pressure Measurement 
Measurement of mean arterial blood pressure indicates whether the flux change in 
the knee joint is a result of changes in systemic blood pressure or not. The cannula 
was connected to a three-way tab, and was carefully attached to the pressure 
transducer (Gould P23ID). The device was checked carefully for any trapped 
bubbles, as they would dramatically influence the measurements. The transducer is 
connected to a PowerLab amplifier system, which in turn transfers the signal to the 
recording software, Chart (PC). The diastolic and systolic pressure will be recorded 
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from the trace. The actual value of mean arterial blood pressure can then be 
calculated from the equation below: 
； j 
• I 
； I r ！ 
Mean Arterial Blood _ Diastolic blood + _1_ Systolic blood Diastolic blood | 




2.2.2.5. Surgical Denervation of the Knee Joint 
Animals were anaesthetized by thiopentone as described in Section 2.2. Animals 
were laid on their backs. The skin between abdomen and hind limb was shaved. The 
shaved area was sterilized by 0.5% chlorhexidine in 70% alcohol. A cut was made 
on the skin, and by blunt dissection the femoral artery was identified among the 
connective tissue. The saphenous nerve arises from the abdomen and arcs down 
towards the left side of the knee, and is found to run parallel to the femoral artery as 
a white fibre. By blunt dissection, the fibre was slowly freed from the blood vessels 
and connective tissue. About 0.5cm of the nerve was excised. The wound was 
stitched up using braided silk sutures, and was treated with 0.5% chlorhexidine in 
70% alcohol and silicone wound dressing (Opsite, Smith & Nephew). Amoxycillin 
was injected intra-muscularly near the site of surgery to prevent post-operative 
infection. Experiments were performed 10 days after the treatment. To see if the 
experimental procedure affects the results, sham operations were performed. The 
surgery procedure runs exactly the same as that described above, but the saphenous 
nerve was left intact after being carefully freed from the surrounding tissue. 
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2.2.2.6. Chemical Denervation of the Knee Joint 
Animals were anaesthetized by thiopentone as described in Section 2.2. 0.1ml of 1% 
capsaicin was injected intra-articularly into one of the knee joints, and the other was 
injected with saline. Solution was injected very slowly as a sudden high dose of 
capsaicin is likely to cause death. Close monitoring of the condition of the animal 
during injection is required. The animals were allowed to recover and experiments 
were performed on these animals 14 days later (Ferrell et al., 1997a). 
2.2.2.7. Induction of Acute Joint Inflammation 
Carrageenan has been used as an animal model of acute arthritis (Hansra et al., 2000). 
In anaesthetized animals, one of their knees was injected with 0.1ml 2% carrageenan 
to induce a monoarthritis. The contralateral knee was injected with 0.1ml saline as 
an internal control. The animals were allowed to recover from anaesthesia. 
2.3. Measurement of Knee Joint Blood Flow 
Laser Doppler Perfusion Imaging (LDI) has been employed for monitoring blood 
flow not only in experimental settings but also in many clinical conditions (Harrison 
1993). The technique enables a non-invasive method to measure relative changes in 
the spatial distribution of blood flow in skin (Karimian 1995). It has many 
advantages over the conventional Laser Doppler Flowmeter (LDF) in that as well as 
giving a single point measurement, LDI also enables a two-dimensional mapping of 
tissue perfusion to be constructed. Its rapid respond time also allows measurement 
of rapid changes in blood flow. The technique is considered to be useful in assessing 
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soft-tissue inflammation in disease condition such as rheumatoid arthritis (Ferrell 
2001). 
The laser beam of a LDI originates from a stable 2mW helium neon gas laser. The 
beam emitted has a red wavelength of 632.8mn，which is thought to probe the full 
dermal thickness. The laser light is deflected by a front coated mirror (Al, Si02) 
which is controlled by two stepping motors, to allow the moving beam to be directed 
across the tissue surface in a back and forth manner. The red blood cells within the 
blood vessels of the blood vessels scatter the laser beam. The back-scattered photons 
of the laser were reflected by the same mirrors and back to the detector, a photo-
diode. After detection, the signals are amplified, processed and digitized to give a 
flux value (an index of blood flow), expressed in arbitrary units. Measurements are 
displayed as a colour-coded perfusion image, with 16 colours range and equally 
spaced over the full range. Blue indicates low perfusion, green and yellow represent 
the mid-range while red and white highlight the regions with highest flux. 
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Figure 2.1. Laser Doppler perfusion imaging. 
2.3.1. Animal Preparation for Measuring Knee Joint Blood Flow 
Animals are anaesthetized as described in Section 2.2, and were laid on their backs. 
An ellipse of skin covering the knee joint was removed and the fasia overlying the 
joint capsule was excised to expose the medial aspect of the knee joint. Two rats 
were placed in close proximity so that their opposite knees will be scanned 
simultaneously. The LDI used was purchased from Moor Instruments, Axminster, 
UK. The distance between the knee joints and the laser source was 28cm. 
The exposed knee joint capsules were rinsed with saline every five minutes for 30 
minutes, allowing the blood flow in the knee joint to become stable. When the knee 
joint blood flow is stable, a bolus of saline in a volume of 0.1ml was applied to the 
knee joint capsule, a control scan was taken immediately after, and then the 
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experiment was commenced. Administration of all drugs (including saline and 
vehicle) were administered in a volume of 0.1ml. 
2.3.2. Specific Procedures 
2.3.2.1. Assessment of the Vasodilatatory Action of Vanilloid Agonists in the 
Knee Joint 
In order to conduct the experiment by exactly the same protocol as that in the 
presence of antagonists (Section 2.4.2.2), the knee joint was treated with saline 10 
minutes prior to administration of the vanilloid agonist. After the control scan was 
taken, a bolus of saline was administered, the knee joint was scanned immediately 
after, and also at 1，2 5, and 10 minutes. The vanilloid agonist (i.e. capsaicin or AEA) 
was then applied topically on the knee joint surface. The administration is followed 
immediately by another scan, and scans were taken at 1，2，5 minutes, and every 
other five minutes until 30 minutes. 
To test whether the agonist displays any sign of tachyphylaxis or desensitization, a 
second bolus of the agonist was administered at 30 minutes. Scans were taken after 
the administration, and at time 1, 2, 5, and every other 5 minutes up to 30 minutes. 
2.3.2.2. Assessment of Antagonists on the Vasodilator Responses to the 
Vanilloid Agonists 
After the control scan is taken, 0.1ml of the antagonist was administered 10 minutes 
prior to the co-administration with the agonists. Scans were immediately taken after 
the administration and at 1，2, 5, and 10 minutes. The experiment continues as 
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mentioned in 2.4.2.1.，except that the agonist was co-administered with the 
antagonist. 
Antagonists tested include V R l antagonists, NKi antagonists, C G R P antagonist, CBi 
antagonist, CB2 antagonist and anandmide transporter inhibitor. 
Administration of drug at different time interval 
Experiment -10 to 0 minutes 0 - 3 0 minutes  
Control Saline VR agonist ~ 
VRi antagonist Capsazepine VR agonist + capsazepine 
lodo-resiniferatoxin VR agonist + iodo-resiniferatoxin 
NKi antagonist SR140333 VR agonist +SR140333 
RP67580 VR agonist + RP67580 
CGRP antagonist CGRPs-a/ VR agonist + CGRP8.37 
CBi antagonist AM281 VR agonist + AM281 
CB2 antagonist AM630 VR agonist + AM630 
Anandamide Transporter AM404 VR agonist + AM404 
inhibitor  
Table 2.4. Protocol for administration of agonists and antagonists in blood flow studies. 
2.3.2.3. Dose Responses of Agonists 
Vasodilatatory responses of capsaicin (lOpmol to O.lfimol) were obtained in order to 
construct a dose response curve. Due to its long lasting action, different doses of 
capsaicin were administered cumulatively without wash out between doses. The 
drug was allowed to act for 10 minutes. Scans were taken immediately after each 
administration of drug and at 1,2, 5, and 10 minutes. 
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Dose response curve of A E A was also constructed. Each dose of A E A (Inmol to 
Ijimol) was allowed to act for 15 minutes, which is followed by wash out. Scans 
were taken immediately after each administration and at 1,2, 5, 10, and 15 minutes. 
2.3.2.4. Neuronal Involvement in the Vasodilator Response to VR1 Agonists 
To assess the role of nerves in the vasodilatatory effects of capsaicin and AEA, dose 
response curves of the two agonists (capsaicin: lOpmol to O.ljj.mol; AEA: Inmol to 
Ijimol) were constructed on animals that had undergone surgical or chemical 
denervation as described in Section 2.3.5. and 2.3.6. Dose responses of capsaicin 
(lOpmol to O.ljLimol) were also tested on animals that had received sham operation, 
to provide control for the surgical procedure. 
2.3.3. Image Analysis 
Perfusion images were analyzed using V I E W software (Moor Instruments Ltd, 
Axminster, UK), which allow statistical analysis of the region of interest. The area 
• 2 
of interest of 0.7cm , which includes most of the vascularized articular tissue with 
minimal inclusion of muscles, was selected. Same area was selected for control and 
test images on the same knee joint, but the area may vary between animals depending 
on the size of their knee joints. The perfusion units of the selected area were 
recorded, from which the % change in flux were calculated. 
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2.3.4. Data Analysis 
Results were expressed as % change in flux 士 SEM. The differences between all 
time points and baseline were analyzed using 1-way A N O V A followed by 
Bonferroni test (GraphPad Prism 4 for Windows). Whereas 2-way A N O V A was 
conducted to calculate the differences between the test and control curves, and 
Bonferroni test was performed for point to point comparison of mean values. 
Significance levels for different 尸-values are: * for P<0.05, ** for P<0.01 and *** 
for 尸<0.001. All 户-values quoted were two-tailed, and n numbers represent number 
of knees examined. 
2.4. Quantification of Plasma Protein Extravasation 
Evans Blue Dye is an anionic dye with large molecular size that has been extensively 
used as a plasma tracer to assess transendothelial leakage of plasma protein. The dye 
molecules bind to the serum proteins such as albumin and can stay in the circulation 
for several hours. Under normal circumstances, the Evans Blue-bound albumin is 
too large to penetrate through the blood vessels. However, the microvessels will 
become leaky when there is inflammation, and gaps between the endothelial cells 
became large enough to permit the passage of Evans Blue-bound albumin from the 
plasma into the surrounding tissue. Thus, the extravasation of Evans Blue-bound 
albumin, i.e. the amount of Evans Blue in the tissue, gives an index of increased 
plasma leakage. 
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2.4.1. Experimental Procedure 
Weight of every anaesthetised rat was recorded. 50mg/kg of Evans Blue was 
injected into the jugular vein of the rat, successM injection will turn the animal into 
blue colour instantly. One knee was then injected with 0.1ml of saline to serve as a 
control, the other was injected with 0.1ml of test drug. The rat was exsanguinated 
after 4 hours. The anterior and posterior portions of the synovial tissues were 
dissected free and weighted. The Evans Blue content of the tissue was extracted by 
transferring the tissue to a solution consisting acetone and 1% aqueous solution of 
sodium sulphate at a ratio of 7:3 (Lam & Ferrell 1989). Since the amount of tissue 
from each knee joint is small, tissue from four rats was pooled in one sample. The 
mixtures were left at room temperature for 24 hours with continuous mild shaking. 
2.4.2. Measurement of Evans Blue Content 
After 24 hours extraction, the mixtures were centrifUged for 10 minutes at 2000 
rev/min. The supernatant of the mixture was collected, and its absorbance was 
measured at 620mn. The amount of Evans Blue was calculated by comparing the 
absorbance with that of a standard curve prepared with known concentrations of 
Evans Blue Solutions. The results were expressed as |ig Evans Blue per gram of 
tissue 士 SEM. 
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2.4.3. Measurement of Knee Joint Size 
Before the sacrifice of the animals at the end of the 4 hour period, the knee joint sizes 
were measured. This was done by placing a digital micrometer across the medial 
aspect of the knee joint. The measurements were expressed as m m . 
2.5. Effect of Capsaicin on Acute Joint Inflammation 
Animals were anaesthetized using thiopentone as described in Section 2.2.1. The 
rats were pretreated with capsaicin for 15 minutes before inducing acute 
inflammation. This entails injection of one of the knees with 0.1ml saline to serve as 
a control, the other (test knee) was injected with 0.1ml of capsaicin (1% or O.ljumol). 
After 15 minutes, another 0.1ml of saline was injected into the control knee, whereas 
the test knee was injected with 0.1ml of 2 % carrageenan as mentioned in Section 
2.2.2.7. The animals were allowed to recover from anaesthesia and rest over night 
with sufficient supply of food and water. Experiments of plasma extravasation were 
performed on the treated animals 24 hours later as described in Section 2.4. 
_ 
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3.1. Effects of Vanilloids on Knee Joint Blood Flow 
3.1.1. Capsaicin 
3.1.1.1. Effects of Cumulative Dosing of Capsaicin 
The dose response relationship of capsaicin was investigated by cumulative 
administrations of the drug onto the rat knee joint with 10 minutes interval between 
each dose. Capsaicin produced a biphasic response: at doses of 10 and lOOpmol, it 
produced dose-dependent increases in blood flow, indicating that it is a vasodilator 
on this tissue. However, a higher dose of Inmol capsaicin produced a vasodilator 
response that was smaller than that produced by lOOpmol, and it reduced the blood 
flow below basal level at 10 and lOOnmol. Simultaneous measurements of systemic 
blood pressure showed that all these doses of capsaicin did not affect the blood 
pressure. These results are shown in Figure 3.1. 
3.1.1.2. Time Course of Capsaicin-induced Vasodilatation 
In the above study, cumulative dosing of capsaicin with 10 minutes interval showed 
that high doses of capsaicin produced smaller vasodilator responses than those 
elicited by low doses of the drug. Caterina et al (2001) have also shown that 
repetitive administrations of capsaicin produced progressively smaller responses, and 
it was suggested to be caused by tachyphylaxis of the tissue. Therefore, this part of 
the study investigates whether tachyphylaxis can be avoided by extending the time 
interval to 30 minutes between each drug administrations. As illustrated in Figure 
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3.2，the first administration of O.lnmol capsaicin produced an immediate vasodilator 
response that peak with 20.9 土 6.6o/o increase in blood flow at 1 minute, and it 
subsided to basal level in approximately 10 minutes. The second administration of 
O.lnmol capsaicin at 30 minutes after the first dose produced 21.0 土 5.6o/o increase in 
blood flow, indicating an absence of tachyphylaxis. Analyses by 2-way A N O V A 
indicates a significant difference between this curve and the curve for saline control 
(P<0.001; Figure 3.2). 
The study was repeated with two higher doses of Irnnol capsaicin. After 
administration of the first dose of Inmol capsaicin, blood flow of the rat knee joint 
was markedly elevated and peak with 50.1 士 5.0o/o increase at 15 minutes. A 
significant proportion of this vasodilator response remained at 30 minutes, at which 
time, administration of the second dose of Inmol capsaicin maintained the increase 
in blood flow at 47.4 士 8.0o/o. Statistical analysis using 1-way A N O V A followed by 
Bonferroni post-hoc test showed that the increase in blood flow was highly 
significant starting from 5 minutes after administration of the first dose of capsaicin 
and through to the end of the experiment at 60 minutes. Analyses by 2-way A N O V A 
indicates a significant difference between this curve and the curves for saline control 
and Inmol capsaicin (户<0.001 for both; Figure 3.2). It was also noted that each 
administration of Inmol capsaicin produced significant fall in systemic blood 
pressure that recovered within 5 minutes (see Figure 3.3). 
To test for the reproducibility of the capsaicin-induced vasodilator response, the 
above experiment with two doses of Inmol capsaicin was repeated a year later. As 
illustrated in Figure 3.4, the repeated experiment showed that the first dose of Inmol 
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capsaicin produced 53.1 土 7.0o/o increase in blood flow, and the second dose 
produced 50.1 士 13.2o/o increase. Statistical analysis by 2-way A N O V A on the 
responses obtained in the original and repeated experiments showed no difference 
between them. Therefore, these two sets of results were pooled together for 
subsequent comparisons of the effects of antagonists on capsaicin-induced 
vasodilatation. 
It should be mentioned that administration of saline alone produced a drop in blood 
flow. The drop was most prominent at 2 minutes, and analysis by 1-way A N O V A 
showed it to be marginally significant (Figure 3.5). This drop is detectable with 
every saline administration. It is suspected to be an "artefact" caused by the presence 
of fluid on the joint capsule producing a transient change in the refractive property of 
the tissue. 
To confirm that the vasodilator action of capsaicin is attributed to the drug itself, the 
effect of its vehicle comprising the same concentration of ethanol (0.005%) and 
cremphor (0.005%) as in Inmol capsaicin was tested. As shown in Figure 3.5, the 
vehicle produced no obvious vasodilator action compared with saline administration. 
3.1.1.3. Effects of VR1 Antagonists on Capsaicin-induced Vasodilatation 
3.1.1.3.1. Capsazepine 
The V R l antagonist capsazepine was used to test whether the vasodilator response to 
capsaicin is mediated by VRl. The procedure involved first administering a dose of 
the antagonist onto the rat knee joint, and 10 minutes later, the same dose of the 
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antagonist was co-administered with Inmol capsaicin. Such treatment with 2 x 
O.Snmol (i.e. a total of Inmol) or 2 x 5nmol capsazepine (i.e. a total of lOnmol) did 
not alter the vasodilator and hypotensive action of capsaicin (Figures 3.6 and 3.7, 
respectively). Control studies with capsazepine alone showed that 1 or 10 nmol of 
the antagonist had no effect on basal blood flow (Figure 3.8). 
3.1.3.1.2. lodo-resiniferatoxin 
The failure of capsazepine to inhibit the action of capsaicin urged the need to test 
another V R l antagonist. Therefore, a newer and more potent V R l antagonist, iodo-
resiniferatoxin (I-RTX) (Wahl et al., 2001), was investigated on capsaicin. As 
illustrated in Figure 3.9, treatment of the rat knee joint with 2 x Inmol I-RTX 
produced substantial inhibition on the vasodilator response to capsaicin (P<0.001); 
maximum increase in blood flow was reduced from 51.4 土 4.0o/o to 20.0 土 8.1o/o. In 
spite of this pronounced inhibition on joint blood flow, the hypotensive action of 
capsaicin was not affected by the antagonist (Figure 3.10). Control experiment with 
2 X Inmol I-RTX showed that it had no effect on basal blood flow (Figure 3.11). 
3.1.1.4. Effects of NKi Antagonists on Capsaicin-induced Vasodilatation 
3.1.1.4丄 SR140333 
V R l activation is suspected to produce a release of neuropeptides from sensory 
nerve terminals. In support of this theory, capsaicin has been shown to release a 
variety of neuropeptides from sensory neurones, including the tachykinins SP and 
N K A , and other peptides such as CGRP and somatostatin (Bevan & Docherty, 1996; 
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Lao et al., 2003; Nemeth et al., 2003a). The vascular actions of tachykinins have 
been shown to be mediated mainly by NKi receptors (Lam & Ferrell, 1991; 1993; 
Lam & Wong，1996). Therefore, a NKi receptor antagonist SR140333 was used to 
test for involvement of tachykinins in the vasodilator response to capsaicin. 
As illustrated in Figure 3.12, the vasodilator response to Inmol capsaicin was 
unaltered by the presence of 2 x Inmol SR140333, but it was abrogated by 2 x 
lOnmol SR140333 (P<0.001). The hypotensive action of capsaicin was unaffected 
by these doses of the antagonist (Figure 3.13). Control studies showed that 2 x 
Inmol SR140333 had no effect, whereas, 2 x lOnmol SR140333 produced a 
significant drop in basal blood flow (P<0.001; Figure 3.14). The time course of the 
vasoconstrictor profile of 2 x lOnmol SR140333 in the absence and in the presence 
of Inmol capsaicin was the same (Figure 3.15). 
3.1.1.4.2. RP67580 
Another NKi receptor antagonist RP67580 was also tested on the vasodilator 
response to capsaicin. As illustrated in Figure 3.16, treatment of the rat knee joint 
with 2 X Irnnol or 2 x lOnmol RP67580 produced no change on the vasodilator 
response to Inmol capsaicin. However, because pre-treatment of the joint with the 
first dose of lOnmol RP67580 produced a significant 16.5 土 15.l。/。increase in blood 
flow (P<0.01), the curve of 2 x lOnmol RP67580 with Inmol capsaicin was found to 
be significantly different to that of the control curve for Inmol capsaicin (P<0.001), 
although their maximum vasodilator responses were the same. The hypotensive 
— 
Chapter 3 - Results 
action of capsaicin was unaffected by 2 x Inmol or 2 x lOnmol of the antagonist (see 
Figure 3.17). 
Control studies with RP67580 alone showed that administrations of 2 x Inmol of the 
antagonist had no effect on basal blood flow. However, administration of the first 
dose of lOnmol RP67580 produced a marked increase in blood flow of 18.9 ± 18.6%, 
which subsided within 5 minutes, and the second administration of lOnmol RP67580 
did not affect the blood flow. These results are shown in Figure 3.18. Analysis of 
the curves for 2 x lOnmol RP67580 in the absence and in the presence of Inmol 
capsaicin showed that they are significantly different (Figure 3.19). This indicates 
that the sustained vasodilator action of capsaicin was not affected by the presence of 
the antagonist. 
Since RP67580 was found to have vasodilator action on its own, a series of doses of 
this antagonist was tested for vasodilator action. Blood flow was monitored for 10 
minutes after administration of each dose of the antagonist. The joint was then 
washed with saline for 10 minutes before administration of the next dose. As 
illustrated in Figure 3.20，the antagonist produced dose-dependent increases in blood 
flow at doses of lOnmol and above. 
3.1.1.5. Effects of CGRP Antagonist on Capsaicin-induced Vasodilatation 
3.1.1.5.1. CGRP8-37 
The C G R P receptor antagonist CGRPg-s?, a peptide fragment of CGRP, was used to 
test for the involvement of CGRP in the capsaicin-induced vasodilator response. As 
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illustrated in Figure 3.21，pre-treatment of the rat knee joint with Inmol CGRPg-s? 
produced a significant 9.8 土 3.5o/o increase in blood flow (P<0.05), but this was not 
seen with the pretreatment of 0. Inmol CGRPg-s?- After 10 minutes, the same doses 
of CGRP8-37 (0.Inmol and Inmol) were co-administered with Inmol capsaicin. Both 
doses of CGRP8-37 resulted in a vasodilator response that was much smaller than that 
produced by capsaicin alone (P<0.001 for both). O.lnmol and Inmol CGRPg-s? 
reduced the maximum increase in blood flow produced by capsaicin at 15 minutes 
from 51.4 土 4.0o/o to 36.3 土 4.2o/o and 18.3 士 10.2o/o，respectively, although the 
magnitude of inhibition was not as much at 30 minutes. There was no change on the 
hypotensive action of capsaicin in the presence of this antagonist (Figure 3.22). 
Control studies showed that Inmol CGRPg-s? produced a slight increase in blood 
flow of 10.1 土 16.30/0，while the second administration of Inmol CGRPg-s? produced 
22.0 土 4.6o/o increase. These changes were found to be significant (P<0.01; Figure 
3.23). A dose response curve of the vasodilator response to CGRPg-s? is shown in 
Figure 3.24. The threshold dose for CGRPg-s? to elicit a vasodilator response is about 
Inmol. 
3.1.1.6. Effects of Denervation on Capsaicin-induced Vasodilatation 
3.1.1.6.1. Chemical Denervation 
Rat knee joints were denervated by pre-treatment with 1% capsaicin as described in 
Section 2.2.2.6. The vasodilator action of capsaicin was tested on the denervated 
knees on day 14 after the denervation procedure. As shown in Figure 3.25a, O.lnmol 
capsaicin produced 21.4 土 6.7o/o increase in blood flow in normal knees but only 0.5士 
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4.O0/0 in denervated knees. Similarly, a higher dose of Inmol capsaicin produced 
13.5 土 3.70/0 increase in normal knees but 4.9 土 3.6o/o decrease in denervated knees. 
Therefore, capsaicin has negligible vasodilator action in denervated knees. 
3.1.1.6.2. Surgical Denervation 
Rat knee joints were denervated by surgical sectioning of the saphenous nerve as 
described in Section 2.2.2.5. The vasodilator action of capsaicin was tested on the 
denervated knees on day 10 after the denervation procedure. The denervated knees 
showed smaller vasodilator responses to capsaicin compared with normal knees, but 
statistical analysis indicate no difference between the two curves. Similarly, 
capsaicin produced vasodilator responses in the sham operated knees that were not 
significantly different to those obtained in normal knees. These results are illustrated 
in Figure 3.25b. 
3.1.2. Anandamide 
3.1.2.1. Dose Responses of Anandamide 
The dose response relationship of A E A (Inmol to If^mol) on blood flow in rat knee 
joint was investigated. Each administration of A E A was followed by monitoring of 
blood flow for 15 minutes. The joint was then washed with saline for 10 minutes 
before the next dose of A E A was added. As illustrated in Figure 3.26, A E A 
produced dose-dependent increases in the knee joint blood flow with no sign of 
tachyphylaxis. A plateau of 53.5 士 9.3o/o increase in blood flow was attained at a 
dose of 0.3|j,mol AEA. The EC50 value calculated from the dose response curve was 
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10.7 土 2.0 nmol. Simultaneous measurements of blood pressure showed that all doses 
of A E A tested had no effect on systemic pressure (Figure 3.27). 
3.1.2.2. Time Course of Anandamide-induced vasodilatation 
A E A is proposed to be the endogenous ligand of V R l (Zygmunt, 1999). Thus, it is 
expected to have similar actions to capsaicin. One way to test this in the rat knee 
joint is to compare the time course of AEA-induced vasodilatation with that of 
capsaicin. As illustrated in Figure 3.28，lOnmol A E A produced a rapid increase in 
blood flow that reached a maximum of 30.3 土 6.7o/o at 1 minute. The response 
subsided within 10 minutes, which is transient compared with that produced by 
capsaicin. The second dose of lOnmol A E A administered 30 minutes later produced 
a maximum increase of 30.6 土 7.3o/o one minute after the administration. Analyses by 
2-way A N O V A indicates a significant difference between this curve and the curve 
for saline control (尸<0.001; Figure 3.28). 
Administrations of two higher doses of lOOnmol AEA, separated by a 30 minutes 
interval, produced maximum increases of knee joint blood of 61.8 土 11.5o/o and 53.3 
土 lO.Qo/o, respectively. Analyses by 2-way A N O V A indicates a significant difference 
between this curve and the curves for saline control and lOnmol A E A (P<0.001 and 
户<0.01，respectively; Figure 3.28). The magnitude of these maximum responses are 
similar to those produced by Inmol capsaicin, but they are much faster in onset 
(within 1 minute) and shorter in duration (< 15 minutes) as compared with those 
produced by capsaicin (see Figure 3.2). Furthermore, unlike capsaicin, 2 x lOrnnol 
and 2 x lOOnmol A E A produced no change on systemic blood pressure (see Figure 
3.29). Control studies with the vehicle of AEA, Tocrisolve™ 100，at concentrations 
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equivalent to 10 and lOOnmol A E A (i.e. 0.34 and 3.45%, respectively) showed that 
the vehicle had no effect on basal blood flow (Figure 3.30). 
3.1.2.3. Effects of VR1 Antagonist on Anandamide-induced Vasodilatation 
3.1.2.3.1 Capsazepine 
The V R l antagonist capsazepine was used to test for the involvement of V R l in the 
AEA-induced vasodilator response. As illustrated in Figure 3.31, lOnmol A E A 
produced a maximum of 30.3 士 increase in blood flow, but this was reduced to 
12.6 土 5.8o/o in the presence of 2 x O.Snmol doses of capsazepine (户<0.05, 
Bonferroni post-hoc test). Two 5nmol doses of capsazepine also reduced the 
maximum response to 7.7 土 2.5o/o (P<0.001, Bonferroni post-hoc test). Analysis by 
2-way A N O V A indicates significant difference between the time course profiles of 
lOnmol A E A alone and in the presence of 2 x 5 rnnol capsazepine (P< 0.01). 
Similarly, treatment of the rat knee joint with 2 x 0.5 or 2 x Snmol capsazepine 
significantly attenuated the vasodilator response to lOOnmol A E A (尸<0.001 for both， 
2-way A N O V A , Figure 3.32). Thus, the maximum vasodilator response to lOOnmol 
A E A was reduced from 61.8 土 11.5o/o to 25.4 土 8.2o/o and 23.7 土 6.5o/o in the 
presence of 2 x 0.Snmol and or 2 x Snmol capsazepine, respectively. These results 
are shown in Figure 3.32. 
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3.1.2.3.1 lodo-Resiniferatoxin 
The effect of another V R l antagonist I-RTX was also tested on the vasodilator 
response to AEA. Treatments of the rat knee joint with 2 x Inmol I-RTX 
significantly inhibited the vasodilator response to lOrnnol A E A (P<0.01) with a 
reduction of the maximum vasodilator response from 30.3 士 6.7o/o to 9.1 士 6.0o/o 
(Figure 3.33). 2 X Irnnol I-RTX also inhibited the vasodilator response to lOOnmol 
A E A (户<0.001) with a reduction of the maximum vasodilator response from 61.8 土 
11.5% to 26.8 土 8.10/0 (Figure 3.34). 
3.1.2.4. Effects of NKi Receptor Antagonists on Anandamide-induced 
Vasodilatation 
3.1.2.4.1 SR140333 
If A E A is acting via VRl, then its vasodilator action probably involves a release of 
neuropeptides from sensory neurones. Therefore, the effect of an NKi receptor 
antagonist, SR140333, was tested on AEA-induced vasodilatation. As illustrated in 
Figure 3.35, the vasodilator action of lOmnol A E A was almost abolished by 2 x 
Inmol SR140333 (P>0.001)，and in the presence of 2 x lOnmol SR140333, A E A 
produced vasoconstriction instead of vasodilatation. This vasoconstrictor response is 
caused by a direct action of SR140333 because administration of 2 x lOmnol 
SRI40333 produced vasoconstriction on its own, and this vasoconstriction was the 
same in the presence of lOmnol A E A (Figure 3.36). 
Since 2 x lOmnol SRI40333 produced marked vasoconstriction on its own, only the 
lower doses of 2 x Inmol SRI40333 were tested on the vasodilator response to 
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lOOnmol AEA. As illustrated in Figure 3.37, the vasodilator response to lOOmnol 
A E A was significantly attenuated by 2 x Inmol SR140333 (P<0.001), and its 
maximum vasodilator response was reduced from 61.8 土 11.5o/o to 16.5 士 6.2o/o. 
3.1.2.4.2. RP67580 
Another NKi antagonist RP67580 was tested on the vasodilator response to AEA. As 
shown in Figure 3.38，treatment of the rat knee joint with 2 x Inmol RP67580 
significantly inhibited the vasodilator response to lOnmol A E A (户<0.01) with a 
reduction of the maximum response from 30.3 土 6.7o/o to 10.5 土 4.3o/o. Increasing the 
dose of RP67580 10 times (i.e. 2 x lOnmol) reduced the maximum vasodilator 
response to 13.0 士 8.8o/o, but this reduction is found to be insignificant according to 
the result of Bonferoni post-hoc test. Nevertheless, analysis by 2-way A N O V A 
indicates significant difference between the effects of A E A alone and in the presence 
of 2 X lOnmol RP67580 (P<0.001). It should be noted that in Figure 3.39, 
administration of the first dose of lOnmol RP67580 produced a marked 44.4 土 12.0o/o 
increase in blood flow on its own and the second dose of lOnmol RP67580 produced 
8.1 土 5.90/0 increase. This vasodilator response to RP67580 was reproducible in the 
presence of lOnmol AEA. 
Since 2 x lOrnnol RP67580 produced marked vasodilatation on their own, only the 
low doses of 2 X Inmol RP67580 were tested on the vasodilator response to lOOnmol 
AEA. As shown in Figure 3.40, the vasodilator response to lOOmnol A E A was 
significantly attenuated by 2 x Inmol RP67580 (P<0.001), and its maximum 
vasodilator response was reduced from 61.8 土 11.5o/o to 18.1 土 4.0%. 
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3.1.2.5 Effects of CGRP Receptor /\nt3gonist on Anandamide-induced 
Vasodilatation 
3.1.2.5.1. CGRP8-37 
The C G R P receptor antagonist CGRPg-s? was used to test for involvement of C G R P 
in the vasodilator response to AEA. As illustrated in Figure 3.41, treatment of the rat 
knee joint with 2 x 0. Inmol CGRPg-s? did not affect the vasodilator response to 
lOnmol AEA, but 2 x Inmol CGRPg-s? significantly suppressed its response (P<0.05) 
with a reduction of the maximum response from 30.3 士 to 13.1 士 5.9o/o. 
Similarly, the vasodilator response to a higher dose of lOOnmol A E A was not 
affected by the treatment of the rat knee joint with 2 x 0. Inmol CGRPg-s?, but it was 
significantly inhibited by 2 x Inmol CGRPg-s? (-P<0.001) with a reduction of the 
maximum response from 61.8 土 11.5o/o to 26.1 土 5.3%. These results are shown in 
Figure 3.52. 
3.1.2.6. Effects of CBi Receptor /[ntdgonist on Anandamide-induced 
Vasodilatation 
3.1.2.6.1 AM281 
A E A was initially classified as the endogenous ligand for the cannabinoid CBi 
receptor, on which it behaves as a partial agonist (Di Marzo, 2001; Devane, 1992). 
A CBi receptor antagonist/inverse agonist, AM281, was tested on the vasodilator 
response to A E A to elucidate the involvement of CBi in its action. As illustrated in 
Figure 3.43，treatment of the rat knee joint with 2 x 0.Inmol AM281 did not affect 
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the vasodilator response to lOnmol AEA. The vasodilator response to a higher dose 
of lOOnmol was also unaffected by 2 x 0.Inmol or 2 x Inmol AM281 (Figure 3.44). 
Control studies showed that AM281 at 2 x 0.Inmol and 2 x Inmol produced no 
change on basal blood flow (Figure 3.45). The dose response curve of AM281 
shown in Figure 3.46 also indicates AM281 at a dose range of 0.01 to 30mnol, 
applied with a 10 minutes interval plus a 10 minutes washout, produced no change 
on basal blood flow. 
3.1.2.7. Effects of CB2 Receptor /Antagonist on Anandamide-induced 
Vasodilatation 
3.1.2.7.1. AM630 
Apart from CBi receptors, there is another type of canabinoid receptor, CB2, which is 
present predominantly on immune cells (Griffin, 2000). A E A has been shown to 
bind to CB2 receptors, although it did not down-modulate mast cell activation in vitro 
like palmitoylethanolamide, another endogenous ligand that binds to CB2 (Facci, 
1995). In this part of the study, the effects of a CB2 receptor antagonist/inverse 
agonist on the vasodilator response to A E A were investigated. As illustrated in 
Figure 3.47, the maximum vasodilator response to lOnmol A E A was reduced from 
30.3 士 6.70/0 to 12.0 土 6.0O/O in the presence of 2 x 0.Inmol AM630. However, 
analysis by 2-way A N O V A and subsequent Bonferroni post-hoc test showed that this 
reduction was insignificant. 
In contrast, treatment of the rat knee joint with 2 x 0. Inmol and 2 x Inmol AM630 
significantly reduced the maximum vasodilator response to lOOnmol A E A from 61.8 
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士 11.50/0 to 45.8 土 8.70/0 and 39.2 土 6.1o/o (PO.OOl and P<0.001, respectively, 
Bonferroni post-hoc test). Analysis by 2-way A N O V A also showed a significant 
difference between the curves of A E A alone and in the presence of 2 x 0. Inmol and 
2 X Inmol A M 6 3 0 (P<0.01 and P<0.05, respectively). These results are illustrated in 
Figure 3.48. Control studies showed that 2 x 0.Inmol and 2 x Inmol AM630 
produced no change on basal blood flow, except for a significant 13.7 土 6.8o/o 
increase in blood flow by the first administration of O.lmnol AM630 (P<0.05, 
Bonferroni post-hoc test; Figure 3.49). 
3.1.2.8. Effects of Anandamide Transporter Inhibitor 0/7 Anandamide-
induced Vasodilatation 
3.1.2.8.1 A M 4 0 4 
The vasodilator action of A E A is terminated by a rapid uptake of the drug into cells 
through a specific carrier-mediated membrane transporter (AEA transporter) 
followed by intracellular inactivation (Maccarrone, 2000). The uptake of A E A by 
the A E A transporter is suggested to facilitate the binding of A E A to its intracellular 
binding site on V R l (De Petrocellis et a l , 2001). This is expected to enhance its 
VRl-mediated effects but reduces its extracellular CB receptor-mediated effects. 
Conversely, inhibitors of the A E A transporter would lead to accumulation of 
extracellular A E A (Beltramo, 1997)，and this should reduce its VRl-mediated effects 
but enhances its CB receptor-mediated effects. In the present study, a high affinity 
A E A transport inhibitor AM404 was tested on the vasodilator action of AEA. 
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Treatment of the rat knee joint with 2 x O.Snmol A M 4 0 4 significantly inhibited the 
vasodilator response to lOnmol A E A (P<0.05) with a reduction of its maximum 
response from 30.3 士 to 6.7 土 7.1o/o. Two O.Smnol doses of A M 4 0 4 also 
suppressed the vasodilator response to a higher dose of lOOnmol A E A (P<0.001) 
with a reduction of its maximum response from 61.8 土 11.5o/o to 8.0 土 2.6o/o. These 
results are illustrated in Figures 3.50 and 3.51, respectively. 
Control studies showed that 2 x O.Snmol AM404 had no effect on basal blood flow 
(Figure 3.52). A M 4 0 4 was also tested on capsaicin to confirm its specificity on 
AEA-induced responses. As shown in Figure 3.53, 2 x 0.5nmol AM404 produced no 
change on the vasodilator response to Inmol capsaicin. 
3.1.2.9. Effects of Denervation on Anandamide-induced Vasodilatation 
3.1.2.9.1. Chemical Denervation 
Rat knee joints were denervated by pre-treatment with 1% capsaicin as described in 
Section 2.2.2.6. The vasodilator action of A E A was tested on the denervated knees 
on day 14 after the denervation procedure. As illustrated in Figure 3.54a, the dose 
response curve to A E A was slightly shifted to the right in the denervated knees 
compared with that obtained in normal knees. However, analysis by 2-way A N O V A 
on the two curves and Bonferroni post-hoc test on their individual means indicate the 
shift was not significant. 
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3.1.2.9.2. Surgical Denervation 
Rat knee joints were denervated by surgical sectioning of the saphenous nerve as 
described in Section 2.2.2.5. The vasodilator action of A E A was tested on the 
denervated knees on day 10 after the denervation procedure. As with chemical 
denervation, A E A produced similar dose response curves in normal and surgical 
denervated knees. This result is shown in Figure 3.54b. 
3.2 Effects of Vanilloids on Plasma Extravasation 
The tachykinin SP contained in sensory neurones has both vasodilator and plasma 
extravasation actions (Lam & Ferrell, 1991; 1993; Lam & Wong, 1996). Vanilloid 
agonists are suggested to promote the release of SP and other neuropeptides from 
sensory fibres via a VRl-mediated mechanism (Bevan & Docherty，1996; Lao et al., 
2003; Nemeth et al., 2003a), and they should therefore have the ability to produce 
vasodilatation and plasma extravasation in the target tissues. Both capsaicin and 
A E A are shown to have vasodilator action in the previous studies. This part of the 
study investigates their effects on plasma extravasation. 
3.2.1. Saline Injection on Plasma Extravasation 
To investigate the effects of drugs on plasma extravasation, rats were prepared for 
measurements of Evans blue extravasation as described in Sections 2.4. Drugs were 
administered into the knee joint by intra-articular injections of boluses of 0.1ml. 
Control experiments with saline injection in one knee and no treatment in the other 
knee showed that injection of saline alone produced significant Evans blue 
extravasation in the rat knee joint. Thus, the amount of Evans blue extravasated in 
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the untreated knee was 48.11 士 1.9jLig/g tissue, whereas, in the saline-injected knee 
was 196.2 士 11.9|^ g/g tissue (P<0.001, Student's paired t-test). This result is shown 
in Figure 3.55. 
3.2.2. Capsaicin on Plasma Extravasation 
The effects of a range of doses of capsaicin (0.1 to lOOnmol) on plasma extravasation 
have been tested. Figure 3.56 shows that knee joints injected with 0.1, 1 and 
lOOnmol capsaicin produced plasma extravasation that were not significantly 
different to those of their respective saline-injected contralateral knees. However, in 
knee joints injected with lOnmol capsaicin, the Evans Blue level (152.1 土 15.9jLig/g 
tissue) was significantly lower than that in their contralateral knees ( 1 8 6 . 7 土 
31.5|ig/g tissue; P>0.05, Student's paired t-test). 
There were considerable variations in the amount of Evans blue extravasated in the 
saline-injected contralateral knees of different groups. Thus, compared with the 
saline-injected control shown in Figure 3.55, the saline-injected contralateral knees 
of animals that had received O.lnmol capsaicin injection in their test knees exhibited 
much higher level of Evans blue (P<0.001, Students unpaired t-test), whereas, the 
contralateral knees of those received lOOnmol capsaicin in their test knees showed 
less (P<0.01, Students unpaired t-test). These variabilities cannot be eliminated by 
increasing the n number to 23 (i.e. 23 x 4 = 92 rats) in one of the groups. 
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3.2.3. Effects of Capsaicin on Knee Joint Sizes 
Plasma extravasation is often accompanied with swelling of the affected tissue. Thus 
the size of the rat knee joint was measured to assess the degree of swelling after 
capsaicin treatment. Joint sizes were determined by the methods described in 
Section 2.3.3. As illustrated in Figure 3.57, the various capsaicin-treated groups 
showed no change in knee joint size compared with their respective saline-injected 
contralateral knees. Only in the control group where knee joints injected with saline 
showed bigger knee joint sizes than their respective untreated knees (尸<0.001， 
Student's paired t-test). 
3.2.4. Effects of Anandamide on Plasma Extravasation 
The effects of 100 and lOOOnmol A E A on plasma extravasation have been tested. As 
shown in Figure 3.58, the amount of Evans blue extravasated in rat knees treated 
with lOOmnol A E A was not different to that of their saline-injected contralateral 
knees. However, rat knees treated with lOOOnmol A E A produced significantly lower 
Evans blue extravasation (168.6 土 29.3)^ g/g tissue) compared with their saline-
injected contralateral knees (210.8 土 36.2|ig/g tissue;户<0.01, Student's paired t-test). 
3.2.5. Effects of Anandamide on Knee Joint Size 
The effects of 100 and lOOOnmol A E A on knee joint sizes were also assessed. Joint 
sizes were determined by the methods described in Section 2.4.3. As shown in 
Figure 3.59a, sizes of rat knees treated with lOOnmol A E A were the same as those of 
their saline-injected contralateral knees. However, rat knees treated with a higher 
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dose of lOOOnmol A E A had biggest sizes than those of their saline-injected 
contralateral knees (P<0.01, Student's unpaired t-test). In control studies, saline-
injected knees were also bigger than those of their contralateral untreated knees 
(P<0.001, Student's unpaired t-test). Substracting the knee joint size of 100 and 
lOOOmnol A E A with that of their contralateral knees shows that these treatments 
produce a little swelling (Figure 3.59b). 
3.3. Effects of Vanilloid Agonists on Carrageenan-induced Acute 
Inflammation 
Carrageenan has been used extensively as an experimental model of non-immune 
mediated inflammation. It has an advantage over Freund's complete adjuvant 
(FCA)-induced arthritis in that the inflammatory reaction is localized and is not 
complicated by systemic effects (Radhakrishnan, 2003). An acute arthritis can be 
induced by carrageenan over 24 hours, but it can also be used to produce chronic 
arthritis (Radhakrishnan, 2003; Hansra, 2000). In this study, the effects of capsaicin 
and A E A were tested on acute joint inflammation induced by carrageenan. 
3.3.1. Capsaicin on Carrageenan-induced Plasma Extravasation 
Effects of capsaicin on carrageenan-induced plasma extravasation were investigated 
using the protocol described in Section 2.5. As shown in Figure 3.60a, in rat knees 
injected with 0.1ml saline followed 15 minutes later by an injection of 0.1ml 2% 
carrageenan, 206.8 土 11.2fj_g/g tissue Evans blue was extravasated. This is 
significantly more than that extravasated in their contralateral knees that had received 
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paralleled 0.1ml saline injections (127.0 土 16.3 \igjg tissue; P<0.01, Student's paired 
t-test). As a control, rat knees were injected with 1% capsaicin followed by an 
injection of 0.1ml saline 15 minutes later，375.0 土 27.6|ig/g tissue Evans blue was 
extravasated, which is much more than that extravasated in their saline-injected 
contralateral knees (166.2 土 16.1|ag/g tissue;户<0.001, Student's paired t-test). In rat 
knees that had received injection of 1% capsaicin followed 15 minutes later by an 
injection of 2 % carrageenan, 271.0 士 26.7|Lig/g tissue Evans blue was extravasated. 
This is also substantially more than that extravasated in their saline-injected 
contralateral knees (101.0 土 16.8|Lig/g tissue; P<0.001, Student's paired t-test). 
Figure 3.60b shows the relative increases in Evans blue extravasation in the three 
groups of test knees after subtracted the amount of Evans blue extravasated in their 
respective contralateral knees. The result indicates that injections of saline plus 
carrageenan produced the smallest increase in Evans blue extravasation, capsaicin 
plus carrgeenan is at the middle, and saline plus capsaicin produced the greatest 
amount of Evans blue extravasation. Student's unpaired t-test showed no significant 
difference between the latter two groups, but the former saline plus carrageenan 
group was significant different to the latter two groups (P<0.05 and 0.001， 
respectively). The theoretical effect of 1% capsaicin plus 2% carrageenan 
constructed by adding the effect of 1% capsaicin plus saline and saline plus 2% 
carrageenan is found to be significantly higher than that of saline plus 2% 
carrageenan (户<0.01). The theoretical effect is, however, significantly different from 
other groups (P>0.05). 
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The above studies indicated that intra-articular injection of 1% (i.e. 3.27jimol) 
capsaicin produced marked Evans blue extravasation on its own. In fact, injection of 
this dose of capsaicin is very toxic as it caused 25% mortalilty. Therefore, a lower 
dose of lOOnmol capsaicin was tested on carrageenan-induced inflammation. As 
shown previously, rat knees injected with saline plus 2 % carrageenan produced 206.8 
土 11.2j_ig/g tissue Evans blue extravasation, which is more than that extravasated in 
their saline-injected contralateral knees (127.0 士 16.3|^ g/g tissue;户<0.01，Student's 
paired t-test). Injections of saline plus lOOnmol capsaicin produced 226.3 土 26.6|Lig/g 
tissue Evans blue extravasation, which is not significantly different to that 
extravasated in their saline-injected contralateral knees (221.0 土 24.7)_ig/g tissue). In 
rat knees that had received injections lOOnmol capsaicin plus 2 % carrageenan, 179.2 
士 11.3|ig/g tissue Evans blue was extravasated. This is significantly more than that 
extravasated in their saline-injected contralateral knees (105.9 土 10.4jig/g tissue; 
户<0.001，Student's paired t-test). These results are shown in Figure 3.61a. 
Figure 3.61b shows the relative increases in Evans blue extravasation in the three 
groups of test knees after subtracted the amount of Evans blue extravasated in their 
respective contralateral knees. The result indicates that the group injected with saline 
plus capsaicin produced the smallest increase in Evans blue extravasation, capsaicin 
plus carrageenan is at the middle, and saline plus carrageenan produced the greatest 
amount of Evans blue extravasation. The theoretical effect of lOOnmol capsaicin 
plus 2 % carrageenan constructed by adding the effect of lOOnmol capsaicin plus 
saline and saline plus 2 % carrageenan was found to be slightly higher than that of 
saline plus 2 % carrageenan. Student's unpaired t-test showed no significant 
difference between all these groups (P>0.05). 
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3.3.2. Capsaicin on Carrageenan-induced Joint Swelling 
In addition to vasodilatation and plasma extravasation, oedema/swelling of the 
affected tissue is another indicator of inflammation. Therefore, the effects of 
capsaicin on carrageenan-induced joint swelling were investigated. Joint sizes were 
determined by the method described in Section 2.4.3. As shown in Figure 3.62a, in 
rat knees injected with 0.1ml saline followed 15 minutes later by an injection of 
0.1ml 2 % carrageenan, their mean knee joint size was 10.91 土 0.09mm. This is 
significantly bigger than the mean knee joint size of 9.45 士 0.06mm of their 
contralateral knees that had received paralleled 0.1ml saline injections (户<0.001, 
Student's paired t-test). Similarly, in rat knees injected with 1% capsaicin followed 
by an injection of 0.1ml saline 15 minutes later, their mean knee joint size was 10.09 
土 0.14mm, which is significantly bigger than their saline-injected contralateral knees 
(9.53 土 0.11mm;户<0.001，Student's paired t-test). In rat knees that had received 
injection of 1% capsaicin followed 15 minutes later by an injection of 2 % 
carrageenan, their mean knee joint size was 11.64 土 0.13mm. This is also 
substantially bigger than their saline-injected contralateral knees (9.61 土 0.06mm; 
户<0.001，Student's paired t-test). 
Figure 3.62b shows the relative increases in joint sizes in the three groups of test 
knees after subtracted their respective contralateral knee joint sizes. The result 
indicates that injections of saline plus capsaicin produced the smallest increase in 
knee joint size, saline plus carrageenan is at the middle, and capsaicin plus 
carrageenan produced the greatest increase. Student unpaired t-tests show that mean 
knee joint size of saline plus carrageenan treated knees is significantly different from 
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that of capsaicin 1% plus carrageenan 2 % (户<0.001)，capsaicin 1% plus saline 
treated knees (P<0.001) and the theoretical effect of capsaicin 1% plus carrageenan 
2 % (PO.Ol). The mean knee joint sizes of capsaicin 1% and saline treated knee is 
significantly different from the theoretical effect of capsaicin 1% plus carrageenan 
2 % and actual effect of capsaicin 1% plus carrageenan treated knee (P<0.001). 
A lower dose of lOOmnol capsaicin was also tested on carrageenan-induced joint 
swelling. As shown previously, rat knees injected with saline plus 2 % carrageenan 
had a mean knee joint size of 10.91 土 0.09mm, which is bigger than the mean knee 
joint size of their saline-injected contralateral knees (9.45 土 0.06mm; P<0.001, 
Student's paired t-test). In rat knees injected with saline plus 1% capsaicin, their 
mean knee joint size was 9.34 士 0.05mm. This is not different to that of their saline-
injected contralateral knees (9.27 土 0.04mm). In rat knees that had received 
injections 1% capsaicin plus 2 % carrageenan, their mean knee joint size was 10.14 土 
0.15mm. This is significantly bigger than their saline-injected contralateral knees 
(9.22 士 0.07mm; P<0.001, Student's paired t-test). These results are shown in Figure 
3.63a. 
Figure 3.63b shows the relative increases in joint sizes in the three groups of test 
knees after subtracted their respective contralateral knee joint sizes. The result 
indicates that injections of saline plus capsaicin produced no change in knee joint 
size，capsaicin plus carrageenan produced a small increase, and saline plus 
carrageenan produced the greatest increase. The theoretical swelling of lOOnmol 
capsaicin and 2% carrageenan constructed by adding the effect of lOOmnol capsaicin 
plus saline and saline plus 2 % carrageenan is even higher than the actual swelling 
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produced by saline plus 2 % carrageenan. Unpaired t-tests indicate that the mean 
knee joint size of lOOnmol capsaicin plus carrageenan treated knees is significantly 
different from that of all other groups (P<0.001), including the theoretical joint 
swelling (P<0.001). The mean knee joint size of capsaicin 1% and saline treated 
knee is significantly lower than the theoretical effect of capsaicin 1% plus 
carrageenan 2 % (P<0.001) and actual effect of saline plus carrageenan treated knee 
(P<0.01). 
3.3.3. Anandamide on Carrageenan-induced Plasma Extravasation 
Effects of A E A on carrageenan-induced plasma extravasation were investigated 
using the protocol described in Section 2.5. As shown in Figure 3.64a, in rat knees 
injected with saline plus 2 % carrageenan, 206.8 土 11.2)^ g/g tissue Evans blue was 
extravasated. This is significantly more than that extravasated in their saline-injected 
contralateral knees (127.0 士 16.3|Lig/g tissue; P<0.01, Student's paired t-test). 
Injections of saline plus lOOnmol A E A produced 126.6 士 11.7jLig/g tissue Evans blue 
extravasation, which is not significantly different to that extravasated in their saline-
injected contralateral knees (115.3 土 7.3|Lig/g tissue). In rat knees that had received 
injections of lOOnmol A E A plus 2 % carrageenan, 124.8 土 12.2|ig/g tissue Evans blue 
was extravasated. This is significantly more than that extravasated in their saline-
injected contralateral knees (83.68 士 6.20|Lig/g tissue; P<0.001, Student's paired t-
test). 
Figure 3.64b shows the relative increases in Evans blue extravasation in the three 
groups of test knees after subtracted the amount of Evans blue extravasated in their 
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respective contralateral knees. The result indicates that the group injected with saline 
plus A E A produced a minor and insignificant increase in Evans blue extravasation, 
A E A plus carrageenan is at the middle, and saline plus carrageenan produced the 
greatest amount of Evans blue extravasation. Student's unpaired t-test showed 
significant difference between the former and the latter group only (户<0.05). Only 
the effect of lOOnmol A E A plus saline was found to be significantly different from 
the theoretical effect of lOOnmol A E A plus 2 % carrageenan (P<0.05). 
3.3.4. Anandamide on Carrageenan-induced Joint Swelling 
The effects of A E A on carrageenan-induced joint swelling were investigated. Joint 
sizes were determined by the method described in Section 2.4.3. As shown in Figure 
3.65a, in rat knees injected with saline plus 2 % carrageenan, their mean knee joint 
size was 10.91 土 0.09mm. This is significantly bigger than the mean knee joint size 
of 9.45 士 0.06mm of their contralateral knees that had received paralleled saline 
injections (P<0.001, Student's paired t-test). In rat knees injected with saline plus 
lOOnmol AEA, their mean knee joint size was 9.49 土 0.05mm. This is not different to 
that of their saline-injected contralateral knees (9.55 土 0.07mm). In rat knees that had 
received injection of lOOnmol A E A plus 2 % carrageenan, their mean knee joint size 
was 10.63 土 0.13mm. This is significantly bigger than their saline-injected 
contralateral knees (9.42 士 0.08mm; P<0.001, Student's paired t-test). 
Figure 3.65b shows the relative increases in joint sizes in the three groups of test 
knees after subtracted their respective contralateral knee joint sizes. The result 
indicates that knee joints injected with saline plus A E A produced no change in joint 
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sizes，AEA plus carrageenan produced a small increase, and saline plus carrageenan 
produced a slightly bigger increase. Student's impaired t-test showed significant 
difference between the A E A lOOnmol plus saline treated knees and the other two 
groups (P<0.001). On the other hand, the theoretical effect of A E A plus 2% 
carrageenan was only found to be significantly different from that of A E A lOOnmol 
plus saline (P<0.001). 
— 
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Fig 3.1(a). Dose response curve of capsaicin on blood flow in the rat knee joint. 
Boluses of 0.1ml capsaicin were administered topically onto the exposed knee joint 
in a cumulative manner with 10 minutes interval between each administration. Data 
are expressed as % change in flux 土 SEM, n=5. 
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Figure 3.1(b). Trace showing the concomitant effect of capsaicin on blood pressure. 
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Figure 3.2. Time course of saline, 0. Inmol and Inmol capsaicin on blood flow of rat 
knee joint. Saline was applied 10 minutes prior to administration of the first dose of 
capsaicin at time 0, and the second dose was applied at 30 minutes. The first doses 
of 0.Inmol and Inmol capsaicin produced maximum increases in blood flow of 
21.0% and 50.1% respectively, and their second applications produced 21.0% and 
47.40/0 increase, respectively. Analyses by 2-way A N O V A indicates a significant 
difference between the curves for saline (V; n=13) and 0.Inmol capsaicin (•； ••鲁 
P<0.001, n=8) or Inmol capsaicin (•; ^  户<0.001; n=9), and between the curves for 
0.Inmol capsaicin and Inmol capsaicin (*** 户<0.001). Bonferroni post-hoc test also 
showed significant difference between the means for saline and 0.Inmol capsaicin 
(•••P<0.001) or Inmol capsaicin 广尸<0.05, 户<0.001) at time points indicated. 
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Figure 3.3. A trace showing the effect of capsaicin on blood pressure. Drugs were 
administered as a bolus onto the rat knee joint surface in a volume of 0.1ml. Saline 
was administered 10 minutes prior to the administration of Inmol capsaicin, and a 
second dose of Inmol capsaicin was applied 30 minutes later. Each administration 
of Inmol capsaicin produced a transient drop in blood pressure that recovered within 
5 minutes. 
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Figure 3.4. Two identical experiments performed a year apart on the vasodilator 
action of capsaicin in rat knee joint. Saline was administered 10 minutes prior to the 
administration of Inmol capsaicin at time 0 and a second dose of Inmol capsaicin 
was administered 30 minutes later. The vasodilator profiles for the two doses of 
capsaicin obtained in the original experiment (•) and in the repeated experiment (•) 
are the same (P>0.05, 2-way A N O V A ; n=9 and 7, respectively). 
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Fig 3.5. Comparison of saline and vehicle of capsaicin on blood flow of rat knee 
joint. Saline (•) or vehicle of capsaicin (V) was administered as a bolus applied 
onto the rat knee joint surface in a volume of 0.1ml at time -10，0 and 31 minutes. 
There is no significant difference between the curves for saline and vehicle 
administrations (P>0.05, 2-way A N O V A ; n= 13 and 8’ respectively). 
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Figure 3.6. Effects of the VRl antagonist capsazepine on capsaicin-induced 
vasodilatation. Rat knee joints were pretreated topically with either 0.5 or Sninol 
capsazepine at -10 minutes, and then the same dose of capsazepine was co-
administered with Inmol capsaicin at time 0. Analysis by 2-way A N O V A indicate 
no significant difference between the curves for capsaicin alone (•； n=l6) and 
capsaicin in the presence Inmol (A; n=10) or lOnmol (•； n=18) capsazepine. 
However, subsequent analysis by Bonferroni post-hoc test indicate a significant 
difference for capsaicin alone and capsaicin in the presence of Inmol capsazepine at 
the 25 minutes time point (* 户<0.05). 
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Figure 3.7. A trace showing the effect of 2 x Snmol of the VRl antagonist 
capsazepine on capsaicin-induced hypotension. Drugs were administered as a bolus 
applied onto the rat knee joint surface in a volume of 0.1ml. A dose of Snmol 
capsazepine was administered to the joint 10 minutes prior to co-administration of a 
second dose of the antagonist with Inmol capsaicin. This treatment with capsazepine 
did not affect the hypotensive action of capsaicin. 
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Figure 3.8. Comparison of saline and the VRl antagonist capsazepine on blood flow 
of rat knee joint. Saline (•)，0.Snmol capsazepine (〇）and Snmol capsazepine (•) 
were administered as a bolus applied onto the rat knee joint surface in a volume of 
0.1ml at -10 minutes and 0 minutes. There is no significant difference between the 
curves for saline and that of 2 x 0.Snmol capsazepine or 2 x Snmol capsazepine 
(P>0.05 for both, 2-way A N O V A ; n- 10, 6 and 8, respectively). 
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Figure 3.9. Effects of the VRl antagonist iodo-resiniferatoxin (I-RTX) on capsaicin-
induced vasodilatation. Rat knee joints were pretreated topically with Inmol I-RTX 
at -10 minutes, and then the same dose of I-RTX was co-administered with Inmol 
capsaicin at time 0. Analysis by 2-way A N O V A indicates significant difference 
between the curves for capsaicin alone (•) and capsaicin in the presence 2nmol I-
R T X (〇；*** 户<0.001; n二 16 and 8, respectively). Bonferroni post-hoc test also 
showed significant difference between their means at the time points indicated (** 
户<0.01,*** 户<0.001). 
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Figure 3.10. A trace showing the effects of 2 x Inmol of the VRl antagonist iodo-
resiniferatoxin (I-RTX) on capsaicin-induced hypotension. A dose of Inmol I-RTX 
was administered to the joint 10 minutes prior to co-administration of the same of the 
antagonist with Inmol capsaicin. I-RTX did not inhibit the hypotensive action of 
capsaicin. 
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Figure 3.11. Comparison of saline and the V R l antagonist iodo-resiniferatoxin (I-
RTX) on blood flow of rat knee joint. Saline (•) and Inmol I-RTX (〇）were 
administered as a bolus applied onto the rat knee joint surface in a volume of 0.1ml 
at -10 minutes and 0 minutes. There is no significant difference between the curves 
for saline and that of 2 x Inmol I-RTX (P>0.05，2-way A N O V A ; n= 10 and 6, 
respectively). 
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Figure 3.12. Effects of the NKi receptor antagonist SR140333 on capsaicin-induced 
vasodilatation. Rat knee joints were pretreated topically with either 1 or lOnmol 
SR140333 at -10 minutes, and then the same dose of SR140333 was co-administered 
with Inmol capsaicin at time 0. Analysis by 2-way A N O V A indicates no significant 
difference between the curves for capsaicin alone (•； n=l6) and capsaicin in the 
presence 2 x Inmol SR140333 (V; n=8)，but there is a significant difference between 
the curves for capsaicin alone and capsaicin in the presence of 2 x lOnmol SRI40333 
(A; n=6; *** 户<0.001). Bonferroni post-hoc test also showed significant difference 
between their means at the time points indicated (^PO.OS, *尸<0.01，拼户<0.001). 
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Figure 3.13. Traces showing the effects of (a) 2 x Inmol and (b) 2 x lOnmol of the 
NKi receptor antagonist SRI40333 on capsaicin-induced hypotension. Drugs were 
administered as a bolus applied onto the rat knee joint surface in a volume of 0.1ml. 
A dose of 1 or lOrnnol SR140333 was administered to the joint 10 minutes prior to 
co-administration of a second dose of the antagonist with Inmol capsaicin. These 
treatments with SRI 4033 3 did not affect the hypotensive action of capsaicin. 
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Figure 3.14. Comparison of saline and the NKi receptor antagonist SR140333 on 
blood flow of rat knee joint. Saline (•), Inmol SR140333 (〇）and lOnmol 
SR140333 (•) were administered as a bolus applied onto the rat knee joint surface in 
a volume of 0.1ml at -10 minutes and 0 minutes. There is no significant difference 
between the curves for saline and that of 2 x Inmol SR140333 (P>0.05, 2-way 
A N O V A ; n二 10 and 8, respectively), but there is a significant difference between the 
curves for saline and that of 2 x lOnmol SR140333 (*** 户<0.001，2-way A N O V A ; 
n=10 and 6, respectively). Bonferroni post-hoc test also showed significant 
difference between their means at the time points indicated (*** 户<0.001). 
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Figure 3.15. Time course of the vasoconstrictor action of the NKi receptor 
antagonist SR140333 alone and in the presence of capsaicin on rat knee joint. The 
curve for antagonist alone (•) was constructed by two consecutive administrations 
of lOnmol of the antagonists at -10 and 0 minute. The curve for antagonist with 
capsaicin (A) was constructed by administering lOnmol of the antagonist at -10 
minutes, and then the same dose of the antagonist was co-administered with Inmol 
capsaicin at 0 minute. The vasoconstrictor action of the antagonist was the same in 
the absence or the presence of capsaicin (P>0.05, 2-way A N O V A ; n=10 and 6, 
respectively). 
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Figure 3.16. Effects of the NKi receptor antagonist RP67580 on capsaicin-induced 
vasodilatation. Rat knee joints were pretreated topically with either 1 or lOnmol 
RP67580 at -10 minutes, and then the same dose of RP67580 was co-administered 
with Inmol capsaicin at time 0. Analysis by 2-way A N O V A indicates no significant 
difference between the curves for capsaicin alone (•； n=16) and capsaicin in the 
presence 2 x Inmol RP67580 (•； n=6), but there is a significant difference between 
the curves for capsaicin alone and capsaicin in the presence of 2 x lOnmol RP67580 
(V; n=6; ^ P<0.001). Bonferroni post-hoc test also showed a significant difference 
for capsaicin alone and capsaicin in the presence of 2 x lOrnnol RP67580 at the time 
points indicated (+户<0.05, "^P<0.01). 
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Figure 3.17. Traces showing the effects of (a) 2 x Inmol and (b) 2 x lOnmol of the 
NKi receptor antagonist RP67580 on capsaicin-induced hypotension. Drugs were 
administered as a bolus applied onto the rat knee joint surface in a volume of 0.1ml. 
A dose of 1 or lOnmol RP67580 was administered to the joint 10 minutes prior to co-
administration of a second dose of the antagonist with Inmol capsaicin. These 
treatments with RP67580 did not affect the hypotensive action of capsaicin. 
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Figure 3.18. Comparison of saline and the NKi receptor antagonist RP67580 on 
blood flow of rat knee joint. Saline (•), Inmol RP67580 (A) and lOnmol RP67580 
(•) were administered as a bolus applied onto the rat knee joint surface in a volume 
of 0.1ml at -10 minutes and 0 minutes. There is no significant difference between 
the curves for saline and that of 2 x Inmol RP6758 (P>0.05, 2-way A N O V A ; n=10 
and 8, respectively), but there is a significant difference between the curves for saline 
and that of 2 x lOnmol RP67580 (*** 户<0.001, 2-way A N O V A ; n二 10 and 6, 
respectively). Bonferroni post-hoc test also showed significant difference between 
their means at the time points indicated (*** 户<0.001). 
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Figure 3.19. Time course of the NKi receptor antagonist RP67580 alone and in the 
presence of capsaicin on rat knee joint. The curve for antagonist alone (•) was 
constructed by two consecutive administrations of lOnmol of the antagonists at -10 
and 0 minute. The curve for antagonist with capsaicin (•) was constructed by 
administering lOnmol of the antagonist at -10 minutes, and then the same dose of the 
antagonist was co-administered with Inmol capsaicin at 0 minute. Analysis of 2-way 
A N O V A indicates that the two curves are significantly different (*** P<0.001, 2-way 
A N O V A ; n=10 and 6, respectively). 
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Figure 3.20. Dose response relationship of the vasodilator effect ofNKi antagonist, 
RP67580 on blood flow in the rat knee joint. RP67580 was administered topically 
onto the exposed knee joint as a bolus at a volume of 0.1ml. The action of the drug 
was observed for 10 minutes, followed by a 10 minutes wash out. Data are 
expressed as % change in flux 土 SEM, n二8. 
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Figure 3.21. Effects of the CGRP receptor antagonist CGRPg-sy on capsaicin-
induced vasodilatation. Rat knee joints were pretreated topically with 0.1 or Inmol 
CGRP8-37 at -10 minutes, and then the same doses of CGRPg-s? were co-administered 
with Inmol capsaicin at time 0. Analysis by 2-way A N O V A indicates a significant 
difference between the curves for capsaicin alone (•； n=16) and capsaicin in the 
presence 0.2nmol CGRPg-sy (•;户<0.001; n=8) or 2nmol CGRPg-ay (〇；户<0.001; 
n=6). Bonferroni post-hoc test also showed significant difference between the means 
for capsaicin alone and capsaicin in the presence of 0.2nmol CGRPg-s? (* 户<0.05, ** 
户<0.01，*** P<0.001) or 2nmol CGRPg-sv CP<0.05, P<0.01,得户<0.001) at the 
time points indicated. 
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Figure 3.22. Traces showing the effects of a) 2 x O.lnmol and b) 2 x Inmol of the 
CGRP antagonist CGRPg-s? on capsaicin-induced hypotension. A dose of O.lnmol or 
Inmol CGRPg-sv was administered to the joint 10 minutes prior to co-administration 
of the same of the antagonist with Inmol capsaicin. CGRPg-s? did not inhibit the 
hypotensive action of capsaicin. 
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Figure 3.23. Comparison of saline and the C G R P receptor antagonist CGRPg-s? on 
blood flow of rat knee joint. Saline (•)，0. Inmol CGRPg-s?(〇）and Inmol CGRPg. 
37 (•) were administered as a bolus applied onto the rat knee joint surface in a 
volume of 0.1ml at -10 minutes and 0 minutes. There is a significant difference 
between the curves for saline and that of 2 x O.lmnol CGRPg-s? (* 尸<0.01, 2-way 
A N O V A ; n=10 and 6, respectively). There is also significant difference between the 
curves for saline and that of 2 x Inmol CGRPg-s? C"尸<0.001, 2-way A N O V A ; n=10 
and 6, respectively). Bonferroni post-hoc test also showed significant difference 
between their means at the time points indicated (** 户<0.01, *** P<0.001). 
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Figure 3.24. Dose response relationship of the vasodilator effect of C G R P antagonist, 
CGRP8-37 on blood flow in the rat knee joint. CGRPg-s? was administered topically 
onto the exposed knee joint as a bolus at a volume of 0.1ml. The action of the drug 
was observed for 10 minutes, followed by a 10 minutes wash out. Data are 
expressed as % change in flux 土 SEM, n=8. 
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Figure 3.25. Dose responses of capsaicin (O.Olmnol to O.l^ imol; n=8) on blood flow 
in the rat knee joint that has been denervated by a) 1% capsaicin (•； n二7)，by b) 
surgical denervation of saphenous nerve (〇；n二7) and sham-operated (•; n二7). 
Capsaicin was administered topically onto the exposed knee joint as a bolus at a 
volume of 0.1ml, in a cumulative maimer with 10 minutes interval between each 
administration. 1% Capsaicin treatment significantly reduced vasodilatation to 
capsaicin at doses of 0.1 and Inmol (* 尸<0.05). There is no significant difference in 
surgical denervated and sham-operated knees compared to normal knee (P>0.05, 2-
wayANOVA). 
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Figure 3.26. Dose responses curve of anandamide (AEA) on blood flow in the rat 
knee joint. Boluses of 0.1ml anandamide were administered topically onto the 
exposed knee joint. The action of the drug was observed for 15 minutes, followed by 
10 minutes wash out and administration of the next dose. Data are expressed as % 
change in flux 土 SEM, n=5. 
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Figure 3.27. Traces showing the concomitant effects of topical administration of 
A E A on systemic blood pressure. 
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Figure 3.28. Time course of lOrnnol (•； n=10) and lOOnmol (•； n=8) A E A on 
blood flow of rat knee joint. Saline was applied 10 minutes prior to administration of 
the first dose of A E A at time 0, and a second dose was applied 30 minutes later. The 
first doses of lOrnnol and lOOnmol produced maximum increases of blood flow of 
30.3% and 61.8% respectively, and their second doses produced a 30.6% and 53.3% 
increase, respectively. Increase in blood flow to A E A was shorter lasting than that of 
Inmol capsaicin (see Fig 3.2). Analyses by 2-way A N O V A indicates a significant 
difference between the curves for saline (V; n=13) and lOnmol A E A (•••PO.OOl) 
or lOOnmol A E A C^ P<0.001), and between the curves for lOnmol A E A and 
lOOnmol A E A (** P<0.01). Bonferroni post-hoc test also showed significant 
difference between their means at the time points indicated. 
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Figure 3.29. Traces showing effects of a) lOnmol and b) lOOnmol A E A on blood 
pressure. Drugs were administered as a bolus applied onto the rat knee joint surface 
in a volume of 0.1ml. Saline was applied 10 minutes prior to the first administrations 
of A E A at time 0 and the second administrations of A E A applied at 30 minutes. 
Both doses of A E A did not affect the systemic blood pressure. 
— 一 
Chapter 3 - Results 
80-1 
-O-Sal ine 
70- • V e h i c l e 0.35% 




1 30- i 
1 1 1 1 1 -r- , ~ 
- 1 0 0 10 2 0 3 0 4 0 5 0 6 0 
Time (min) 
Figure 3.30. Comparison of saline and vehicle of A E A Tocrisolve™ 100，on blood 
flow of rat knee joint. Saline (•) or vehicle 0.35% (•) and 3.45% (•) was 
administered as a bolus applied onto the rat knee joint surface in a volume of 0.1ml 
at -10, 0 and 31 
minutes. There is no significant difference between the curves for 
saline and that of 0.35% or 3.45% Tocrisolve™ 100 (i^O.05 for both; 2-way 
A N O V A ; n=7 and 6, respectively). 
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Figure 3.31. Effects of the V R l antagonist capsazepine on AEA-induced 
vasodilatation. Rat knee joints were pretreated topically with either 0.5 or Snmol 
capsazepine at -10 minutes, and the same dose of capsazepine was co-administered 
with lOmnol A E A at time 0. Analysis by 2-way A N O V A indicates no significant 
difference between the curves for lOnmol A E A alone (•； n=10) and A E A in the 
presence of 2 x O.Snmol capsazepine (•; n=8; P>0.05), but there is a significant 
difference between the curves for lOnmol A E A alone and A E A in the presence of 2 x 
5nmol capsazepine (〇；n=8; * 户<0.01). Bonferroni post-hoc tests showed a 
significant difference between the means of lOnmol A E A and lOnmol A E A in the 
presence of 2 x O.Snmol capsazepine (* _P<0.05). There is also a significant 
difference between the means of lOnmol A E A and lOmnol A E A in the presence of 2 
X 5iunol capsazepine (^P<0.001, "^P<0.01, +P<0.05). 
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Figure 3.32. Effects of the V R l antagonist capsazepine on AEA-induced 
vasodilatation. Rat knee joints were pretreated topically with either 0.5 or Snmol 
capsazepine at -10 minutes, and the same dose of capsazepine was co-administered 
with lOOnmol A E A at time 0. Analysis by 2-way A N O V A indicates significant 
difference between the curves for lOOnmol A E A alone (•； n=8) and A E A in the 
presence of 2 x O.Snmol capsazepine (A; n二8; *** 户<0.001), and there is significant 
difference between the curves for lOnmol A E A alone and A E A in the presence of 2 x 
5mnol capsazepine (V; n=8;袖户<0.001). Bonferroni post-hoc tests showed a 
significant difference between the means of lOOnmol A E A and lOOnmol A E A in the 
presence of 2 x O.Snmol capsazepine (*** 户<0.001, * P<0.05). There is also a 
significant difference between the means of lOOnmol A E A and lOOnmol A E A in the 
presence of 2 x Snmol capsazepine (^P<0.001, "^P<0.0l/P<0.05). 
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Figure 3.33. Effects of the VRl antagonist iodo-resiniferatoxin (I-RTX) on AEA-
induced vasodilatation. Rat knee joints were pretreated topically with Inmol I-RTX 
at -10 minutes, and the same dose of I-RTX was co-administered with lOnmol A E A 
at time 0. Analysis by 2-way A N O V A indicates a significant difference between the 
curves for lOnmol A E A alone (•； n=10) and A E A in the presence of 2 x Inmol I-
R T X (A; n=8; ** P<0.01). Bonferroni post-hoc tests also showed a significant 
difference between the means of lOnmol A E A and lOnmol A E A in the presence of 2 
X Inmol I-RTX (** P<0.01, * P<0.05). 
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Figure 3.34. Effects of the VRl antagonist iodo-resiniferatoxin (I-RTX) on AEA-
induced vasodilatation. Rat knee joints were pretreated topically with Inmol I-RTX 
at -10 minutes, and the same dose of I-RTX was co-administered with lOOnmol A E A 
at time 0. Analysis by 2-way A N O V A indicates significant difference between the 
curves for lOOnmol A E A alone (•； n=8) and A E A in the presence of 2 x Inmol I-
R T X (A; n=8; *** P<0.001). Bonferroni post-hoc tests also showed a significant 
difference between the means of lOOnmol A E A and lOOnmol A E A in the presence of 
2 X Inmol I-RTX (** P<0.01, * P<0.05). 
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Figure 3.35. Effects of the NKi antagonist SR140333 on AEA-induced 
vasodilatation. Rat knee joints were pretreated topically with either 1 or lOnmol 
SR140333 at -10 minutes, and the same doses of SR140333 were co-administered 
with lOnmol A E A at time 0. Analysis by 2-way A N O V A indicates significant 
difference between the curves for lOnmol A E A alone (•； n=10) and A E A in the 
presence of 2 x Inmol SR140333 (A; n=8; *** 户<0.001) or in the presence of 2 x 
lOnmol SR140333 ( V ; n=8; ^ P<0.001). Bonferroni post-hoc tests showed a 
significant difference between the means of lOnmol A E A and lOnmol A E A in the 
presence of 2 x limiol SR140333 (*** P<0.001, * P<0.05). There is also a significant 
difference between the means of lOnmol A E A and lOnmol A E A in the presence of 2 
X lOnmol SR140333 P<0.001, ^ 户<0.01, + 户<0.05). 
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Figure 3.36. Time course of the vasoconstrictor action of the NKi receptor 
antagonist SR140333 alone and in the presence of A E A on rat knee joint. The curve 
for antagonist alone (•) was constructed by two consecutive administrations of 
lOnmol of the antagonists at -10 and 0 minute. The curve for antagonist with A E A 
(A) was constructed by administering lOnmol of the antagonist at -10 minutes, and 
then the same dose of the antagonist was co-administered with Inmol A E A at 0 
minute. The vasoconstrictor action of the antagonist was the same in the absence or 
the presence of A E A (P>0.05, 2-way A N O V A ; n=7 and 8, respectively). 
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Figure 3.37. Effects of the NKi antagonist SR140333 on AEA-induced 
vasodilatation. Rat knee joints were pretreated topically with Inmol SR140333 at -
10 minutes, and the same dose of SRI40333 was co-administered with lOOnmol 
A E A at time 0. Analysis by 2-way A N O V A indicates a significant difference 
between the curves for lOOnmol A E A alone (•； n=8) and A E A in the presence of 2 
X Inmol SR140333 (•； n-6; *** PO.OOl). Bonferroni post-hoc tests showed a 
significant difference between the means of lOOmnol A E A and lOOnmol A E A in the 
presence of 2 x Inmol SR140333 (*** 户<0.001, * _P<0.05). 
— 
Chapter 3 - Results 
+ AEA lOnmol "] * * • 
- A - AEA 10nmol + RP67580 2nmol + + + 
AEA 10nmol + RP67580 20nmol � 
60_ +++ 
+++ 
40- /I * *** 
-20-
~ I 1 1 1 —r-
-10 0 10 20 30 
Time (min) 
Figure 3.38. Effects of the NKi antagonist RP67580 on AEA-induced vasodilatation. 
Rat knee joints were pretreated topically with either 1 or lOnmol RP67580 at -10 
minutes, and the same doses of RP67580 were co-administered with lOnmol A E A at 
time 0. Analysis by 2-way A N O V A indicates significant difference between the 
curves for lOnmol A E A alone (•； n=10) and A E A in the presence of 2 x Inmol 
RP67580 (A; n=8; ** 户<0.01) or in the presence of 2 x lOrnnol RP67580 (V; n二8; 
"^P<0.001). Bonferroni post-hoc tests showed a significant difference between the 
means of lOnmol A E A and lOnmol A E A in the presence of 2 x Inmol RP67580 (*** 
户<0.001, * P<0.05). There is also a significant difference between the means of 
lOnmol A E A and lOnmol A E A in the presence of 2 x lOnmol RP67580 
尸 <0.001). 
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Figure 3.39. Time course of the vasodilator action of the NKi receptor antagonist 
RP67580 alone and in the presence of A E A on rat knee joint. The curve for 
antagonist alone (•) was constructed by two consecutive administrations of lOrnnol 
of the antagonists at -10 and 0 minute. The curve for antagonist with A E A (•) was 
constructed by administering lOnmol of the antagonist at -10 minutes, and then the 
same dose of the antagonist was co-administered with lOrnnol A E A at 0 minute. The 
vasodilator action of the antagonist was the same in the absence or the presence of 
A E A (P>0.05, 2-way A N O V A ; n=6 and 8, respectively). 
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Figure 3.40. Effects of the NKi antagonist RP67580 on AEA-induced vasodilatation. 
Rat knee joints were pretreated topically with Inmol RP67580 at -10 minutes, and 
the same dose of RP67580 was co-administered with lOOnmol A E A at time 0. 
Analysis by 2-way A N O V A indicates a significant difference between the curves for 
lOOmnol A E A alone (•； n=8) and A E A in the presence of 2 x Inmol SR140333 (•； 
n二6; *** P<0.001). Bonferroni post-hoc tests showed a significant difference 
between the means of lOOmnol A E A and lOOnmol A E A in the presence of 2 x Inmol 
RP67580 (*** P<0.001, * 户<0.05). 
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Figure 3.41. Effects of the CGRP antagonist CGRPg-sv on AEA-induced 
vasodilatation. Rat knee joints were pretreated topically with either 0.1 or Inmol 
CGRP8-37 at -10 minutes, and the same doses of CGRPg-s? were co-administered with 
lOnmol A E A at time 0. Analysis by 2-way A N O V A indicates significant difference 
between the curves for lOnmol A E A alone (•; n=10) and A E A in the presence of 2 
X Inmol CGRP8-37 (〇;n=8; + P<0.05) but not in the presence of 2 x 0.Inmol CGRPg. 
37 (A; n=8; P>0.05). Bonferroni post-hoc tests showed a significant difference 
between the means of lOnmol A E A and lOnmol A E A in the presence of 2 x Inmol 
CGRPg-s? C^P<0.001), but there is no significant difference between the means of 
lOnmol A E A and lOrnnol A E A in the presence of 2 x 0.Inmol CGRP8-37 (P>0.05). 
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Figure 3.42. Effects of the CGRP antagonist CGRPg-sy on AEA-induced 
vasodilatation. Rat knee joints were pretreated topically with either 0.1 or Inmol 
CGRPg-s? at -10 minutes, and the same dose of CGRPg-s? was co-administered with 
lOOnmol A E A at time 0. Analysis by 2-way A N O V A indicates significant 
difference between the curves for lOOnmol A E A alone (•； n=8) and A E A in the 
presence of 2 x Inmol CGRPg-s? (•； n=8; "^^<0.001, ^ P<0.01) but not in the 
presence of 2 x 0.Inmol CGRPg-s? (A; n=6; P>0.05). Bonferroni post-hoc tests 
showed a significant difference between the means of lOOnmol A E A and lOOnmol 
A E A in the presence of 2 x Inmol CGRPg-s? (^P<0.001, ^P<0.01), but there is no 
significant difference between the means of lOOnmol A E A and lOnmol A E A in the 
presence of 2 x 0.Inmol CGRPg-s? (P>0.05). 
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Figure 3.43. Effects of the CBi antagonist AM281 on AEA-induced vasodilatation. 
Rat knee joints were pretreated topically with 0. Inmol AM281 at -10 minutes, and 
the same dose of AM281 was co-administered with lOnmol A E A at time 0. Analysis 
by 2-way A N O V A indicates no significant difference between the curves for lOnmol 
A E A alone (•； n=10) and A E A in the presence of 2 x 0.Inmol AM281 (A; n=8; 
P>0.05). Bonferroni post-hoc tests showed no significant difference between their 
means (P>0.05). 
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Figure 3.44. Effects of the CBi antagonist AM281 on AEA-induced vasodilatation. 
Rat knee joints were pretreated topically with either 0.1 or Irnnol AM281 at -10 
minutes, and the same dose of AM281 was co-administered with lOOnmol A E A at 
time 0. Analysis by 2-way A N O V A indicates no significant difference between the 
curves for lOOnmol A E A alone (•； n=8) and A E A in the presence of 2 x O.lnmol 
AM281 (〇；n=6; P>0.05) or in the presence of 2 x Inmol AM281 (•； n=6; P>0.05). 
Bonferroni post-hoc tests showed no significant difference between the means of 
lOOnmol A E A and lOOnmol A E A in the presence of 2 x O.lnmol AM281 (P>0.05), 
or in the presence of 2 x Inmol AM281 (P>0.05). 
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Figure 3.45. Comparison of saline and the CBi receptor antagonist AM281 on blood 
flow of rat knee joint. Saline (•), 0. Inmol AM281 (〇）and Inmol AM281 (A) 
were administered as a bolus applied onto the rat knee joint surface in a volume of 
0.1ml at -10 minutes and 0 minutes. There is no significant difference between the 
curves for saline and that of 2 x 0. Irnnol AM281 or 2 x Inmol AM281(P>0.05, 2-
way A N O V A ; n=10, 7，and 6 respectively). Bonferroni post-hoc test also showed no 
significant difference for saline and 2 x 0.Irnnol AM281 or 2 x Inmol AM281 (P> 
0.05 for both). 
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Figure 3.46. Dose response relationship of the vasodilator effect of CBi antagonist, 
AM281 (O.Olnmol to 30nmol; n=6) on blood flow in the rat knee joint. AM281 was 
administered topically onto the exposed knee joint as a bolus at a volume of O.lmmol. 
The action of the drug was observed for 10 minutes, followed by a 10 minutes wash 
out. Data are expressed as % change in flux 土 SEM. 
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Figure 3.47. Effects of the CB2 antagonist AM630 on AEA-induced vasodilatation. 
Rat knee joints were pretreated topically with 0. Inmol AM630 at -10 minutes, and 
the same dose of AM630 was co-administered with lOnmol A E A at time 0. Analysis 
by 2-way A N O V A indicates no significant difference between the curves for lOnmol 
A E A alone (•； n二 10) and A E A in the presence of 2 x 0.Inmol AM630 (A; n=8; 
P>0.05). Bonferroni post-hoc tests showed no significant difference between their 
means (P>0.05). 
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Figure 3.48. Effects of the CB2 antagonist AM630 on AEA-induced vasodilatation. 
Rat knee joints were pretreated topically with either 0.1 or Irnnol AM630 at -10 
minutes, and the same doses of AM630 were co-administered with lOOnmol A E A at 
time 0. Analysis by 2-way A N O V A indicates significant difference between the 
curves for lOOnmol A E A alone (•； n=8) and A E A in the presence of 2 x 0.Inmol 
AM630 (〇；n=8; ** P<0.01) or in the presence of 2 x Inmol AM630 (•； n=8; + 
户<0.05). Bonferroni post-hoc tests showed significant difference between the means 
of lOOnmol A E A alone and lOOnmol A E A in the presence of 2 x 0.Inmol AM630 
(** 户<0.01, * 户<0.05), or in the presence of 2 x Inmol AM630 C^P<0.001) at time 
points indicated. 
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Figure 3.49. Comparison of saline and the CB2 receptor antagonist AM630 on blood 
flow of rat knee joint. Saline (•), 0. Inmol AM630 (•) and Inmol AM630 (〇） 
were administered as a bolus applied onto the rat knee joint surface in a volume of 
0.1ml at -10 minutes and 0 minutes. There is no significant difference between the 
curves for saline and that of 2 x 0.Inmol AM630 or 2 x Inmol AM630 (P>0.05, 2-
way A N O V A ; n=10, 6，and 6 respectively). Bonferroni post-hoc test showed no 
significant difference for saline and 2 x 0. Inmol AM281, but there is a significant 
difference for saline and 2 x Inmol AM281 at time -1 Imin (* P< 0.05). 
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Figure 3.50. Effects of the anandamide transporter inhibitor AM404 on AEA-
induced vasodilatation. Rat knee joints were pretreated topically with O.Smnol 
A M 4 0 4 at -10 minutes, and the same dose of AM404 was co-administered with 
lOnmol A E A at time 0. Analysis by 2-way A N O V A indicates a significant 
difference between the curves for lOnmol A E A alone (•； n=10) and A E A in the 
presence of 2 x 0.5mnol AM404 (A; n=8; * 尸<0.05). Bonferroni post-hoc tests 
showed significant difference between their means at time points indicated (*** 
P<0.001, ** P<0.01). 
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Figure 3.51. Effects of the anandamide transporter inhibitor AM404 on AEA-
induced vasodilatation. Rat knee joints were pretreated topically with O.Snmol 
AM404 at -10 minutes, and the same dose of AM404 was co-administered with 
lOOnmol A E A at time 0. Analysis by 2-way A N O V A indicates a significant 
difference between the curves for lOOnmol A E A alone (•； n=8) and A E A in the 
presence of 2 x O.Snmol AM404 (A; n=9; *** 户<0.001). Bonferroni post-hoc tests 
showed significant difference between their means at time points indicated (*** 
P<0.001). 
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Figure 3.52。Comparison of saline and the anandamide transporter inhibitor AM404 
on blood flow of rat knee joint. Saline (•), O.Snmol AM404 (A) were administered 
as a bolus applied onto the rat knee joint surface in a volume of 0.1ml at -10 minutes 
and 0 minutes. There is no significant difference between the curves for saline and 
that of 2 X O.Smnol AM404 (P>0.05, 2-way A N O V A ; n = 1 0�7 respectively). 
Bonferroni post-hoc test showed no significant difference for saline and 2 x O.Snmol 
AM404. 
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Figure 3.53. Effects of the anandamide transporter inhibitor AM404 on capsaicin-
induced vasodilatation. Rat knee joints were pretreated topically with 0.5nmol 
AM404 at -10 minutes, and the same dose of AM404 was co-administered with 
Irnnol capsaicin at time 0. Analysis by 2-way A N O V A indicates no significant 
difference between the curves for Inmol capsaicin alone (參；n=16) and capsaicin in 
the presence of 2 x 0.5nmol AM404 (A; n=6; P>0.05). Bonferroni post-hoc tests 
also showed significant difference between their means (P>0.05). 
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Figure 3.54. Dose responses of A E A (Inmol to Ijimol; n=6) on blood flow in the rat 
knee joint that has been denervated by a) 1% capsaicin (•； n=6), by b) surgical 
denervation of saphenous nerve (〇；n二9). A E A was administered topically onto the 
exposed knee joint as a bolus at a volume of 0.1ml. The action of the drug was 
observed for 10 minutes, followed by a 15 minutes wash out. Data are expressed as 
% change in flux 士 SEM. There is no significant difference for AEA-induced 
vasodilatation and that on 1% capsaicin-treated or surgically denervated knees 
(P>0.05 for both, 2-way ANOVA). 
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Figure 3.55. Effect of saline injection on plasma extravasation in rat knee joint. 
Injection of saline produced a significant increase in plasma extravasation (*** 
P<0.001;n=32). 
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Figure 3.56. a) Effect of capsaicin on plasma extravasation. Capsaicin at doses of 
0.Inmol (11=23), lOnmol (n=12) and lOOnmol (n=5) produced extravasation of Evans 
blue (EB) that were not different from their respective contralateral knees (P>0.05, 
paired t-tests), whereas Inmol of capsaicin produced higher extravasation of EB 
compared with its respective contralateral knee (^P<0.05, paired t-tests, n=14). 
Unpaired t-test reveals a significant difference for saline-induced extravasation of EB 
(see Fig. 3.55) and that produced by contralateral knees of animals that receive a 
treatment of 0.1 and lOOnmol capsaicin (*** 尸<0.001, ** 户<0.01). b) Relative 
changes in extravasation of EB caused by capsaicin after subtracted the amount of 
EB extravasated in their respective contralateral knees. Unpaired t-tests indicates 
significant difference between groups as indicated (* P<0.05). 
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Figure 3.57. a) Effect of saline and capsaicin on joint swelling. There is no 
significant difference between capsaicin (0.1 - lOOnmol) and their respective 
contralateral knees (P>0.05, paired t-tests, n=35, 28, 20，and 24 respectively). 
Injection of saline produced a significantly higher joint swelling compared with its 
uninjected contralateral knee (*** P<0.001, paired t-tests, n=99). b) Relative 
changes in joint swelling caused by capsaicin (0.1-lOOnmol) after subtracted the size 
of their respective contralateral knees. Unpaired t-tests indicate significant 
difference between groups as indicated (*** 户<0.001, * P<0.05). 
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Figure 3.58. a) Effect of A E A on plasma extravasation. A E A at a dose of lOOnmol 
produced an extravasation of Evans blue (EB) that was not significantly different 
from that of its respective contralateral knee (P>0.05, paired t-tests, n二6), but the 
extravasation of EB produced by lOOOnmol A E A was significantly lower than that of 
its contralateral knee (** 户<0.01, paired-t-tests�n=6). Unpaired t-test did not show 
any significant difference for saline-induced extravasation of EB (shown in Figure 
3.55) and that produced by A E A (P>0.05). b) Relative changes in extravasation of 
EB caused by 100 and lOOOnmol A E A after subtracted the amount of EB 
extravasated in their respective contralateral knees. Unpaired t-tests indicate that 
there is no significant difference between the two groups (P>0.05). 
— 
Chapter 3 - Results 
a) 
… ** ** 
10-1 I 1 I 1 













oLc———t^n^ ,/ / 
Figure 3.59. a) Effect of saline and A E A on joint swelling. There is no significant 
difference between A E A (lOOnmol) and its respective contralateral knees (P>0.05, 
paired t-tests, n= 24), but A E A at a dose of lOOOnmol produced a swelling that is 
significantly higher than its respective contralateral knee (*** 尸<0.001, paired t-tests, 
n二24). Injection of saline as indicated in Figure 3.57a, produced a significantly 
higher joint swelling compared with its uninjected contralateral knee (*** 户<0.001, 
paired t-tests, n=92). b) Relative changes in joint swelling caused by 100 and 
lOOOnmol of A E A after subtracted the size of their respective contralateral knees. 
Unpaired t-tests indicate significant difference between groups as indicated (** 
P<0.01). 
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Figure 3.60. a) Effect of 1% (or 3.27|imol) capsaicin on acute inflammation evoked by 2% 
carrageenan. Extravasation of Evans blue (EB) produced by infra-articular injection of 
saline plus 2 % carrageenan was 206.8 士 11.2|j^ g/g tissue, this is significantly higher than that 
of their contralateral knees (127.0 士 16.3 ]ig/g tissue; *** P<0.001; paired t-tests; n=9). 1% 
capsaicin plus saline produced 375.0 士 27.6 jj-g/g tissue EB extravasation, which is higher 
than that extravasated in their contralateral knees (166.2 士 16.1|j^ g/g tissue; *** P < 0 . 0 0 1 ; 
n=8). 1% capsaicin plus 2% carrageenan produced 271.0 土 26.7|j<g/g tissue EB extravasation, 
which is also significantly higher than their contralateral knees (101.0 士 16.8|Lig/g tissue; +++ 
P<0.001; n=9). b) Relative changes in extravasation of EB caused by the three treatments 
after subtracted the amount of EB extravasated in their respective contralateral knees. 
Unpaired t-tests shows that EB extravasation produced by saline plus carrageenan was 
significantly different from that produced by cap 1% plus 2% carageenan (* P<0.05), cap 1% 
plus saline (** P<0.01) and the theoretical EB extravasation produced by adding the effects 
of cap 1% plus saline and saline plus carrageenan (** P<0.01). _ 
Chapter 3 - Results 
a) 
400-^ +++ 
(A 300-‘ ‘ “‘ 
I — , 
23 200- : ^ ^ nj|i 
L I l _ _ 
b) 






S =1 100- 工 工 
—。l_ T _ _ 
7 V / / 
/ / 一' z 
Figure 3.61. a) Effect of lOOnmol capsaicin on acute inflammation evoked by 2% 
carrageenan. As shown previously, extravasation of Evans blue (EB) produced by 
intra-articular injection of saline plus 2% carrageenan was 206.8 土 11.2|ig/g tissue, 
this is significantly higher than that of their contralateral knees (127.0 土 16.3 fig/g 
tissue;扮户<0.001; paired t-tests; n二9). lOOnmol capsaicin plus saline produced 
226.3 士 26.6 )ig/g tissue EB extravasation, which is not significantly different from 
that extravasated in their contralateral knees (221.0 土 24.7|Lig/g tissue; P>0.05; n二8). 
lOOnmol capsaicin plus 2% carrageenan produced 179.2 士 11.3|Lig/g tissue EB 
extravasation, this was significantly higher than their contralateral knees (105.9 士 
\QA\xg/g tissue; n二7). b) Relative changes in extravasation of EB 
caused by the three treatments after subtracted the amount of EB extravasated in their 
respective contralateral knees. Unpaired t-tests indicate that there is no significant 
difference between all groups (P>0.05). 
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Figure 3.62. a) Effect of 1% (or 3.27}j.mol) capsaicin on joint swelling evoked by 
2 % carrageenan. Mean knee joint size of saline plus 2 % carrageenan treated knee 
was 10.91 土 0.09mm. This is significantly higher than that of their contralateral 
knees (9.45 土 0.06mm; *** 户<0.001; paired t-tests; n=34)，capl% plus saline treated 
knees (10.09 土 0.14mm; *** P<0.001; unpaired t-tests; n=28), and smaller than cap 
1% plus carrageenan 2 % treated knees (11.64 土 0.13mm; *** 尸<0.001; unpaired t-
tests; n=30). Mean joint sizes of 1% capsaicin plus saline and 1% capsaicin plus 2% 
carrageenan treated knees are significantly different from their contralateral knees 
(9.53 土 0.11mm and 9.61 土 0.06mm, respectively; *** P<0.001; paired t-test; n二28 
and 30). 
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Figure 3.62. b) Relative changes in joint swelling caused by the three treatments 
after subtracted the knee joint sizes of their respective contralateral knees. Unpaired 
t-tests shows that mean knee joint size of saline plus carrageenan treated knees is 
significantly different from that of capsaicin 1 % plus carrageenan 2 % (*** 户<0.001), 
and cap 1% plus saline treated knees (*** P<0.01) and the theoretical joint swelling 
produced by adding the effects of capsaicin 1% plus saline and saline plus 
carrageenan (** P<0.01). The mean knee joint sizes of capsaicin 1% and saline 
treated knee is significantly different from the theoretical effect of capsaicin 1% plus 
carrageenan 2 % and capsaicin 1% plus carrageenan treated knee (*** 戶<0.001). 
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Figure 3.63. a) Effect of lOOnmol capsaicin on joint swelling evoked by 2 % 
carrageenan. As shown previously, the mean knee joint size of saline plus 2 % 
carrageenan treated knee was 10.91 士 0.09mm�this is significantly higher than their 
contralateral knees. It is also significantly different from the joint sizes of capsaicin 
lOOnmol plus 2 % carrageenan and lOOnmol capsaicin plus saline treated knees 
(10.14 土 0.15 and 9.34 士 0.05mm; *** P<0.001; unpaired t-tests). Mean joint size of 
lOOnmol capsaicin plus saline is not significantly different from that of their 
contralateral knees (9.27 土 0.04mm; P>0.05; paired t-test; n=29). The mean joint 
size of lOOnmol capsaicin plus 2 % carrageenan is significantly higher than that of 
their contralateral knees (9.22 土 0.07mm; 户<0.001; paired t-tests; n=24). 
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Figure 3.63. b) Relative changes in joint swelling caused by the three treatments 
after subtracted the knee joint size of their respective contralateral knees. Unpaired t-
tests indicate that the mean knee joint size of lOOnmol capsaicin plus carrageenan 
treated knees is significantly different from that of all other groups, including the 
theoretical joint swelling produced by adding the effects of capsaicin lOOnmol plus 
saline and saline plus carrageenan (*** P<0.001). The mean knee joint sizes of 
capsaicin lOOnmol and saline-treated knee is significantly lower than that of the 
theoretical effect of capsaicin lOmnol plus carrageenan 2% and saline plus 
carrageenan treated knee (*** 尸<0.001). 
— 




S 300- ** 
•二 I I 
200- ‘""“~‘ fiTni 
1 
, Kt.j.tH , II Mil 
/ / , 合 / 
��,z / / / Z 




« i 300-2 •= * 芒 o> ‘ ‘ o m 200- * <j uj r 1 :O) 
2 100-
Q. ^ ^^ IMfTnU—IMI • 
Z y 
r 合 rV ^ * 
/ ‘ , / 
Figure 3.64. a) Effect of lOOnmol AEA on acute inflammation evoked by 2% carrageenan. 
As shown previously, extravasation of Evans blue (EB) produced by intra-articular injection 
of saline plus 2% carrageenan was 206.8 士 11.2]Lig/g tissue, this is significantly higher than 
that of their contralateral knees (127.0 土 16,3 |Lig/g tissue; ** 尸<0.01; paired t-tests; n=9). 
lOOnmol AEA plus saline produced 126.6 ± 11.7 |j.g/g tissue EB extravasation, which is not 
significantly different from that extravasated in their contralateral knees (115.3 士 7.3)^ g/g 
tissue; P>0.05; n=6). lOOnmol AEA plus 2% carrageenan produced 124.8 土 12.2fig/g tissue 
EB extravasation, this was significantly higher than their contralateral knees (83.7 士 6.2|j<g/g 
tissue; * P<0.05; n=6). b) Relative changes in extravasation of EB caused by the three 
treatments after subtracted the amount of EB extravasation in their respective contralateral 
knees. Unpaired t-tests indicate EB extravasation caused by saline plus 2% carrageenan was significantly lower than th  of AEA lOOnmol plus saline and the theoretical EB extravasation derived from adding the effects f AEA lOOnmol plus saline and sali e plus car gee an (* P<0.05 f r both). 
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Figure 3.65. a) Effect of lOOnmol AEA on joint swelling evoked by 2% carrageenan. As 
shown previously, the mean knee joint size of saline plus 2% carrageenan treated knee was 
10.91 士 0.09mm, this is significantly higher then their contralateral knees. It is also 
significantly different from the joint sizes of lOOnmol AEA plus 2% carrageenan and 
lOOnmol AEA plus saline treated knees (10.63 土 0.13 and 9.49 土 0.05mm; *** 尸<0.001; 
impaired t-tests). Mean joint size of lOOnmol AEA plus saline is not significantly different 
from their contralateral knees (9.55 士 0.07mm; P>0.05; paired t-test; n=19). The mean joint 
size of lOOnmol AEA plus 2% carrageenan is significantly higher than that of their 
contralateral knees (9.42 土 0.08mm; *** P<0.001; paired t-tests; n=34). b) Relative changes 
in joint swelling caused by the three treatments after subtracted the knee joint size of their 
respective contralateral knees. Unpaired t-tests indicate that the mean knee joint size of 
lOOnmol AEA plus saline treated knees is significantly lower than that of all other groups, 
including the theoretical joint swelling produced by adding the effects of lOOnmol AEA plus 
saline and saline plus carrageenan (*** P<0.001). 
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The present thesis reports the actions of two vanilloid agonists on blood vessels of rat 
knee joint. Capsaicin is a vanilloid agonist derived from pepper plants belonging to 
the genus Capsicum. Anandamide (AEA) is an endogenous eicosanoid that has 
agonist activity on both caimabinoid and vanilloid receptors. These two vanilloid 
agonists were demonstrated to be vasodilators in the rat knee joint, but they act via 
mechanisms that are somewhat different from each other. Capsaicin-induced 
vasodilatation was found to be susceptible to inhibition by a relatively new VRl 
antagonist, I-RTX, but not by another frequently used classical VRl antagonist, 
capsazepine. By activating VRl, capsaicin is expected to elicit a release of 
neuropeptides such as substance P and C G R P from primary afferent fibres (Rigoni et 
al., 2003). In this study, CGRP, but not substance P, was found to play a role in 
mediating the vasodilator action of capsaicin. On the other hand, both substance P 
and C G R P were found to contribute to the vasodilator action of AEA. The two VRl 
antagonists I-RTX and capsazepine and also the A E A transporter inhibitor AM404 
were effective in suppressing the AEA-induced response, whereas, caimabinoid 
receptor antagonists did not. This supports a VRl rather than a caimabinoid 
receptor-mediated mechanism. The finding that capsazepine inhibited the 
vasodilator response to A E A but not that of capsaicin suggest the two agonists might 
be acting on different populations of V R L 
Capsaicin and A E A at doses that were effective in producing vasodilatation had no 
effect on vascular permeability or sizes of the rat knee joint. Only with toxic doses at 
fiM range did capsaicin produced an increase in vascular permeability. These 
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findings suggest that sensory neuropeptides are probably more effective in producing 
vasodilatation, and higher quantities of these peptides had to be released by the 
vanilloid agonists in order to increase vascular permeability in the rat knee joint. 
Furthermore, carrageenan-induced inflammation was not altered by acute 
pretreatment of the rat knee joint with capsaicin, but significantly attenuated by AEA. 
This indicates that the amount of neuropeptides released by the two vanilloid 
agonists were insufficient to augment the inflammatory processes elicited by 
carrageenan. The result also suggests an anti-inflammation action for AEA. 
4.1. Capsaicin-induced Long Lasting Vasodilatation 
In the present study, the use of LDI provides a direct measurement of spatial 
distribution of tissue perfusion that represents an overall response of the tissue 
(Karimian et al., 1995). This is an ideal assessment of knee joint blood flow as it 
measures most of the joint surfaces, which is superior to conventional laser Doppler 
flowmeters (LDF) that offer only single point measurement of blood flow changes. 
Using the LDI technique, capsaicin was confirmed to be a vasodilator in the rat knee 
joint. Capsaicin has also been shown to be a vasodilator in other tissues such as skin 
(Brain et al., 1993; Buckley et al., 1990; Escott & Bmin�1993; Hughes & Brain, 
1991; Lynn et al., 1992), hind paw (Lin et al., 1999) and mouse ear (Grant et al., 
2002) by means of LDF and xenon (Xe) clearance. The vasodilator action of 
capsaicin was found to last for at least half an hour. Previous findings also 
confirmed capsaicin has long-lasting vasodilator action that sometimes could take 
two hours to subside (Grant et al., 2002; Lin et a l , 1999; 1992). 
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Repeated administrations of increasing doses of capsaicin failed to show a dose 
dependent relationship (Figure 3.1). This is likely to be due to tachyphylaxis caused 
by continuous application of capsaicin at 10 minutes interval. Tachyphylaxis is a 
well characterized property of repeated administrations of capsaicin in cell studies 
(Docherty et aL, 1996; Mohapatra & Nau, 2003; Piper et al., 1999). It has also been 
demonstrated in nociceptive models that showed a marked decrease in pain response 
to capsaicin when the drug was injected into mouse hind paw at 15 minutes intervals 
(Sakurada et aL, 2003). In the present study, administrations of two equal doses of 
capsaicin 30 minutes apart produced similar vasodilator responses (Figures 3.2 and 
3.4). This finding suggests that tachyphylaxis to capsaicin can be avoided if a 
sufficiently long time interval is allowed between repeated administrations of the 
drug. 
In addition to a local vasodilator action, topical administration of capsaicin onto the 
rat knee joint produced a drop in systemic blood pressure that is transient and 
reproducible (Figure 3.3). Several studies have reported a hypotensive action of 
capsaicin when the drug was administered intravenously (Godlewski et al., 2003; 
Lee & Limdberg, 1994; Malinowska et aL, 2001; Porszasz & Szolcsanyi, 1991), 
intra-arterially (Smith & McQueen, 2001; Strong & Green�1991), and intrathecally 
(del Carmen Garcia et aL, 2003). It was suggested that capsaicin activates local 
primary vascular afferents, which in turn relay the stimuli to the brain stem to cause a 
reflex fall in blood pressure (Smith & McQueen, 2001). Some studies have indicated 
V R l involvement in this reflex, as capsazepine and ruthenium red were found to 
abrogate the fall in blood pressure (Lee et al., 1994; Malinowska et al,, 2001; Smith 
et al., 2001). However, the present study showed that all the antagonists tested, 
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which include capsazepine, I-RTX, SR140333, RP67580 and CGRPg-s? failed to 
block the hypotensive action of capsaicin. Therefore, there is no support for 
involvement of V R l or neuropeptides in the response. The exact mechanisms for the 
hypotensive action of capsaicin remain to be elucidated. 
4.2. Capsaicin-induced Vasodilatation 一 a VR1-mediated Effect? 
Capsazepine has long been used as a pharmacological probe for studying the 
physiological action of VRl. Therefore, it is suspected that the vasodilator action of 
capsaicin is mediated by VRl and the response should be susceptible to inhibition by 
the V R l antagonist capsazepine. Surprisingly, the present study showed that 
capsazepine did not inhibit the vasodilator response to capsaicin (Figure 3.6). The 
failure of capsazepine to inhibit the capsaicin-induced response is unlikely to be due 
to inadequate amount of the antagonist being used. In fact, it has been shown in 
subsequent studies that Inmol and lOnmol of capsazepine inhibited the 
vasodilatatory action of AEA, indicating these doses are sufficient to block VRl. 
Since its development in 1992 (Bevan et a l , 1992), capsazepine has been shown to 
be effective in inhibiting various capsaicin-induced responses, including 
bronchoconstriction (Ellis et al,, 1995), unrinary bladder contraction (Maggi et al., 
1993)，and pain (Seabrook et al., 2002). An affinity for capsazepine to VRl was 
supported by its ability to displace [^H]RTX binding in a competitive manner 
(Szallasi, 1994). However, a recent finding suggests capsazepine acts as an 
incomplete antagonist on rat TRPV in cell studies (Mclntyre et al., 2001). 
Capsazepine has also been shown to have a non-specific action on voltage-gated 
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Ca杆 channels, although this required a concentration that was ten times more than 
that to block V R l (Docherty et al., 1997). 
Reports on the effects of capsazepine on capsaicin-induced responses are not 
unanimous. For example, the antagonist was shown to be effective in blocking the 
vasodilator action of capsaicin in hepatic and mesenteric arteries of rat, and in pig 
basilar arteries of guinea pig (Zygmunt et al., 1999). However, it did not affect the 
vasodilator action of capsaicin in pig nasal mucosa, pig skin (Kinder et al., 1996), 
and rabbit coronary artery (Yeon et a l , 2001). In tissues such as guinea-pig trachea 
and spinal cord where capsazepine was effective in blocking capsaicin-induced 
responses, it exhibited potent displacement of [^H]RTX binding in these tissues 
(Szallasi�1995). In contrast, capsazepine was unable to displace R T X binding in 
nasal mucosa (Kinder et al., 1996), where it lacks inhibitory effects. It was 
suggested that the inter- and intra-species heterogeneity in the affinity by which 
vanilloid receptors recognize capsazepine suggests different types of receptors in 
different regions (Szallasi, 1995). 
The lack of inhibitory effect of capsazepine on capsaicin-induced vasodilatation 
urged the need to test another VRl antagonist. I-RTX is a relatively new VRl 
antagonist that shows selectivity in inhibiting the responses to capsaicin in cell 
studies, spinal cord (Rigoni et al., 2003), urinary bladder (Rigoni et al., 2003)，pain 
tests (Wahl et al., 2001), and also responses to R T X in guinea-pig airways (Undem 
& Kollarik, 2002). I-RTX was also claimed to be at least forty times more potent 
than capsazepine (Wahl et a l , 2001). In the present study, capsaicin-evoked 
vasodilatation was blocked by I-RTX, suggesting that it is indeed a VRl-mediated 
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action. This VRl appears to be insensitive to inhibition by capsazepine, but it will 
further require studies at a cellular level to confirm that the two antagonists have 
different binding affinities for this rat knee joint vanilloid receptor. 
4.3. Substance P and CGRP in Capsaicin-induced Vasodilatation 
Activation of V R l is known to release neuropeptides such as substance P and CGRP 
from the afferent nerve terminals and this has been measured in various tissues, 
including spinal cord slices (Marvizon et al., 2003; Rigoni et al., 2003; Wardle et a l , 
1997) and trachea (Flores et al., 2001; Nemeth et al., 2003a). Both substance P and 
C G R P have been shown to play a role in modulating blood flow in the rat knee joint 
(Ferrell et al., 1997a; McMurdo et al., 1997). In the present study, the contribution 
of these two neuropeptides to capsaicin-induced vasodilatation was tested with the 
use of NKi and CGRP antagonists. Two NKi antagonists were tested, SR140333 
and RP67580, and both of them failed to inhibit the vasodilator action of capsaicin 
(Figure 3.12 and 3.16). Previous studies of our laboratory have indicated the doses 
of these antagonists used were sufficient to abolish substance P or NKi agonist-
induced vasodilator responses (unpublished data). Thus, the lack of inhibition in the 
present study is not due to inadequate amount of the antagonists being used. Other 
studies have also shown SR140333 to be ineffective in blocking capsaicin-evoked 
vasodilatation in mouse ear (Grant et al., 2002) and in mesenteric arteries 
(Andersson et al., 2002). Moreover, since substance P-induced vasodilatation is 
transient and prone to tachyphylaxis (Lam & Ferrell, 1993; Franco-Cereceda et al., 
1987), it is unlikely to be responsible for the long-lasting vasodilator action of 
capsaicin. 
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It should be noted that 20mnol SR140333 produced marked reduction in the 
vasodilator response to capsaicin, but this is unlikely to be due to NKi receptor 
inhibition because at this dose, the antagonist alone produced vasoconstriction 
(Figure 3.14). Interestingly, the other NKi receptor RP67580 at 20mnol was found 
to possess vasodilator action (Figures 3.18，3.19 and 3.20). Both RP67580 and 
SRI40333 have been shown to exhibit calcium channel antagonist activity in in vitro 
studies (Rupniak et al., 1993). RP67580 is about a hundred fold, and SR140333 is 
more than ten thousands fold more selective in blocking NKi receptors than to inhibit 
L-type calcium channels (Rupniak et al., 2003). This difference in calcium channel 
blocking potencies might be a reason for RP67580 but not SR140333 in exhibiting 
vasodilator action at high doses. A vasoconstrictor response to SR140333 is highly 
unexpected. The mechanisms for this action remain to be elucidated. 
Capsaicin-induced vasodilatation was found to be markedly suppressed by the C G R P 
receptor antagonist CGRPg-sv (Figure 3.21). This is in agreement with previous 
studies that demonstrated C G R P involvement in the vascular responses to capsaicin 
in arterioles of nasal mucosa and skin of pig (Kim et a l , 1997; Kinder et aL, 1996a), 
rat (Escott & Brain, 1993), and rabbit (Brain et al., 1993; Hughes & Brain�1991). 
C G R P is also known to produce long-lasting vasodilatation that resembles the 
vasodilator action of capsaicin (Franco-Cereceda et al., 1987; Lam & Ferrell, 1993). 
A small vasodilator response was observed with high doses of CGRPg-s? alone 
(Figures 3.21, 3.23 and 3.24), which was also reported previously (Brain et al., 1993). 
It could indicate that high doses of CGRPg-s? possess agonist activity on CGRP 
receptors. 
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4.4. Anandamide-induced Vasodilatation 
Like that of capsaicin, topical administrations of A E A produced increases in blood 
flow of the rat knee joint. However, unlike capsaicin, the vasodilator actions of A E A 
were short-lasting, dose-dependent, had no sign of tachyphylaxis, and no 
concomitant change in systemic blood pressure (Figures 3.26, 3.27，and 3.28). In 
addition, A E A required a relatively high dose (lOOmnol) to produce comparable 
vasodilator response to that of capsaicin (Inmol). A low potency of A E A on VRl 
has also been reported in electrophysiological studies (Zygmunt et al., 1999), but it is 
possible that this is an underestimation due to the biophysical nature of A E A and its 
requirement for co-factors such as ATP, and P K C for optimal action (Smart et al., 
2000b; Di Marzo et al., 2001). There is also observation that suggests a low 
concentration A E A could activate both CBi receptors and V R l (Di Marzo et al., 
2002). The matter is further complicated by findings that showed A E A is a full 
agonist on human V R l (Smart et al., 2000) but a partial agonist on rat VRl 
(Zygmunt et al., 1999). It remains to be confirmed that A E A truly has a lower 
potency than capsaicin in the present experimental set up. 
Being an endogenously produced substance, A E A is known to have a short duration 
of action due to rapid inactivation (Piomelli et al., 1999). The short lasting nature of 
AEA-induced vasodilatation was confirmed in the present study and it has also been 
shown in previous study on mesenteric blood vessels (Garcia et al., 2001). The 
process of A E A inactivation involves first a capturing of extracellular A E A by a 
carrier-mediated transport system, the so-called A E A transporter, into neuronal and 
non-neuronal cells. This is followed by intracellular hydrolysis of A E A into free 
fatty acid and ethanolamine by fatty acid amide hydrolase (FAAH) (Giuffrida et al., 
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2001). It is suspected that this inactivation process accounts for the transient action 
of A E A in the present study. The presence of such inactivating process can be 
confirmed if the action of A E A can be prolonged in the presence of a F A A H 
inhibitor such as AM374 (Giuffrida et al., 2001). However, this was not carried out 
due to the finite time scale of the present project. 
In in vitro studies, A E A has been shown to relax mesenteric, hepatic and basilar 
vasculatures in guinea pig with EC50 values of lOOnM, 300nM and lOOOnM 
respectively (Zygmunt et al, 2000b; Zygmunt et al., 1999). The present in vivo 
study showed that A E A produced vasodilatation in the rat knee joint with an ED50 of 
10.7 土 2mnol (i.e. EC50 of 107|iM), which is about a hundred to a thousand times 
higher than those reported in in vitro studies. These differences are conceivable 
because in in vitro experiments, the administered A E A will remain in the bathing 
solution and have sufficient time to equilibrate and interact with the whole tissue. 
On the other hand, A E A was administered topically in the present in vivo study and it 
would be dispersed out of the knee joint very quickly, and therefore the volume and 
the contact time of the drug with the target tissue are limited and probably 
insufficient to achieve maximum effect. In line with this assumption, another in vivo 
study showed that the lowest dose of A E A required to elicit a response in mesenteric 
blood vessels was 4mg/kg (Garcia et al,, 2001), which is about 2.88|amol per rat. 
Unlike capsaicin, A E A at all doses did not interfere with the systemic blood pressure 
in the present study. A previous study has shown that intravenous bolus injection of 
A E A produced bradycardia and hypotension, which was dose-dependently inhibited 
by the CBi receptor antagonist SR141716A and was absent in CBi receptor gene 
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knockout animals (Hogestatt & Zygmunt, 2002). The failure of A E A to produce 
hypotension in the present study suggests insufficient amount of the drug was 
absorbed into the systemic circulation. 
4.5. VR1 in AEA-induced Vasodilatation 
There is substantial evidence that indicate A E A interacts with VRl. For example, 
displacement of [^H]AEA binding can be achieved with vanilloids such as capsaicin, 
resiniferatoxin (RTX ) and olvanil (Olah et al., 2001). A E A can produce currents in 
cells expressing VRl, and it caused increase in intracellular Ca"^ that are blocked by 
capsazepine (Jernian et al., 2002; Olah et al., 2001). Capsazepine is also effective in 
inhibiting AEA-induced cough in guinea pigs, its excitatory actions in medullary 
dorsal horn and trigeminal ganglia (Jennings et al., 2003; Jia et al., 2002)， its 
vasodilator actions in mesenteric arteries, hepatic arteries and guinea pig basilar 
arteries (White et al., 2001; Zygmunt et al., 1999), and the vasodilator action of the 
stable A E A analogue Met-AEA in rabbit aorta ring (Mukhopadhyay et a l , 2002; 
Ralevic et a l , 2000). In accordance to these findings, the present study showed that 
capsazepine and I-RTX are effective in blocking the vasodilator action of A E A in the 
rat knee joint (see Figures 3.31, 3.32, 3.33 and 3.34). 
However, capsazepine failed to inhibit the vasodilator responses to A E A and 
capsaicin in coronary blood vessels (Grainger et al., 2001; White et al., 2001; Yeon 
et al., 2001). Capsazepine also lack inhibitory action on capsaicin-induced 
vasodilatation in the present study, although it significantly reduced the AEA-
induced response. On the other hand, both capsaicin and AEA-induced responses 
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were suppressed by I-RTX. The discrimination of capsazepine on capsaicin and 
AEA-induced responses was somewhat surprising. It probably indicates that the two 
agonists act on different receptor types to produce their vasodilator actions, although 
I-RTX does not appear to discriminate these receptor types. 
4.6. Neuropeptides in AEA-induced Vasodilatation 
At high concentrations, A E A has been demonstrated to evoke neuropeptide release 
via V R l in dorsal horn (Tognetto et al., 2001). It is likely that release of 
neuropeptides also occurs at peripheral terminals and they could mediate the 
vasodilator action of AEA. Such speculation is supported by the present finding that 
AEA-induced vasodilatation was suppressed by the NKi receptor antagonists 
SR140333 and RP67580 (Figures 3.35，3.37，3.38 and 3.40), which implicate 
involvement of substance P in the response. It should be noted that the same 
antagonists failed to inhibit the vasodilator response to capsaicin. This provided 
further evidence that the vasodilator actions of capsaicin and A E A are mediated by 
different receptors. 
In addition to substance P, the present study also suggests involvement of CGRP in 
the AEA-induced vasodilator response. This was demonstrated by a significant 
inhibition of the AEA-induced response by the CGRP receptor antagonist CGRPg-s? 
(see Figures 3.41 and 3.42). Involvement of CGRP in AEA-induced vasodilatation 
has also been reported in in vitro studies (Zygmunt et al, 1999), and for the 
vasodilator action of the A E A analogue Met-AEA (Ralevic et al., 2000). 
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Furthermore, A E A has been shown to evoke release of C G R P from sensory neurones 
(Zygmunte^ al, 1999). 
4.7. Cannabinoid Receptors in AEA-induced Vasodilatation 
The vascular action of A E A has been intensively studied in in vitro situations in 
recent years. However, the precise mechanisms of its action remain uncertain. 
Earlier studies based on the use of a CBi receptor antagonist, SR141716A�suggest 
that the vasodilator action of A E A is mediated by CBi receptors (Deutsch et a l , 
1997; Fulton & Quilley, 1998; Ishioka & Bukoski�1999; Randall et al., 1996; 
Randall & Kendall�1997; White & Hiley, 1997; Zygmimt et al., 1997). Involvement 
of CBi receptors is supported by a study that demonstrated the presence of CBi 
receptor m R N A in human aorta endothelial cells using reverse transcription-
polymerase chain reaction (Liu et al., 2000). However, there is emerging evidence 
that suggest SR141716A does not act purely as a CBi receptor antagonist, and that its 
inhibitory action on A E A might involve action on other cellular targets (Chaytor et 
aL, 1999; Mukhopadhyay et al., 2002). In the present study, another CBi receptor 
antagonist, AM281, was used. This antagonist was found to have no effect on the 
vasodilator response to A E A (Figures 3.43 and 3.44). A E A has also been reported to 
produce a CBi receptor-independent vasodilator response in rat coronary artery, and 
rat and rabbit mesenteric arteries, where CBi antagonists AM251 and LY320135 
showed no inhibition (Ho & Hiley, 2003; White et al., 2001). Moreover, CBi 
receptor agonists, HU210 and W I N 55, 212-2, were shown not to mimic the actions 
of A E A in rat hepatic, mesenteric artery and in guinea pig basilar arteries (Zygmimt 
et al., 1999). Taken together, the evidence does not support a role for CBi receptors 
in mediating AEA-induced vasodilatation. 
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In fact, recent studies revealed that the vascular event induced by A E A is indeed a 
very complex process. It is hypothesized to involve two components: an 
endothelium-independent component that is mediated by VRl, and an endothelium-
dependent component that is sensitive to SR141716A (Ho & Hiley, 2003; 
Mukhopadhyay et al., 2002). This is based on in vitro observations in rabbit aorta 
that showed the vasodilator action of A E A was partly sensitive to endothelium 
removal and SR141716A�but when the endothelium was removed, the sensitivity to 
inhibition by SR141716A was lost (Mukhopadhyay et al., 2002) (Randall�2003). 
On the other hand, capsazepine and CGRPg-s? partly attenuated the vasodilator 
response to A E A in endothelium-intact tissue, but greatly reduced the response in 
endothelium-denuded preparation (Mukhopadhyay et al., 2002). The exact target 
that SR141716A interacts with is uncertain. There is speculation that it could be a 
new type of cannabinoid receptor or ‘anandamide receptor，，which is distinct to CBi 
and CB2 receptors (Jarai et al,, 1999; Wagner et a l , 1999). Whether such putative 
new receptor is involved in the residual portion of the vasodilator response to A E A 
in the presence of capsazepine and I-RTX (Figures 3.31, 3.32, 3.33 and 3.34) is not 
certain, and it should be investigated in future studies. 
CB2 receptors are mainly present on immune cells such as macrophages and B-cells 
(Axelrod & Felder, 1998). Nonetheless, the CB2 antagonist, AM630, has been tested 
in the knee joint, and was found to have no significant effect on the maximum 
vasodilator response to AEA, although it seems to have slightly attenuated duration 
of the response. The lack of inhibition by AM630 on the peak response to A E A is 
consistent with the finding that this antagonist and another CB2 antagonist SRI44528 
produced no change on the vasodilator action of A E A in coronary and mesenteric 
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arteries of the rat (Ford et al., 2002; White et a l , 2001). Therefore, CB2 receptor is 
unlikely to have a role in mediating the vasodilator action of AEA. 
4.8. Role of Anandamide Transporter in AEA-induced Vasodilatation 
A E A re-uptake into cells has been shown to fulfill the four key criteria of carrier-
mediated transport: fast rate, temperature-dependent, saturable and substrate 
selective, and it was designated as the anandamide transporter (AMT) (Beltramo et 
al., 1997; Giuffrida et al., 2001). The recapture of A E A back into neuronal or non-
neuronal cells is thought to constitute a part of the inactivation process for AEA. 
Beltramao et al (1997) by investigating a series of structural A E A analogues 
discovered that AM404 is a competitive inhibitor of A M T . 
Inhibition of the cellular re-uptake of A E A would prevent its hydrolysis, and should 
therefore augment the magnitude and duration of its actions. In accordance to this 
theory, inhibition of A M T by AM404 was found to potentiate the AEA-mediated 
hypotensive action in guinea-pig and reduction in c A M P in neurones that were also 
sensitive to inhibition by CBi receptor antagonists (Beltramo et al., 1997; Calignano 
et al., 1997). Surprisingly, the present study showed that AM404 almost abolished 
the vasodilator action of A E A in the rat knee joint (Figures 3.50 and 3.51). In fact, 
AM404 was also reported to attenuate AEA-induced vasodilatation in vitro 
preparations of sheep coronary artery and rabbit mesenteric artery (Chaytor et al., 
1999; Grainger & Boachie-Ansah, 2001). The answer may lie on a finding that 
suggests facilitated transport is required for A E A to activate VRl (De Petrocellis et 
al., 2001). This implicates that AEA, like that of capsaicin, works by binding to an 
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intracellular region of V R l (Jordt & Julius�2002). Therefore, inhibition of A M T by 
A M 4 0 4 would attenuate VRl-dependent effects of AEA. Conversely, the binding of 
A E A on CBi receptor occurs extracellular (Di Marzo et al., 2002), and thus blocking 
A M T by A M 4 0 4 would enhance CBi receptor-mediated effects of A E A (Beltramo et 
a l , 1997; Calignano et al., 1997). These data consolidate the view that AEA-
induced vasodilatation in the rat knee joint is mediated by V R l and not cannabinoid 
receptors. 
A M 4 0 4 (3|liM) has been reported to act as a V R l agonist to induce currents and 
causing Ca"^ influx in cellular studies (De Petrocellis et a l , 2000; Zygmunt et a l , 
2000a). The transporter inhibitor, at concentrations ranging from InM to has 
also been shown to elicit dose-dependent vasodilatation in rat isolated mesenteric 
artery, which was sensitive to inhibition by capsazepine (Ralevic & Kendall�2001; 
Zygmunt et a l , 2000a). With the doses (Inmol or lO^M) employed in the present 
study, an agonist action of AM404 was not observed in the rat knee joint. 
4.9. A Neural Mechanism for Capsaicin- and AEA-induced 
Vasodilatation? 
Studies on denervated rat knee joints were conducted to determine whether there is a 
neurogenic component in the vasodilator actions of capsaicin and AEA. Surgical 
sectioning of the saphenous nerve has been shown to cause degeneration of 
unmyelinated fibres in the rat knee joint (Ferrell et al., 1997a). An earlier study also 
shown axotomy caused depletion of substance P-containing fibres and reduced 
neuropeptides levels (Ahmed et al., 1995). In addition, intra-articular treatment of 
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high concentrations of capsaicin (>0.5%) has been shown to deplete SP and CGRP-
containing fibres beyond day 7 (Ferrell et aL, 1992; Mapp et al., 1996). The present 
study has employed both the surgical method and the chemical method for 
denervation of the rat knee joint. 
The vasodilator response to A E A was found to be unaltered by surgical or chemical 
denervation of the rat knees. Capsaicin-induced vasodilatation was also unaffected 
in surgically denervated knees, but it was significantly attenuated in chemically 
denervated knees. It was suspected that capsaicin and A E A produce vasodilatation 
in the rat knee joint by activating VRl to cause release of vasodilator neuropeptides 
from sensory neurones. Therefore, a neural component for their responses should be 
demonstrable. The relative mild or lack of inhibition of the vasodilator responses to 
capsaicin and A E A in the denervated knees in the present studies have cast doubts on 
whether complete denervation was achieved by the two denervation procedures. The 
present surgical denervation method involved sectioning of the saphenous nerve, and 
this has been shown to cause degeneration of unmyelinated fibres in the rat knee 
joint (Ferrell et al., 1997a). However, the saphenous nerve innervates mainly the 
medial aspect of the knee joint, and there is also the tibial nerve that innervate the 
posterior aspect of the joint. Therefore, sectioning of the saphenous nerve alone 
might not be sufficient to accomplish full denervation of the joint. In retrospect, all 
these nerves should be sectioning to ensure complete denervation of the rat knee joint. 
Chemical denervation by high dose capsaicin has been shown to deplete SP and 
CGRP-containing fibres (Ferrell et a l , 1992; Mapp et aL, 1996). This method of 
denervation seems to be more effective in reducing the vasodilator actions of both 
capsaicin and AEA, although the reduction of AEA-vasodilatation did not reach a 
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significant level. Therefore, chemical denervation was more successful, but it has 
also been reported that re-growth of unmyelinated nerve can occur 14 days after 
intra-articular treatment of capsaicin (Ferrell et al., 1992). Perhaps, a second dose of 
capsaicin should be administered at day 7 to abolish the re-growth. 
An alternative explanation for the present finding would be that the vasodilator 
actions of capsaicin and A E A are not mediated by a neural mechanism. Therefore, 
their actions were not affected even though the knee joints were adequately 
denervated by the two methods. This may appear contradictory to the classical view 
that vanilloid agonist actions are dependent on their effects on nociceptive neurones. 
In fact, there are now evidence supporting the existence of non-neuronal VRl, such 
as those found in smooth muscle and epithelial cells of urinary bladder (Birder et al., 
2001)，gastric glands (Kato et a l , 2003), human skin keratinocytes (Denda et al., 
2001; Inoue et al., 2002; Stander et a l , 2004)，mast cells (Biro et al., 1998; Stander 
et al., 2004), and spleen, where they are suggested to play a role in regulating the 
immune response (Szallasi, 2002). Activation of V R l on epidermal keratinocytes 
also caused a release of interleukin-8 and PGE2, suggesting non-neuronal cells do 
release pro-inflammatory mediators in response to vanilloids (Southall et al., 2003). 
In mast cells, capsaicin elicited an increase in intracellular Ca种 similar to that seen 
in dorsal root ganglion (DRG) cells (Biro et al., 1998). A release of neuropeptides 
from non-neuronal cells in response to VRl activation has not been documented. 
Nonetheless, the possibility of these cells releasing neuropeptides should not be ruled 
out, as productions of substance P from monocytes and lymphocytes under baseline 
condition have been demonstrated (Lambrecht et al., 1999). 
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4.10. Effects of Capsaicin and AEA on Plasma Extravasation 
Activation of V R l by capsaicin has been shown to release substance P and C G R P 
from nerve terminals (Wardle et al., 1997; Yaksh, 1988), and A E A would do the 
same at high concentrations (Ahluwalia et al., 2003; Nemeth et al., 2003b; Tognetto 
et al., 2001). Neuropeptides, especially substance P, have prominent effects on 
plasma extravasation (Scott et al., 1991). Thus activation of V R l is expected to 
cause vasodilatation as well as increasing vascular permeability, leading to plasma 
extravasation. Indeed, an increase in plasma extravasation by capsaicin has been 
demonstrated in several tissues. By employing the Evans blue Leakage technique, 
continuous intra-articular infusion of capsaicin was found to produce plasma 
extravasation in the rat knee joint (Coderre et a l , 1989). Intravenous administration 
of capsaicin evoked plasma extravasation in skin and in all organs containing 
mucous membranes, and substance P was suspected to be the mediator of this effect 
(Saria et al,, 1983). Intravenous capsaicin also produced a small but significant 
plasma extravasation in urinary bladder and trachea, which was shown to be 
mediated by NKi receptors (Eglezos et al., 1991). In addition, the use of 
labelled albumin has demonstrated intradermal injection of capsaicin caused 
extravasation in rabbit skin (Newbold & Brain�1995). 
In spite of the overwhelming evidence supporting capsaicin being an inducer of 
plasma extravasation, the present study could not show a plasma extravasation 
response to capsaicin, except with a very high toxic dose of 1% (i.e. 3.27fimol) 
capsaicin (see Figures 3.56 and 3.60). In fact, capsaicin at a dose of Inmol, which 
was effective in producing vasodilatation, caused a marginal decrease in plasma 
extravasation, although this latter action is possibly insignificance in view of the 
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large variations in basal plasma extravasation levels observed in the present study. 
Capsaicin is known to evoke neuropeptide release in quantities of fmol per ml or per 
m g tissue, depending on the nature of the experiments (Flores et a l , 2001; Nemeth et 
al., 2003a). The amount of substance P required to elicit plasma extravasation in the 
knee joint was reported to be in nmol range (Lam & Ferrell, 1990; Scott et al., 1991)， 
with a threshold at 0.4nmol (Lam & Ferrdl�1990). Therefore, in the present study, it 
is suspected that capsaicin (with the exception of the very high toxic dose) was 
incapable to release sufficient substance P to elicit plasma extravasation, or 
vasodilatation, which was discussed earlier to be insensitive to NKi receptor 
blockade. 
Several other reports are in agreement with the present finding. Thus, a failure for 
capsaicin to produce plasma extravasation has been demonstrated in human skin 
(Schmelz et al., 1997), rabbit trachea (Matheson et al., 1997), murine trachea (Baluk 
et al., 1999) and guinea-pig eyelid (Vieira et a l , 2001). Capsaicin has been shown to 
elicit plasma extravasation in rat skin but only at a high dose (Hughes & Brain, 1991)， 
and at these high doses the selectivity of capsaicin on V R l is questionable. 
There is no previous report on the effects of A E A on plasma extravasation. As 
discussed earlier, substance P is likely to play a role in mediating the vasodilator 
action of AEA, and therefore, it should also mediate the plasma extravasation 
response to AEA. However, the present findings indicate A E A at doses effective in 
producing vasodilatation had no effect on plasma extravasation. Only at a high dose 
of l^imol�AEA did produce a decrease in plasma extravasation together with an 
increase in knee joint size (Figures 3.58 and 3.59). These changes were minor and 
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are possibly insignificant in view of the large fluctuation of baseline levels in these 
studies. 
A E A has been reported to have anti-inflammatory effect which was thought to be 
mediated via CBi as the effect was blocked by SR141716A (Richardson et aL, 
1998b). However, as mentioned earlier, SR141716A may not be a selective inhibitor 
on CBi receptors, thus it remains to be confirmed that CBi receptors are important in 
this effect. A E A has also been shown to inhibit N F - K B (Sancho et al., 2003), 
indicating that it might have long term influence on the inflammatory process. It is 
possible that these anti-inflammatory effects of A E A had suppressed the substance P-
mediated plasma extravasation actions of A E A in the present study, but this 
hypothesis would have to be supported by more evidence. 
4.11. Capsaicin and Anandamide in Acute Inflammation 
Carrageenan is a sulphated mucopolysaccharide extracted from Irish moss and is a 
reliable substance to be used to achieve an experimental model of acute 
inflammation in animals (Hansra et al., 2000). In the present study, 24 hours after 
intra-articular injection of carrageenan, the rat knee joint developed an acute arthritis 
characterized by joint swelling (Figures 3.62a and 3.62b) and marked plasma 
extravasation (Figures 3.60a and 3.60b). Pre-treatment of the rat knee joint with a 
high dose of 1% (i.e. 3.27 fimol) capsaicin 15 minutes prior to induction of the 
arthritis significantly increased the plasma extravasation response to carrageenan 
(Figure 3.60b). Similarly, another study showed that capsaicin at doses of 3 - 10 mg 
potentiated carrageenan-induced oedema in guinea-pig eyelid (Vieira et a l , 2001), 
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but capsaicin alone at these doses also produced oedema. In the present study, 1% 
capsaicin alone also elicited pronounced plasma extravasation (Figure 3.60a) that 
was even greater than that seen with capsaicin plus carrageenan (Figure 3.60b). 
Capsaicin at doses that did not elicit plasma extravasation alone had no effect on the 
plasma extravasation response to carrageenan. Therefore, it cannot be concluded that 
1% capsaicin has an augmenting effect on carrageenan-induced inflammation. It is 
suspected that capsaicin at this high dose, by its action on VRl, could release 
sufficient quantities of neuropeptides to cause arthritis in the knee joint. The effects 
of repeated capsaicin treatment or treatment of capsaicin in neonate rats would be 
different, as these have been shown to effectively inhibit carrageenan-induced 
inflammation that were attributed to a chronic neurotoxic effect of capsaicin causing 
destruction of sensory neurones (Gamillscheg et al., 1984; Lam & Ferrell�1989; 
Raychaudhuri et al., 1991). 
Unlike capsaicin, lOOnmol A E A on its own produced no plasma extravasation, but it 
significantly inhibited the plasma extravasation response to carrageenan. A E A has 
also been shown to attenuate carrageenan-induced inflammation in rat paw 
(Richardson et al” 1998b). As discussed earlier, A E A is endowed with anti-
inflammatory properties, and it is therefore not surprising that it could reduce the 
inflammatory response to carrageenan. 
4.12. Conclusion 
The present study shows that capsaicin and A E A act differently to produce 
vasodilatation, as summarized in Table 4.1 and Figure 4.1. One single type of VRl 
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is not enough to explain the differential actions of capsaicin and AEA, and the 
findings suggest the existence of more than one type of VRs. This is in agreement 
with a few recent studies that also postulated there are two types of VR. Capsazepine 
is able to discriminate the two types of VRs as it only inhibits the AEA-sensitive type 
(VRA) but not the capsaicin-sensitive type (VRc), whereas I-RTX blocks both. 
The present findings also suggest activation of AEA-sensitive V R releases both 
substance P and CGRP, but activation of capsaicin-sensitive V R releases only CGRP. 
It is uncertain whether these peptides are released from neural and/or non-neuronal 
cells. Nevertheless, studies on carrageenan-induced arthritis indicate the release of 
these peptides by capsaicin and A E A are normally insufficient to alter the course of 
the inflammatory process. A E A is found to produce a small anti-inflammatory effect, 
but the mechanisms for this action remain to be elucidated. 
Experiment Capsaicin Anandamide (AEA) 
Knee Joint Blood Flow 
Vasodilatation in Rat knee Joint Sustained Transient 
Effect of various antagonist 
VRl antagonists Reduced by I-RTX but not Reduced by both I-RTX 
capsazepine and capsazepine 
NKi receptor antagonists Not affected Reduced 
CGRP receptor antagonist Reduced Reduced 
CB receptor antagonists NA Not affected 
AMT inhibitor Not affected Reduced 
Plasma Extravasation No apparent increase Reduced except at high toxic dose 
Acute Inflammation No effect at non-toxic Reduced dose  
Table 4.1 Summary of the differential effects of capsaicin and anandamide (AEA) on vasodilatation 
and plasma extravasation in rat knee joints. 
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Figure 4.1 Proposed mechanisms of the vasodilator actions of capsaicin and AEA in rat knee joint. 
VRc and VRa indicate capsaicin-sensitive and anandamide-sensitive vanilloid receptors, respectively. 
‘ 172 “ 
References 
References 
AHLUWALIA, J., URBAN, L., BEVAN, S. & NAGY, L (2003). Anandamide regulates 
neuropeptide release from capsaicin-sensitive primary sensory neurons by activating 
both the caimabinoid 1 receptor and the vanilloid receptor 1 in vitro. European 
Journal of Neuroscience, 17, 2 6 1 1 - 2 6 1 8 . 
AHMED, M.�SRINIVASAN, G.R.�THEODORSSON, E., SCHULTZBERG�M. & KREICBERGS�A. 
(1995). Effects of surgical denervation on substance P and calcitonin gene-related 
peptide in adjuvant arthritis. Peptides, 16, 569-579. 
ANDERSSON, D.A., ADNER, M . � H O G E S T A T T , E .D . & ZYGMUNT, P.M. (2002) . Mechanisms 
underlying tissue selectivity of anandamide and other vanilloid receptor agonists, 
erratum appears in Mol Pharmacol 2002 Oct;62(4):968]. Molecular Pharmacology, 
62, 705-713. 
AXELROD, J. & FELDER, C.C. (1998). Caimabinoid receptors and their endogenous agonist, 
anandamide. Neurochemical Research, 23, 575-581. 
BALUK, P . (1997) . Neurogenic inflammation in skin and airways. Journal of Investigative 
Dermatology. Symposium Proceedings, 2, 76-81. 
BALUK, P. , THURSTON, G . � M U R P H Y , T . J” BUTWETT, N . W . & MCDONALD, D M . (1999). 
Neurogenic plasma leakage in mouse airways. British Journal of Pharmacology, 126, 
522-528. 
BARNES, PJ . (1996). Sensory Neuropeptides and Airway Diseases. In Neurogenic 
Inflammation, ed. Geppetti, P. & Holzer, P. pp. 169-179.: CRC Press Inc. 
BARNES, P.J. (2001). Neurogenic inflammation in the airways. Respiration Physiology, 125, 
145-154. 
BELTRAMO, M ” STELLA, N. , CALIGNANO, A. , LIN, S.Y., MAKRIYANNIS, A. & PIOMELLI, D. 
(1997). Functional role of high-affinity anandamide transport, as revealed by 
selective inhibition. Science, 111, 1094-1097. 
BEVAN, S. & DOCHERTY, R.J. (1996). The Ionic Basis of Capsaicin-evoked Responses. In 
Neurogenic Inflammation, ed. Geppetti, P. & Holzer�P. pp  53-67.: CRC Press Inc. 
BEVAN, S . � H O T H I , S., HUGHES, G., JAMES, L F . � R A N G , H.P. , SHAH, K. , WALPOLE, C.S. & 
YEATS, J.C. (1992). Capsazepine: a competitive antagonist of the sensory neurone 
excitant capsaicin. British Journal of Pharmacology, 107, 544-552. 
BHARALI, L.A. & LISNEY, S.J. (1992). The relationship between unmyelinated afferent type 
and neurogenic plasma extravasation in normal and reinnervated rat skin. 
Neuroscience, 47, 703-712. 
‘ 173 “ 
References 
BILEVICIUTE, I . � L U N D B E R G , T . � E K B L O M , A. & THEODORSSON, E. (1993). Bilateral changes 
of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-
like immimoreactivity in rat knee joint synovial fluid during acute monoarthritis. 
Neuroscience Letter, 152, 37-40. 
BIRDER, L.A., KANAI, A.J., DE GROAT, W.C., Kiss, S., NEALEN, ML., BURKE, N.E., 
DINELEY, K.E.�WATKINS, ., REYNOLDS, I.J. & CATERINA, M.J. (2001). Vanilloid 
receptor expression suggests a sensory role for urinary bladder epithelial cells. 
Proceedings of the National Academy of Sciences of the United States of America, 
98, 1 3 3 9 6 - 1 3 4 0 1 . 
BIRO, T . � M A U R E R , M., MODARRES, S . � L E W I N , N.E. , BRODIE, C., ACS, G., ACS, P., PAUS, 
R. & BLUMBERG�P.M. (1998). Characterization of functional vanilloid receptors 
expressed by mast cells. Blood, 91, 1332-1340. 
BOGATCHEVA, N . V . � G A R C I A , J.G. & V E R I N � A . D . (2002). Molecular mechanisms of 
thrombin-induced endothelial cell permeability. Biochemistry (Moscow), 67, 75-84. 
BRAIN, S.D. (1994). The Microcirculation. In Immunopharmacology of the Microcirculation. 
ed. Brain, S.D. pp. 1-7.: London Academic Press. 
BRAIN, S.D. (1996). Sensory Neuropeptides in the Skin. In Neurogenic Inflammation, ed. 
Geppetti, P. & Holzer�P. pp  229-244.: CRC Press Inc. 
BRAIN, S.D. (1997). Sensory neuropeptides: their role in inflammation and wound healing. 
Immunopharmacology, 37, 133-152. 
BRAIN, S.D. (2000). New feelings about the role of sensory nerves in inflammation. Nature 
Medicine, 6, 134-135. 
BRAIN, S.D. & CAMBRIDGE, H. (1996). Calcitonin gene-related peptide: vasoactive effects 
and potential therapeutic role. General Pharmacology, 27, 607-611. 
BRAIN, S.D” HUGHES, S.R., CAMBRIDGE, H. & O'DRISCOLL, G. (1993). The contribution of 
calcitonin gene-related peptide (CGRP) to neurogenic vasodilator responses. Agents 
& Actions, 38, CI9-21 . 
BRAIN, S.D., MACINTYRE, I. & WILLIAMS�T.J. (1986a). A second form of human calcitonin 
gene-related peptide which is a potent vasodilator. European Journal of 
Pharmacology, 124, 349-352. 
BRAIN, S.D., TIPPINS, J.R., MORRIS, H.R., MACINTYRE, L & WILLIAMS, T.J. (1986b). 
Potent vasodilator activity of calcitonin gene-related peptide in human skin. Journal 
of Investigative Dermatology, 87, 533-536. 
BRAIN, S.D. & WILLIAMS, T.J. (1988). Neuropharmacology of peptides in skin. Seminars in 
Dermatology, 7, 278-283. 
References 
BREYER, R . M . , BAGDASSARIAN, C.K. , MYERS, S.A. & BREYER, M.D. (2001). Prostanoid 
receptors: subtypes and signaling. Annual Review of Pharmacology & Toxicology, 
41,661-690. 
B U C K L E Y � T . L . & BRAIN, S.D. (1994). Functional Interactions between Mediators in the 
Microcirculation and Relevance of a Neurogenic Component. In 
Immunopharmacology of the Microcirculation, ed. Brain, S.D. pp. 63-75. 
BUCKLEY, T.L., BRAIN, S.D. & WILLIAMS, T.J. (1990). Ruthenium red selectively inhibits 
oedema formation and increased blood flow induced by capsaicin in rabbit skin. 
British Journal of Pharmacology, 99，7-8. 
BUKOSKI, R .D. , BATKAI, S., JARAI, Z., WANG, Y. , OFFERTALER�L. , JACKSON, W . F . & 
KUNOS, G. (2002). CB(1) receptor antagonist SR141716A inhibits Ca(2+)-induced 
relaxation in CB(1) receptor-deficient mice. Hypertension, 39, 251-257. 
BussE, R., EDWARDS, G., FELETOU, M. , FLEMING, L, VANHOUTTE, P . M . & WESTON, A.H. 
(2002). EDHF: bringing the concepts together. Trends in Pharmacological Sciences, 
23，374-380. 
CALIGNANO, A. , LARANA, G ” BELTRAMO, M.�MAKRIYANNIS, A . & PIOMELLI�D. (1997) . 
Potentiation of anandamide hypotension by the transport inhibitor, AM404. 
European Journal of Pharmacology, 337, Rl-2. 
CARVAJAL, J .A., GERMAIN, A .M. , HUIDOBRO-TORO, J.P. & WEINER, C.P. (2000). 
Molecular mechanism of cGMP-mediated smooth muscle relaxation. Journal of 
Cellular Physiology, 184，409-420. 
CATERINA, M J . & JULIUS, D. (2001). The vanilloid receptor: a molecular gateway to the 
pain pathway. Annual Review of Neuroscience, 24, 487-517. 
CATERINA, M.J . , LEFFLER, A., MALMBERG, A.B. , MARTIN, W.J . , TRAFTON, J., PETERSEN-
Z E I T Z � K . R . , KOLTZENBURG, M. , BASBAUM, A.I . & J U L I U S�D . (2000). Impaired 
nociception and pain sensation in mice lacking the capsaicin receptor. Science, 288, 
306-313. 
CATERINA, M J . , SCHUMACHER, M.A. , TOMINAGA, M. , ROSEN, T.A. , LEVINE, J .D. & 
JULIUS, D. (1997). The capsaicin receptor: a heat-activated ion channel in the pain 
pathway. Nature, 389, 816-824. 
CHAN, S I . & Fiscus, R.R. (2003). Vasorelaxations induced by calcitonin gene-related 
peptide, vasoactive intestinal peptide, and acetylcholine in aortic rings of endothelial 
and inducible nitric oxide synthase-knockout mice. Journal of Cardiovascular 
Pharmacology, 41，434-443. 
CHAYTOR�A.T. , MARTIN, P.E., EVANS, W.H. , RANDALL, M . D . & GRIFFITH, T .M. (1999). 
The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric 
‘ 175 “ 
References 
artery depends on gap junctional communication. Journal of Physiology, 520, 539-
550. 
CODERRE, T.J. , BASBAUM, A.I. & LEVINE, J .D. (1989) . Neural control of vascular 
permeability: interactions between primary afferents, mast cells, and sympathetic 
efferents. Journal of Neurophysiology, 62, 48-58. 
DE HOON, J.N., PICKKERS, P., SMITS, P., STRUIJKER-BOUDIER, H.A. & VAN BORTEL, L .M. 
(2003). Calcitonin gene-related peptide: exploring its vasodilating mechanism of 
action in humans. Clinical Pharmacology & Therapeutics, 73, 312-321. 
DE PETROCELLIS, L., BISOGNO�T .�DAVIS , J.B., PERTWEE, R .G. & DI MARZO, V. (2000). 
Overlap between the ligand recognition properties of the anandamide transporter and 
the VRl vanilloid receptor: inhibitors of anandamide uptake with negligible 
capsaicin-like activity. FEBSLetters, 483, 52-56. 
DE PETROCELLIS, L., BISOGNO, T., MACCARRONE, M. , DAVIS, J.B., FINAZZI-AGRO, A. & 
DI MARZO, V. (2001). The activity of anandamide at vanilloid VRl receptors 
requires facilitated transport across the cell membrane and is limited by intracellular 
metabolism. Journal of Biological Chemistry, 276, 12856-12863. 
DEL CARMEN GARCIA, M. , ADLER-GRASCHINSKY, E. & CELUCH, S.M. (2003). Hypotensive 
effect of anandamide through the activation of CBI and VRl spinal receptors in 
urethane-anesthetized rats. Naunyn-Schmiedebergs Archives of Pharmacology, 368, 
270-276. 
DENDA, M. , FUZIWARA, S., INOUE, K., DENDA, S., AKAMATSU, H., TOMITAKA, A. & 
MATSUNAGA, K. (2001). Immunoreactivity of VRl on epidermal keratinocyte of 
human skin. Biochemical & Biophysical Research Communications, 285, 1250-1252. 
DEUTSCH, D.G. , GLASER, S.T., HOWELL, J.M., KUNZ, J.S., PUFFENBARGER, R.A., HILLARD, 
C.J. & ABUMRAD, N. (2001). The cellular uptake of anandamide is coupled to its 
breakdown by fatty-acid amide hydrolase. Journal of Biological Chemistry, 276, 
6967-6973. 
DEUTSCH, D.G. , GOLIGORSKY, M.S., SCHMID, P.C., KREBSBACH, R.J.�SCHMID, H.H., DAS, 
S.K., DEY, S.K.�ARREAZA, G., THORUP, C., STEFANO, G. & MOORE, L.C, (1997). 
Production and physiological actions of anandamide in the vasculature of the rat 
kidney. Journal of Clinical Investigation, 100, 1538-1546. 
DEVILLIER, P., REGOLI, D . � A S S E R A F , A., DESCOURS, B., MARSAC, J. & RENOUX, M. 
(1986). Histamine release and local responses of rat and human skin to substance P 
and other mammalian tachykinins. Pharmacology, 32, 340-347. 
DI MARZO, V., BISOGNO, T. & DE PETROCELLIS, L. (2001). Anandamide： some like it hot. 
Trends in Pharmacological Sciences, 22, 346-349. 
_ — -
References 
Dl MARZO, V., BLUMBERG, P.M. & SZALLASI, A. (2002). Endovanilloid signaling in pain. 
Current Opinion in Neurobiology, 12, 3 7 2 - 3 7 9 . 
DOCHERTY, R J . , YEATS, J.C., BEVAN, S. & BODDEKE, H.W. (1996). Inhibition of 
calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured 
dorsal root ganglion neurones from adult rats. Pflugers Archiv - European Journal of 
Physiology, 4 3 1 , 8 2 8 - 8 3 7 . 
DOCHERTY, R J . , YEATS, J.C. & PIPER, A.S. (1997). Capsazepine block of voltage-activated 
calcium channels in adult rat dorsal root ganglion neurones in culture. British 
Journal of Pharmacology, 121, 1 4 6 1 - 1 4 6 7 . 
EGLEZOS, A., GIULIANI, S . � V I T I , G. & M A G G I�C . A . (1991). Direct evidence that capsaicin-
induced plasma protein extravasation is mediated through tachykinin NKI receptors. 
European Journal of Pharmacology, 2 0 9 , 2 7 7 - 2 7 9 . 
ELLIS, E.F., MOORE, S.F. & WiLLOUGHBY, K.A. (1995). Anandamide and delta 9-THC 
dilation of cerebral arterioles is blocked by indomethacin. American Journal of 
Physiology, 269, HI859-1864. 
ESCOTT, K.J . & B R A I N�S . D . (1993). Effect of a calcitonin gene-related peptide antagonist 
(CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat 
saphenous nerve. British Journal of Pharmacology, 110, 772-776. 
E T Z I O N I� a . (2003). Immune deficiency and autoimmunity. Autoimmunity Reviews, 2, 364-
369. 
FERRELL, W.R . & L A M � F . Y . (1996). Sensory Neuropeptides in Arthritis. In Neurogenic 
Inflammation, ed. Geppetti, P. & Holzer, P. pp. 211-228.: CRC Press Inc. 
FERRELL, W.R. , LAM, F.Y. & MONTGOMERY� I . (1992). Differences in the axon 
composition of nerves supplying the rat knee joint following intra-articular injection 
of capsaicin. Neuroscience Letters, 141, 259-261. 
FERRELL, W.R. , LOCKHART, J.C. & KARIMIAN, S.M. (1997a). Tachykinin regulation of 
basal synovial blood flow. British Journal of Pharmacology, 121, 29-34. 
FERRELL, W.R., MCDOUGALL, J.J. & B R A Y � R . C . (1997b). Spatial heterogeneity of the 
effects of calcitonin gene-related peptide (CGRP) on the microvasculature of 
ligaments in the rabbit knee joint. British Journal of Pharmacology, 121, 1397-1405. 
FERRELL, W.R. & RUSSELL, N.J. (1986). Extravasation in the knee induced by antidromic 
stimulation of articular C fibre afferents of the anaesthetized cat. Journal of 
Physiology, 379, 407-416. 
FLORES, C.M., LEONG, A.S., DussoR, G.O., HARDING-ROSE, C , HARGREAVES, K.M. & 
KILO, S. (2001). Capsaicin-evoked C G R P release from rat buccal mucosa: 
development of a model system for studying trigeminal mechanisms of neurogenic 
inflammation. European Journal of Neuroscience, 14, 1113-1120. 
- 177 
References 
FORD, W.R. , HONAN, S.A., WHITE, R. & HILEY, C.R. (2002). Evidence of a novel site 
mediating anandamide-induced negative inotropic and coronary vasodilatator 
responses in rat isolated hearts. British Journal of Pharmacology, 135，1191-1198. 
FRANCO-CERECEDA, A . � R U D E H I L L , A. & LUNDBERG, J.M. (1987). Calcitonin gene-related 
peptide but not substance P mimics capsaicin-induced coronary vasodilation in the 
pig. European Journal of Pharmacology, 142, 235-243. 
FULTON, D. & QUILLEY, J. (1998). Evidence against anandamide as the hyperpolarizing 
factor mediating the nitric oxide-independent coronary vasodilator effect of 
bradykinin in the rat. Journal of Pharmacology & Experimental Therapeutics, 286, 
1146-1151. 
GAMILLSCHEG, A., HOLZER, P., DONNERER, J. & LEMBECK, F. (1984). Effect of neonatal 
treatment with capsaicin on carrageenan-induced paw oedema in the rat. Naunyn-
Schmiedebergs Archives of Pharmacology, 326, 340-342. 
GARCIA, N. , JR., JARAI, Z., MIRSHAHI, F., KUNOS, G. & SANYAL, A.J. (2001). Systemic and 
portal hemodynamic effects of anandamide. American Journal of Physiology -
Gastrointestinal & Liver Physiology, 280, G14-20. 
GELMAN, A.E. & TURKA, L.A. (2003). Autoimmunity heats up. Nature Medicine, 9，1465-
1466. 
GLUFFRIDA, A., BELTRAMO, M. & PLOMELLI, D. (2001). Mechanisms of endocannabinoid 
inactivation: biochemistry and pharmacology. Journal of Pharmacology & 
Experimental Therapeutics, 298, 7-14. 
GODLEWSKI, G., GOTHERT, M. & MALINOWSKA�B. (2003). Cannabinoid receptor-
independent inhibition by cannabinoid agonists of the peripheral 5-HT3 receptor-
mediated von Bezold-Jarisch reflex. British Journal of Pharmacology, 138, 767-774. 
GRADY, E.F., YOSHIMI, S.K., MAA, J., VALEROSO, D , VARTANIAN, R.K., RAHIM, S., KIM, 
E.H., GERARD, C., GERARD, N., BUNNETT, N . W . & KIRKWOOD, K.S. (2000). 
Substance P mediates inflammatory oedema in acute pancreatitis via activation of 
the neurokinin-1 receptor in rats and mice. British Journal of Pharmacology, 130, 
505-512. 
GRAINGER, J. & BOACHIE-ANSAH, G. (2001). Anandamide-induced relaxation of sheep 
coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites 
and potassium channels. British Journal of Pharmacology, 134, 1003-1012. 
GRANT, A.D., GERARD, N.P. & BRAIN, S.D. (2002). Evidence of a role for N K I and CGRP 
receptors in mediating neurogenic vasodilatation in the mouse ear. British Journal of 
Pharmacology, 135, 356-362. 
‘ 178 “ 
References 
GRAY, D . W . & MARSHALL, I. (1992). A pharmacological profile of the endothelium-derived 
relaxant factor released by calcitonin gene-related peptide in rat aorta. Annals of the 
New York Academy of Sciences, 657, 517-8. 
HALL, J .M. & BRAIN, S.D. (1996). Pharmacology of Calcitonin Gene-Related Peptide. In 
Neurogenic Inflammation, ed. Geppetti, P. & Holzer�P. pp. 101-114.: CRC Press Inc. 
HANSRA, P., MORAN, E L . , FORNASIER, V.L. & BOGOCH, E.R. (2000). Carrageenan-induced 
arthritis in the rat. Inflammation, 24, 141-155. 
HARRIS, D., MCCULLOCH, A.L, KENDALL, D.A. & RANDALL, M.D. (2002). 
Characterization of vasorelaxant responses to anandamide in the rat mesenteric 
arterial bed. Journal of Physiology, 539, 893-902. 
HARRISON, S. & GEPPETTI, P. (2001). Substance p. International Journal of Biochemistry & 
Cell Biology, 33，555-576. 
HARTENECK, C., PLANT, T.D. & SCHULTZ, G. (2000). From worm to man: three subfamilies 
of TRP channels. Trends in Neurosciences, 23, 159-166. 
HELYES, Z . � N E M E T H , J., PINTER, E. & SZOLCSANYI, J. (1997). Inhibition by nociceptin of 
neurogenic inflammation and the release of SP and CGRP from sensory nerve 
terminals. British Journal of Pharmacology, 121，613-615. 
HELYES, Z., NEMETH, J., THAN, M � � B O L C S K E I � K . , PINTER, E. & SZOLCSANYI, J. (2003). 
Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide 
release in vivo and neuropathic hyperalgesia in the rat. Life Sciences, 73, 2345-2353. 
HEPPELMANN, B . � S H A H B A Z I A N , Z. & HANESCH, U. (1997). Quantitative examination of 
calcitonin gene-related peptide immunoreactive nerve fibres in the cat knee joint 
capsule. Anatomy & Embryology, 195, 525-530. 
HERBERT, J.M. & BERNAT, A. (1996). Effect of SR 140333, a selective NKI antagonist, on 
antigen-induced oedema formation in rat skin. Journal of Lipid Mediators & Cell 
Signalling, 13, 2 2 3 - 2 3 2 . 
HILLARD, C.J. (2000). Endocannabinoids and vascular function. Journal of Pharmacology & 
Experimental Therapeutics, 2 9 4 , 27-32. 
HO, W.S. & HILEY, C.R. (2003). Endothelium-independent relaxation to cannabinoids in rat-
isolated mesenteric artery and role of Ca2+ influx. British Journal of Pharmacology, 
139, 585-597. 
HOGESTATT, E.D. & ZYGMUNT, P.M. (2002). Cardiovascular pharmacology of anandamide. 
Prostaglandins Leukotrienes & Essential Fatty Acids, 66, 343-351. 
HOKFELT, T., KELLERTH, J.O., NILSSON, G. & P E R N O W � B . (1975). Experimental 
immunohistochemical studies on the localization and distribution of substance P in 
cat primary sensory neurons. Brain Research, 100, 235-252. 
• T79 “ 
References 
HOLZER, P. (1991) . Capsaicin: cellular targets, mechanisms of action, and selectivity for thin 
sensory neurons. Pharmacological Reviews, 43，143-201. 
HOLZER, P . (1998) . Neurogenic vasodilatation and plasma leakage in the skin. General 
Pharmacology, 30, 5-11. 
HUGHES, S .R. & BRAIN, S.D. (1991). A calcitonin gene-related peptide (CGRP) antagonist 
(CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in 
skin. British Journal of Pharmacology, 104, 738-742. 
HWANG, S .W. , CHO, H. , KWAK, J., LEE, S.Y., KANG, C.J. , JUNG, J., CHO, S” MIN, K.H. , 
SUH, Y.G., KIM, D. & O H � U . (2000). Direct activation of capsaicin receptors by 
products of lipoxygenases: endogenous capsaicin-like substances. Proceedings of the 
National Academy of Sciences of the United States of America, 97, 6155-6160. 
INOUE, K . � K O I Z U M I , S” FUZIWARA, S., DENDA, S. & DENDA, M. (2002). Functional 
vanilloid receptors in cultured normal human epidermal keratinocytes. Biochemical 
& Biophysical Research Communications, 291，124-129. 
ISHIOKA, N. & BUKOSKI�R.D. (1999). A role for N-arachidonylethanolamine (anandamide) 
as the mediator of sensory nerve-dependent Ca2+-induced relaxation. Journal of 
Pharmacology & Experimental Therapeutics, 289, 245-250. 
JARAI, Z ” WAGNER, J.A., VARGA, K . � L A K E , K .D . , COMPTON, D.R. , MARTIN, B . R . � 
ZIMMER, A.M., BONNER, T.L, BUCKLEY, N.E., MEZEY, E., RAZDAN, R.K., ZiMMER, 
A. & KUNOS�G. (1999). Carniabinoid-induced mesenteric vasodilation through an 
endothelial site distinct from CBI or CB2 receptors. Proceedings of the National 
Academy of Sciences of the United States of America, 96, 14136-14141. 
JENNINGS, E.A. , VAUGHAN, C . W . � R O B E R T S , LA. & CHRISTIE�M.J . (2003). The actions of 
anandamide on rat superficial medullary dorsal horn neurons in vitro. Journal of 
Physiology, 548, 121-129. 
JERMAN, J .C. , GRAY, J., BROUGH, S.J., Ooi, L., OWEN, D. , DAVIS, J .B. & S M A R T � D . (2002). 
Comparison of effects of anandamide at recombinant and endogenous rat vanilloid 
receptors. British Journal of Anaesthesia, 89, 882-887. 
JIA, Y., MCLEOD, R.L., WANG, X” PARRA, L.E., EGAN, R.W. & H E Y � J . A . (2002). 
Anandamide induces cough in conscious guinea-pigs through VRl receptors. British 
Journal of Pharmacology, 137, 831-836. 
JORDT, S.E. & JULIUS, D. (2002). Molecular basis for species-specific sensitivity to "hot" 
chili peppers. Cell, 108, 421-430. 
JUNG, J., HWANG, S.W., KWAK, J , LEE, S.Y., KANG, C.J. , KIM, W.B. , KIM, D. & O H � U . 
(1999). Capsaicin binds to the intracellular domain of the capsaicin-activated ion 
channel. Journal of Neuroscience, 19, 529-538. 
References 
KARIMIAN, S .M. , MCDOUGALL, J J . & F E R R E L L � W . R . (1995) . Neuropeptidergic and 
autonomic control of the vasculature of the rat knee joint revealed by laser Doppler 
perfusion imaging. Experimental Physiology, 80, 341-348. 
KATO, S . � A I H A R A , E. , NAKAMURA, A. , XIN, H. , MATSUI, H. , KOHAMA, K . & TAKEUCHI, K . 
(2003). Expression of vanilloid receptors in rat gastric epithelial cells: role in cellular 
protection. Biochemical Pharmacology, 66，1115-1121. 
KATZ, L .M. , MARR, C . M . & ELLIOTT, J. (2003). Characterisation of the response of equine 
digital arteries and veins to substance P. Journal of Veterinary Pharmacology & 
Therapeutics, 26, 361-368. 
KRESS, M .�GUTHMANN, C.�AVERBECK, B. & REEH, P.W. (1999). Calcitonin gene-related 
peptide and prostaglandin E2 but not substance P release induced by antidromic 
nerve stimulation from rat skin in vitro. Neuroscience, 89, 303-310. 
LAM, F .Y . & FERRELL�W.R. (1989). Inhibition of carrageenan induced inflammation in the 
rat knee joint by substance P antagonist. Annals of the Rheumatic Diseases, 48, 928-
932. 
LAM, F.Y. & FERRELL, W.R. (1990). Mediators of substance P-induced inflammation in the 
rat knee joint. Agents & Actions, 31, 298-307. 
LAM, F .Y . & F E R R E L L � W . R . (1991). Specific neurokinin receptors mediate plasma 
extravasation in the rat knee joint. British Journal of Pharmacology, 103，1263-1267. 
LAM, F .Y . & FERRELL, W . R . (1993). Effects of interactions of naturally-occurring 
neuropeptides on blood flow in the rat knee joint. British Journal of Pharmacology, 
108, 694-699. 
LAM, F.Y. & WONG, M.C. (1996). Characterization of tachykinin receptors mediating 
plasma extravasation and vasodilatation in normal and acutely inflamed knee joints 
of the rat. British Journal of Pharmacology, 118, 2107-2114. 
LAMBRECHT, B.N.�GERMONPRE, P.R. , EVERAERT�E.G. , CARRO-MUINO, L, DE VEERMAN, 
M. , DE FELIPE, C., HUNT, S.P., THIELEMANS, K. , JOOS, G.F. & PAUWELS, R .A. 
(1999). Endogenously produced substance P contributes to lymphocyte proliferation 
induced by dendritic cells and direct TCR ligation. European Journal of Immunology, 
29, 3815-3825. 
LAO, L.J. , SONG, B. & MARVIZON, J.C. (2003). Neurokinin release produced by capsaicin 
acting on the central terminals and axons of primary afferents: relationship with N-
methyl-D-aspartate and GABA(B) receptors. Neuroscience, 121, 667-680. 
LEE, L .Y. & LUNDBERG, J .M. (1994). Capsazepine abolishes pulmonary chemoreflexes 
induced by capsaicin in anesthetized rats. Journal of Applied Physiology, 76, 1848-
1855. 
- 181 ‘ 
References 
LIN, Q., WU, J. & WILLIS, W . D . (1999). Dorsal root reflexes and cutaneous neurogenic 
inflammation after intradermal injection of capsaicin in rats. Journal of 
Neurophysiology, 82, 2 6 0 2 - 2 6 1 1 . 
LIU, J., GAO, B.�MIRSHAHI, F., SANYAL, A.J. , KHANOLKAR, A.D., MAKRIYANNIS, A. & 
KUNOS, G. (2000). Functional CBI cannabinoid receptors in human vascular 
endothelial cells. Biochemical Journal, 346, 835-840. 
LU, L.F. & FISCUS�R.R. (1999). Nitric oxide donors enhance calcitonin gene-related 
peptide-induced elevations of cyclic AMP in vascular smooth muscle cells. 
European Journal of Pharmacology, 376, 307-314. 
LUM, H. & MALIK, A.B. (1994). Regulation of vascular endothelial barrier function. 
American Journal of Physiology’ 267, L223-241. 
LYNN, B., YE, W . & COTSELL, B. (1992). The actions of capsaicin applied topically to the 
skin of the rat on C-fibre afferents, antidromic vasodilatation and substance P levels. 
British Journal of Pharmacology, 107，400-406. 
MAGGI, C.A., BEVAN, S., WALPOLE, C . S , RANG, H.P. & GIULIANI, S. (1993). A 
comparison of capsazepine and ruthenium red as capsaicin antagonists in the rat 
isolated urinary bladder and vas deferens. British Journal of Pharmacology, 108, 
801-805. 
MALINOWSKA, B., KWOLEK, G. & GOTHERT, M. (2001). Anandamide and methanandamide 
induce both vanilloid VRl- and cannabinoid CBI receptor-mediated changes in 
heart rate and blood pressure in anaesthetized rats. Naunyn-Schmiedebergs Archives 
of Pharmacology, 364, 562-569. 
MAPP, P.L (1995). Innervation of the synovium. Annals of the Rheumatic Diseases, 54, 398-
403. 
MAPP, P.L, KERSLAKE, S., BRAIN, S.D., BLAKE, D.R. & CAMBRIDGE, H. (1996). The effect 
of intra-articular capsaicin on nerve fibres within the synovium of the rat knee joint. 
Journal of Chemical Neuroanatomy, 10, 11-18. 
MARVIZON, J.C., WANG, X ” MATSUKA, Y . � N E U B E R T , J .K. & SPIGELMAN, I. (2003). 
Relationship between capsaicin-evoked substance P release and neurokinin 1 
receptor internalization in the rat spinal cord. Neuroscience, 118, 535-545. 
MATHESON, M J . , RYNELL, A . C . � M C C L E A N � M . A . & BEREND, N. (1997). Tachykinins do 
not cause plasma leakage in the rabbit trachea. Respiration Physiology, 108, 165-170. 
MATHEWS, C.K., HOLDE, K.E. & AHERN�K.G. (1999). Biochemistry.-. Wesley Longman Inc. 
MCCLESKEY, E.W. & GOLD, M.S. (1999). Ion channels of nociception. Annual Review of 
Physiology, 61, 835-856. 
MCGILL, S.N., AHMED, N.A. & CHRISTOU, N.V. (1998). Endothelial cells: role in infection 
and inflammation. World Journal of Surgery, 22, 171-178. 
References 
MCINTYRE, P. , M C L A T C H I E�L . M . , CHAMBERS, A. , PHILLIPS, E., CLARKE, M. , SAVIDGE, J., 
TOMS, C . � P E A C O C K , M . � S H A H , K ” WINTER, J., WEERASAKERA, N. , WEBB, M . � 
RANG, H.P., BEVAN, S. & JAMES, LF. (2001). Pharmacological differences between 
the human and rat vanilloid receptor 1 (VRl). British Journal of Pharmacology, 132, 
1084-1094. 
MCMURDO, L., LOCKHART, J .C. & FERRELL, W.R. (1997). Modulation of synovial blood 
flow by the calcitonin gene-related peptide (CGRP) receptor antagonist, CGRP(8-
37). British Journal of Pharmacology, 121, 1075-1080. 
MECHICHE, H . � K O R O G L U , A. , CANDENAS, L . � P I N T O , F . M . � B I R E M B A U T � P . , BARDOU, M. , 
ELAERTS, J. & DEVILLIER, P. (2003). Neurokinins induce relaxation of human 
pulmonary vessels through stimulation of endothelial NKI receptors. Journal of 
Cardiovascular Pharmacology, 41，343-355. 
MECHOULAM, R., FRIDE, E. & Dl MARZO, V. (1998). Endocannabinoids. European Journal 
of Pharmacology, 359, 1-18. 
MOHAPATRA, D.P . & NAU, C. (2003). Desensitization of capsaicin-activated currents in the 
vanilloid receptor TRPVI is decreased by the cyclic AMP-dependent protein kinase 
pathway. Journal of Biological Chemistry, 278, 50080-50090. 
MUKHOPADHYAY, S., CHAPNICK, B . M . & HOWLETT, A .C . (2002) . Anandamide-induced 
vasorelaxation in rabbit aortic rings has two components: G protein dependent and 
independent. American Journal of Physiology - Heart & Circulatory Physiology, 
282, H2046-2054. 
NEMETH, J., HELYES, Z., OROSZI, G., JAKAB, B.�PINTER, E., SZILVASSY, Z. & SZOLCSANYI, 
J. (2003a). Role of voltage-gated cation channels and axon reflexes in the release of 
sensory neuropeptides by capsaicin from isolated rat trachea. European Journal of 
Pharmacology, 458, 3 1 3 - 3 1 8 . 
NEMETH, J” HELYES, Z., THAN, M .� J A K A B , B., PINTER, E. & SZOLCSANYI, J. (2003b). 
Concentration-dependent dual effect of anandamide on sensory neuropeptide release 
from isolated rat tracheae. Neuroscience Letters, 336, 89-92. 
NEWBOLD, P. & BRAIN, S.D. (1995) . An investigation into the mechanism of capsaicin-
induced oedema in rabbit skin. British Journal of Pharmacology, 114, 570-577. 
NEWBY, D.E., SCIBERRAS, D.G., FERRO, C.J., GERTZ, B.J.�SOMMERVILLE, D., MAJUMDAR, 
A., LOWRY, R.C. & WEBB, D.J. (1999). Substance P-induced vasodilatation is 
mediated by the neurokinin type 1 receptor but does not contribute to basal vascular 
tone in man. British Journal of Clinical Pharmacology, 48, 336-344. 
OFFERTALER, L . � M O , F.M., BATKAI, S., LIU, J., BEGG, M., RAZDAN, R.K., MARTIN, B.R., 
BUKOSKI, R .D. & KUNOS, G. (2003) . Selective ligands and cellular effectors of a G 
References 
protein-coupled endothelial cannabinoid receptor, [comment]. Molecular 
Pharmacology, 63, 699-705. 
OKU, R . � S A T O H , M . & TAKAGI, H. (1987). Release of substance P from the spinal dorsal 
horn is enhanced in polyarthritic rats. Neuroscience Letters, 74, 315-319. 
OLAH, Z., KARAI, L. & LADAROLA, M.J. (2001). Anandamide activates vanilloid receptor 1 
(VRl) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing 
VRl. Journal of Biological Chemistry, 276, 31163-31170. 
PlOMELLI, D., BELTRAMO, M.�GLASNAPP, S., LIN, S.Y., GOUTOPOULOS, A., XlE, X.Q. & 
MAKRIYANNIS, A. (1999). Structural determinants for recognition and translocation 
by the anandamide transporter. Proceedings of the National Academy of Sciences of 
the United States of America, 9 6， 5 8 0 2 - 5 8 0 7 . 
PlOMELLI, D., GIUFFRIDA, A., CALIGNANO, A. & RODRIGUEZ DE FONSECA, F. (2000). The 
endocannabinoid system as a target for therapeutic drugs. Trends in 
Pharmacological Sciences, 21, 2 1 8 - 2 2 4 . 
PIPER, A.S., YEATS, J.C., BEVAN, S. & DOCHERTY, R.J . (1999). A study of the voltage 
dependence of capsaicin-activated membrane currents in rat sensory neurones before 
and after acute desensitization. Journal of Physiology, 518, 721-733. 
PLANE, F., HOLLAND, M., WALDRON, G.J., GARLAND, C.J. & BOYLE, J.P. (1997). Evidence 
that anandamide and EDHF act via different mechanisms in rat isolated mesenteric 
arteries. British Journal of Pharmacology, 121, 1509-1511. 
PORSZASZ, R. & SZOLCSANYI, J. (1991). Circulatory and respiratory effects of capsaicin and 
resiniferatoxin on guinea pigs. Acta Biochimica et Biophysica Hungarica, 26, 131-
138. 
PRATT, P.F. , HILLARD, C J . , EDGEMOND, W.S . & CAMPBELL, W.B. (1998). N-
arachidonylethanolamide relaxation of bovine coronary artery is not mediated by 
CBI cannabinoid receptor. American Journal of Physiology, 274, H375-381. 
RALEVIC, V. & KENDALL, D.A. (2001). Cannabinoid inhibition of capsaicin-sensitive 
sensory neurotransmission in the rat mesenteric arterial bed. European Journal of 
Pharmacology, 418, 117-125. 
RALEVIC, V . � K E N D A L L , D . A . � R A N D A L L , M .D . & SMART, D. (2002). Cannabinoid 
modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: 
roles in regulation of cardiovascular function. Life Sciences, 71, 2577-2594. 
RALEVIC, V. , KENDALL, D.A., RANDALL, M.D. , ZYGMUNT, P.M., MOVAHED, P. & 
HOGESTATT, E.D. (2000). Vanilloid receptors on capsaicin-sensitive sensory nerves 
mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and 
small mesenteric arteries. British Journal of Pharmacology, 130, 1483-1488. 
— 
References 
RANDALL, M.D. (2003). A new endothelial target for camiabinoids. Molecular 
Pharmacology, 63, 469-470. 
RANDALL, M . D . , ALEXANDER, S.P., BENNETT, T. , BOYD, E . A . � F R Y , J . R .� G A R D I N E R , S.M., 
KEMP, P.A., M C C U L L O C H �A . I . & KENDALL, D . A . (1996) . An endogenous 
cannabinoid as an endothelium-derived vasorelaxant. Biochemical & Biophysical 
Research Communications, 2 2 9 , 114-120. 
RANDALL, M . D . & KENDALL, D.A. (1997). Involvement of a cannabinoid in endothelium-
derived hyperpolarizing factor-mediated coronary vasorelaxation. European Journal 
of Pharmacology, 335, 205-209. 
RANDALL, M . D . & K E N D A L L � D . A . (1998). Anandamide and endothelium-derived 
hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. 
European Journal of Pharmacology, 346 , 51-53. 
RANDALL, M . D . , MCCULLOCH, A.L & K E N D A L L�D . A . (1997). Comparative pharmacology 
of endothelium-derived hyperpolarizing factor and anandamide in rat isolated 
mesentery. European Journal of Pharmacology, 333, 191-197. 
RANG, H.P., DALE, M.M., RITTER, J .M. & MOORE, P.K. (2003). Pharmacology, 5出 edition, 
London: Churchill Livingstone. 
RAYCHAUDHURI, A. , COLOMBO, C., PASTOR, G., WONG, M . & J E N G � A . Y . (1991). Effect of 
capsaicin on carrageenan-induced inflammation in rat pleurisy and exudate 
substance P level. Agents & Actions, 34, 251-253. 
RESLEROVA, M . & LOUTZENHISER, R. (1998). Renal microvascular actions of calcitonin 
gene-related peptide. American Journal of Physiology, 274, F1078-1085. 
RICHARDSON, J.D., AANONSEN, L. & HARGREAVES, K.M. (1998a). Antihyperalgesic effects 
of spinal cannabinoids. European Journal of Pharmacology, 345, 145-153. 
RICHARDSON, J.D•，KILO, S. & HARGREAVES, K . M . (1998b). Cannabinoids reduce 
hyperalgesia and inflammation via interaction with peripheral CBI receptors. Pain, 
75, 111-119. 
RICHARDSON, J.D. & VASKO, M.R. (2002). Cellular mechanisms of neurogenic 
inflammation. Journal of Pharmacology & Experimental Therapeutics, 302, 839-
845. 
RIGONI, M. , TREVISANI, M. , GAZZIERI, D., NADALETTO, R. , TOGNETTO, M.�CREMINON, C., 
DAVIS, LB. , CAMPI, B., AMADESI, S., GEPPETTI, P. & HARRISON, S. (2003). 
Neurogenic responses mediated by vanilloid receptor-1 (TRPVl) are blocked by the 




KINDER, J. & LUNDBERG, J.M. (1996). Effects of hCGRP 8-37 and the NKI-receptor 
antagonist SR 140.333 on capsaicin-evoked vasodilation in the pig nasal mucosa in 
vivo. Acta Physiologica Scandinavica, 156, 115-122. 
KINDER, J., SZALLASI, A. & LUNDBERG, J .M. (1996). Capsaicin-, resiniferatoxin-, and lactic 
acid-evoked vascular effects in the pig nasal mucosa in vivo with reference to 
characterization of the vanilloid receptor. Pharmacology & Toxicology, 78, 327-335. 
RUPNIAK, N.M. , BOYCE, S.�WILLIAMS, A . R .�C O O K , G., LONGMORE, J.�SEABROOK, G.R., 
CAESER, M. , IVERSEN, S.D. & HILL, R.G. (1993). Antinociceptive activity of NKI 
receptor antagonists: non-specific effects of racemic RP67580. British Journal of 
Pharmacology, 110, 1 6 0 7 - 1 6 1 3 . 
RUPNIAK, N.M. , CARLSON, E.J., SHEPHEARD, S � BENTLEY�G., WILLIAMS, A.R., HILL, A., 
SWAIN, C., MILLS, S.G., DI SALVO, J., KILBURN, R., CASCIERI, M.A. , KURTZ, M.M., 
TSAO�K丄•�GOULD, S.L. & CHICCHI�G.G. (2003). Comparison of the functional 
blockade of rat substance P (NKI) receptors by GR205171, RP67580, SR140333 
and NKP-608. Neuropharmacology, 45, 231-241. 
SACERDOTE, P., CARRABBA, M.�GALANTE, A., PISATI, R.�MANFREDI, B. & PANERAI�A.E. 
(1995). Plasma and synovial fluid interleukin-1, interleukin-6 and substance P 
concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti 
inflammatory drugs indomethacin, diclofenac and naproxen. Inflammation Research, 
44, 486-490. 
SAKURADA, T.�MATSUMURA, T.�MORIYAMA, T., SAKURADA, C., UENO, S. & SAKURADA� 
s. (2003). Differential effects of intraplantar capsazepine and ruthenium red on 
capsaicin-induced desensitization in mice. Pharmacology, Biochemistry & Behavior, 
75, 115-121. 
SANCHO, R., CALZADO, M.A., DI MARZO, V., APPENDING, G. & MUNOZ, E. (2003). 
Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid 
receptor-independent pathway. Molecular Pharmacology, 63, 429-438. 
SARIA, A.�LUNDBERG, J.M., SKOFITSCH, G. & LEMBECK, F. (1983). Vascular protein 
linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, 
histamine and by antigen challenge. Naunyn-Schmiedebergs Archives of 
Pharmacology, 324, 212-218. 
SAUERSTEIN, K., KLEDE, M., HILLIGES, M. & SCHMELZ, M. (2000). Electrically evoked 
neuropeptide release and neurogenic inflammation differ between rat and human 
skin. Journal of Physiology, 529, 803-810. 
SCHMELZ, M., L u z , O., AVERBECK, B. & BiCKEL, A. (1997). Plasma extravasation and 
neuropeptide release in human skin as measured by intradermal microdialysis. 
Neuroscience Letters, 230, 117-120. 
“ 186 “ ‘ 
References 
SCHMELZ, M. , MICHAEL, K., WEIDNER, C .� S C H M I D T , R ” TOREBJORK, H.E. & 
HANDWERKER, H.O. (2000). Which nerve fibers mediate the axon reflex flare in 
human skin? Neuroreport, 11, 645-648. 
SCHMELZ, M . & PETERSEN, L.J. (2001). Neurogenic inflammation in human and rodent skin. 
News in Physiological Sciences, 16, 33-37. 
SCHMIDT, R . , S C H M E L Z � M . � F O R S T E R , C . � R I N G K A M P , M . , TOREBJORK, E . & 
HANDWERKER, H. (1995). Novel classes of responsive and unresponsive C 
nociceptors in human skin. Journal ofNeuroscience, 15, 333-341. 
SCOTT, D.T., LAM, F.Y. & FERRELL, W.R. (1991). Time course of substance P-induced 
protein extravasation in the rat knee joint measured by micro-turbidimetry. 
Neuroscience Letters, 129, 74-76. 
SCOTT, D.T., LAM, F.Y. & FERRELL�W.R. (1994). Acute joint inflammation-mechanisms 
and mediators. General Pharmacology, 25, 1285-1296. 
SEABROOK, G . R . , SHEPHEARD, S丄 .�W I L L I A M S O N , D . J . � T Y R E R , P . , RIGBY, M . , CASCIERI, 
M . A . � H A R R I S O N , T., HARGREAVES, R.J. & HILL, R.G. (1996). L-733,060, a novel 
tachykinin NKI receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular 
and dural extravasation assays. European Journal of Pharmacology, 317, 129-135. 
SEABROOK, G.R., SUTTON, K.G., JAROLIMEK, W. , HOLLINGWORTH, G.J., TEAGUE, S., 
WEBB, J., CLARK, N., BOYCE, S., KERBY, J., ALI, Z., CHOU, M., MIDDLETON, R., 
KACZOROWSKI, G. & JONES, A.B. (2002). Functional properties of the high-affinity 
TRPVl (VRl) vanilloid receptor antagonist (4-hydroxy-5 -iodo-3 -
methoxyphenylacetate ester) iodo-resiniferatoxin. Journal of Pharmacology & 
Experimental Therapeutics, 303, 1052-1060. 
SILVERSTEIN, R.L. (1999). The Vascular Endothel ium. In Inflammation: Basic Principles 
and Clinical Correlates, ed. Gallin, J.L & Snyderman, R. pp. 207-225. Philadephia: 
Lippincott Williams & Wilkins. 
SMART, D ” GUNTHORPE, M.J., JERMAN, J.C., NASIR, S . � G R A Y , J., MUIR, A.L, CHAMBERS, 
J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a 
full agonist at the human vanilloid receptor (hVRl). British Journal of 
Pharmacology, 129, 227-230. 
SMITH, P J . & MCQUEEN, D.S. (2001). Anandamide induces cardiovascular and respiratory 
reflexes via vasosensory nerves in the anaesthetized rat. British Journal of 
Pharmacology, 134, 655-663. 
SOUTHALL, M.D., Ll, T., GHARIBOVA, L.S•，PEI, Y.，NICOL, G.D. & TRAVERS, J.B. (2003). 
Activation of epidermal vanilloid receptor-1 induces release of proinflammatory 
mediators in human keratinocytes. Journal of Pharmacology & Experimental 
Therapeutics, 304, 217-222. 
— 
References 
SPRINGER, J., GEPPETTI, P. , FISCHER, A . & G R O N E B E R G�D . A . (2003) . Calcitonin gene-
related peptide as inflammatory mediator. Pulmonary Pharmacology Therapeutics, 
16, 121-130. 
STANDER, S., MOORMANN, C., SCHUMACHER, M . � B U D D E N K O T T E , J . � A R T U C , M . � 
SHPACOVITCH, V. , BRZOSKA, T. , LIPPERT, U. , HENZ, B . M . , LUGER, T.A. , METZE, D. 
& STEINHOFF, M. (2004). Expression of vanilloid receptor subtype 1 in cutaneous 
sensory nerve fibers, mast cells, and epithelial cells of appendage structures. 
Experimental Dermatology, 13, 1 2 9 - 1 3 9 . 
STRONG, E .B . & G R E E N� J . F . (1991). Multireceptor activation of the pulmonary chemoreflex. 
Journal of Applied Physiology, 70, 3 6 8 - 3 7 0 . 
SZALLASI, A. (1994). The vanilloid (capsaicin) receptor: receptor types and species 
differences. General Pharmacology, 25, 223-243. 
SZALLASI, A. (1995). Autoradiographic visualization and pharmacological characterization 
of vanilloid (capsaicin) receptors in several species, including man. Acta 
Physiologica Scandinavica. Supplementum, 629, 1-68. 
SZALLASI, A. (1996). The Vanilloid Receptor. In Neurogenic Inflammation, ed. Geppetti, P. 
& Holzer, P. pp. 43-52. 
SZALLASI, A. (2002). Vanilloid (capsaicin) receptors in health and disease. American 
Journal of Clinical Pathology, 118, 110-121. 
SZALLASI, A. & BLUMBERG�P.M. (1999). Vanilloid (Capsaicin) receptors and mechanisms. 
Pharmacological Reviews, 51, 159-212. 
SZALLASI�A. & DL MARZO, V. (2000). New perspectives on enigmatic vanilloid receptors. 
Trends in Neurosciences, 23, 491-497. 
SZOLCSANYI, J. (2000). Anandamide and the question of its functional role for activation of 
capsaicin receptors. Trends in Pharmacological Sciences, 21, 203-204. 
SZOLCSANYI, J. (1996). Neurogenic inflammation: reevaluation of axon reflex theory. In 
Neurogenic Inflammation, ed. Geppetti, P. & Holzer, P. pp. 33-42.: CRC Press Inc. 
TAKEBA, Y., SUZUKI, N., KANEKO, A., A S A I � T . & SAKANE, T. (1999). Evidence for neural 
regulation of inflammatory synovial cell functions by secreting calcitonin gene-
related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis. 
Arthritis & Rheumatism, 42，2418-2429. 
TIRUPPATHI, C., MINSHALL, R.D., PARIA, B.C., VOGEL, S.M. & MALIK, A.B. (2002). Role 
of Ca2+ signaling in the regulation of endothelial permeability. Vascular 
Pharmacology, 39, 173-185. 
TOGNETTO, M. , AMADESI, S., HARRISON, S., CREMINON, C., TREVISANI, M. , CARRERAS, 
M ” MATERA, M. , GEPPETTI, P. & BIANCHI�A. (2001). Anandamide excites central 
~ “ m “ “ 
References 
� 
terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. Journal 
of Neuroscience, 2 1， 1 1 0 4 - 1 1 0 9 . 
UNDEM, B J . & KOLLARIK, M. (2002). Characterization of the vanilloid receptor 1 
antagonist iodo-resiniferatoxin on the afferent and efferent function of vagal sensory 
C-fibers. Journal of Pharmacology & Experimental Therapeutics, 303, 716-722. 
VAN HINSBERGH, V . W . & VAN NIEUW AMERONGEN, G.P. (2002). Intracellular signalling 
involved in modulating human endothelial barrier function. Journal of Anatomy, 200, 
549-560. 
VIEIRA, C., FETZER, S., SAUER, S.K., EVANGELISTA, S., AVERBECK, B., KRESS, M. , REEH, 
P .W. , CIRILLO, R.’ LIPPI, A ” MAGGI, C .A. & MANZINI, S. (2001). Pro- and anti-
inflammatory actions of ricinoleic acid: similarities and differences with capsaicin. 
Naunyn-Schmiedebergs Archives of Pharmacology, 364, 87-95. 
VON BANCHET, G.S., PETROW, P.K., BRAUER, R. & SCHAIBLE, H.G. (2000). Monoarticular 
antigen-induced arthritis leads to pronounced bilateral upregulation of the expression 
of neurokinin 1 and bradykinin 2 receptors in dorsal root ganglion neurons of rats. 
Arthritis Research, 2, 4 2 4 - 4 2 7 . 
WAGNER, J.A., VARGA, K . � J A R A I , Z. & KUNOS, G. (1999). Mesenteric vasodilation 
mediated by endothelial anandamide receptors. Hypertension, 33, 429-434. 
WAHL, P., FOGED, C . � T U L L I N , S. & THOMSEN, C. (2001). Iodo-resiniferatoxin, a new potent 
vanilloid receptor antagonist. Molecular Pharmacology, 59, 9-15. 
WANG, C., HAN, C., FISCUS�R.R. (1991). Calcitonin gene-related peptide (CGRP) causes 
endothelium-dependent cyclic AMP, cyclic GMP and vasorelaxant responses in rat 
abdominal aorta. Neuropeptides, 20, 115-24. 
WALLENGREN, J. (1997). Vasoactive peptides in the skin. Journal of Investigative 
Dermatology. Symposium Proceedings, 2, 49-55. 
WARDLE, K A . , RANSON, J. & SANGER�G.J . (1997). Pharmacological characterization of the 
vanilloid receptor in the rat dorsal spinal cord. British Journal of Pharmacology, 121, 
1012-1016. 
WEIDNER, C., KLEDE, M., RUKWIED, R.�LISCHETZKI, G., NEISIUS, U.’ SKOV, P.S., 
PETERSEN, L.J. & SCHMELZ�M. (2000). Acute effects of substance P and calcitonin 
gene-related peptide in human skin--a microdialysis study. Journal of Investigative 
Dermatology, 115, 1015-1020. 
WESTERMAN, R . A ” LOW, A., PRATT, A ” HUTCHINSON, J.S., SZOLCSANYI, J., MAGERL, W .� 
HANDWERKER, H.O. & K O Z A K � W . M . (1987). Electrically evoked skin 
vasodilatation: a quantitative test of nociceptor function in man. Clinical & 
Experimental Neurology, 23, 81-89. 
~~ “ 189 
References 
WHITE, R. & H I L E Y � C . R . (1997). A comparison of EDHF-mediated and anandamide-
induced relaxations in the rat isolated mesenteric artery. British Journal of 
Pharmacology, 122，1573-1584. 
WHITE, R., HO, W.S., BOTTRILL, F . E , FORD, W.R. & H I L E Y�C . R . (2001). Mechanisms of 
anandamide-induced vasorelaxation in rat isolated coronary arteries. British Journal 
of Pharmacology, 134，921-929. 
WiMALAWANSA, S.J. (1996). Calcitonin gene-related peptide and its receptors: molecular 
genetics, physiology, pathophysiology, and therapeutic potentials. Endocrine 
Reviews, 17, 533-585. 
WISE, H. & JONES, R. (2000). IP receptors in the vasculature, in Prostacyclin and its 
receptors, ed. pp. 137-188.: Kluwer academic/Plenum Publishers. 
WISSKIRCHEN, F.M., GRAY, D .W. & MARSHALL, I. (1999). Receptors mediating CGRP-
induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary 
artery differentiated by h(alpha) CGRP(8-37). British Journal of Pharmacology, 128, 
283-292. 
WOJCIAK-STOTHARD, B. & RIDLEY, A.J. (2002). Rho GTPases and the regulation of 
endothelial permeability. Vascular Pharmacology, 39, 187-199. 
YAKSH, T.L. (1988). Substance P release from knee joint afferent terminals: modulation by 
opioids. Brain Research, 458，319-324. 
YEON, D., KWON, S., LEE, Y . � L E E M , J., NAM, T. & AHN, D. (2001). Capsaicin-induced 
relaxation in rabbit coronary artery. Journal of Veterinary Medical Science, 63, 499-
503. 
YUAN, S.Y. (2002). Protein kinase signaling in the modulation of microvascular 
permeability. Vascular Pharmacology, 39, 213-223. 
ZYGMUNT, P.M., CHUANG, H., MOVAHED, P., J U L I U S � D . & HOGESTATT�E.D. (2000a). The 
anandamide transport inhibitor AM404 activates vanilloid receptors. European 
Journal of Pharmacology, 396, 39-42. 
ZYGMUNT, P.M., HOGESTATT, E .D .�WALDECK, K., EDWARDS, G., KIRKUP, A.J. & 
WESTON, A.H. (1997). Studies on the effects of anandamide in rat hepatic artery. 
British Journal of Pharmacology, 122, 1 6 7 9 - 1 6 8 6 . 
ZYGMUNT, P.M., JULIUS, L � D I MARZO, L & HOGESTATT, E.D. (2000b). Anandamide - the 
other side of the coin.[see comment]. Trends in Pharmacological Sciences, 21, 43-
44. 
ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A” CHUANG, H . � S O R G A R D , M., DI 
MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory 





•1圓11 ssLJBjqLn >|HnD 
